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Abstract
Many healthy women with no history of cognitive dysfunction experience subjective executive difficulties
during menopause. Indicators of risk for executive function difficulties at menopause are lacking, as is a
mechanistic understanding of how loss of estradiol unmasks this vulnerability. We hypothesized that adverse
childhood experiences (ACE) increase the risk of executive dysfunction during menopause via alterations in
monoaminergic neurotransmission. To test this hypothesis, we evaluated the effect of ACE on subjective and
objective measures of executive function as well as executive activation, functional connectivity, and
neurochemistry. We used tryptophan depletion (TD) and lisdexamfetamine (LDX) to probe serotonergic
and catecholaminergic function, respectively. High ACE women endorsed greater symptoms of executive
dysfunction and performed worse on tasks probing sustained attention and working memory. These negative
ACE effects were partially mediated by anxiety and depressive symptoms. ACE moderated the impact of TD
on DLPFC activation in hypogonadal women such that TD increased activation in high ACE participants but
decreased activation in low ACE participants. Importantly, treatment with estradiol attenuated the effects of
both ACE and TD. ACE similarly moderated the impact of TD on within-network connectivity. While ACE
was associated with lower within-network connectivity regardless of depletion condition, TD increased
connectivity in the high ACE group but had no effect on connectivity in the low ACE group. ACE also
moderated response to LDX. In the high ACE group, LDX (vs placebo) increased activation in the insula and
reduced symptoms related to difficulty with organization and activation for work. In contrast, response to
LDX was not significantly different from placebo in the low ACE group.
These results have several clinical and mechanistic implications. First, they highlight that addressing
concurrent mood changes is a critical step in treating menopause-induced executive difficulties. Second, this
work suggests that early life adversity has latent impacts on serotonergic circuits underlying executive function
that are unmasked by loss of estradiol during menopause. Third, they indicate that early adversity may have
lasting effects on catecholaminergic neurotransmission and may moderate response to stimulant medications.
Together, they emphasize the importance of considering ACE when treating executive difficulties with
pharmacologic agents during menopause.
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ABSTRACT 
 
IMPACT OF ADVERSE CHILDHOOD EXPERIENCES ON BEHAVIORAL AND 
NEURAL MARKERS OF EXECUTIVE FUNCTION IN MENOPAUSAL WOMEN 
Sheila Shanmugan 
Dr. C. Neill Epperson 
 
Many healthy women with no history of cognitive dysfunction experience subjective 
executive difficulties during menopause. Indicators of risk for executive function 
difficulties at menopause are lacking, as is a mechanistic understanding of how loss of 
estradiol unmasks this vulnerability. We hypothesized that adverse childhood 
experiences (ACE) increase the risk of executive dysfunction during menopause via 
alterations in monoaminergic neurotransmission. To test this hypothesis, we evaluated 
the effect of ACE on subjective and objective measures of executive function as well as 
executive activation, functional connectivity, and neurochemistry. We used tryptophan 
depletion (TD) and lisdexamfetamine (LDX) to probe serotonergic and catecholaminergic 
function, respectively. High ACE women endorsed greater symptoms of executive 
dysfunction and performed worse on tasks probing sustained attention and working 
memory. These negative ACE effects were partially mediated by anxiety and depressive 
symptoms. ACE moderated the impact of TD on DLPFC activation in hypogonadal 
women such that TD increased activation in high ACE participants but decreased 
activation in low ACE participants. Importantly, treatment with estradiol attenuated the 
effects of both ACE and TD. ACE similarly moderated the impact of TD on within-
network connectivity. While ACE was associated with lower within-network connectivity 
regardless of depletion condition, TD increased connectivity in the high ACE group but 
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had no effect on connectivity in the low ACE group. ACE also moderated response to 
LDX. In the high ACE group, LDX (vs placebo) increased activation in the insula and 
reduced symptoms related to difficulty with organization and activation for work. In 
contrast, response to LDX was not significantly different from placebo in the low ACE 
group.  
These results have several clinical and mechanistic implications. First, they 
highlight that addressing concurrent mood changes is a critical step in treating 
menopause-induced executive difficulties. Second, this work suggests that early life 
adversity has latent impacts on serotonergic circuits underlying executive function that 
are unmasked by loss of estradiol during menopause. Third, they indicate that early 
adversity may have lasting effects on catecholaminergic neurotransmission and may 
moderate response to stimulant medications. Together, they emphasize the importance 
of considering ACE when treating executive difficulties with pharmacologic agents during 
menopause. 
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CHAPTER 1  
	
	
General Introduction: Could Early 
Life Adversity Increase Risk for 
Executive Dysfunction during 
Menopause? 
 
  
2	
	
The Clinical Problem 
The menopause transition is marked initially by fluctuating levels of ovarian 
hormones and ends with an overall dearth of estrogen in the postmenopausal period 
(Burger et al., 2007; Henderson and Popat, 2011; Shanmugan and Epperson, 2014). 
During this transition, many women report experiencing a decline in cognitive function 
(Greendale et al., 2009; Mitchell and Woods, 2011), specifically in areas of memory and 
attention (Halbreich et al., 1995; Weber and Mapstone, 2009; Schaafsma et al., 2010; 
Mitchell and Woods, 2011). Recent reports have suggested that healthy women with no 
history of cognitive dysfunction experience increased difficulty with everyday tasks 
requiring executive processes such as working memory, focus, attention, organization, 
and planning (Epperson et al., 2011; Shanmugan and Epperson, 2014; Epperson et al., 
2015; Shanmugan et al., 2017). Evidence as to whether this midlife onset in cognitive 
decline can be attributed to the menopause transition is suggestive but not conclusive 
(Henderson and Popat, 2011). This variability in results across studies has traditionally 
been attributed to lack of consistency in the stages of menopause examined, covariates 
considered, and the use of cognitive measures with varying degrees of ecological 
validity (Luetters et al., 2007). A more recent hypothesis is that individual biological and 
environmental differences contribute to risk vs resilience for executive dysfunction with 
waning estradiol (Shanmugan and Epperson, 2014). In particular, there is preliminary 
evidence that adverse childhood experiences (ACE) including abuse, neglect, and 
household dysfunction may confer a vulnerability for executive difficulties that is revealed 
by loss of estradiol during menopause (Shanmugan and Epperson, 2014). This 
hypothesis is based on the negative impacts of ACE on executive functions and 
cognitive aging as well as the converging effects of estradiol and early life stress on 
monoaminergic function in the prefrontal cortex (PFC). 
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The Prefrontal Cortex: Location and Function 
Before discussing the effects of estradiol and early life adversity on the PFC at 
the neurotransmitter level, it is important to review the anatomical and working nature of 
the PFC. The PFC is located at the anterior of the frontal lobes of the brain and includes 
Brodmann’s areas 8, 9, 10, 11, 44, 45, 46, and 47 (Shanmugan and Epperson, 2014). 
The PFC is important for executive processes such as inhibiting distracting information 
and stimuli, planning, evaluating consequences when making decisions, and working 
memory. Working memory is often defined as the ability to keep desired or target 
information ‘‘online’’ and accessible as well as the ability to manipulate this information 
while being presented with new information that could serve as a distraction. Several 
clinical neuroimaging studies and preclinical studies in rodents and nonhuman primates 
have established the importance of the PFC in such behaviors. Rodents and monkeys 
with PFC lesions exhibit impaired performance on tasks requiring working memory 
(Butters and Pandya, 1969; Brito and Brito, 1990; Carlson et al., 1997; Chafee and 
Goldman-Rakic, 1998; Funahashi and Inoue, 2000; Lauwereyns et al., 2001; Chang et 
al., 2002; Baeg et al., 2003), reversal learning and flexibility (Rolls et al., 1996; Meunier 
et al., 1997; Dias and Aggleton, 2000; Chudasama and Robbins, 2003; Kim and 
Ragozzino, 2005; Floresco and Ghods-Sharifi, 2007; Rygula et al., 2010), and decision-
making (Mobini et al., 2002; Floresco and Ghods-Sharifi, 2007; Kim et al., 2008; 
Churchwell et al., 2009; Hauber and Sommer, 2009; Endepols et al., 2010; O'Neill and 
Schultz, 2010). In healthy human subjects, performing tasks requiring these processes, 
particularly working memory, increases blood oxygen level dependent (BOLD) signal in 
the PFC (Barch et al., 1997; Braver et al., 1997; D'Esposito et al., 1998; Callicott et al., 
1999; Clark et al., 2000; Diwadkar et al., 2000; Owen et al., 2005). The results of this 
research suggest that certain portions of the PFC are important for particular executive 
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functions. For example, the dorsal and lateral portions of the PFC are key in the 
regulation of attention, whereas the ventral and medial portions are important for 
emotional regulation (Arnsten, 2009). Optimal executive functioning and PFC regulation 
of subcortical brain structures are dependent upon prefrontal concentrations of 
monoamines, specifically dopamine (Arnsten, 2011), norepinephrine (Arnsten, 2011), 
and serotonin (5-HT) (Boulougouris and Tsaltas, 2008; Shanmugan and Epperson, 
2014). 
As suggested by Arnsten and colleagues, dopamine and norepinephrine exhibit 
an inverted U-shaped dose–response curve on PFC regulation of behavior (Arnsten, 
2009, 2011). When present at ideal levels, norepinephrine maintains network 
connectivity through the stimulation of postsynaptic α2A-receptors and dopamine inhibits 
inappropriate attention to stimuli through stimulation of D1 receptors (Arnsten, 2009, 
2011). Insufficient stimulation of these receptors at lower concentrations can lead to 
symptoms of executive dysfunction such as fatigue, distractibility, and impulsivity while 
the excessive D1 stimulation and inappropriate norepinephrine α1 and β1 stimulation 
that occur at higher neurotransmitter concentrations mimic symptoms of excessive 
stress such as mental inflexibility (Arnsten, 2009; Shanmugan and Epperson, 2014) 
 While serotonin also contributes to PFC modulation of executive function 
(Boulougouris and Tsaltas, 2008), its mechanisms of action are less well understood. 
Serotonin has a predominantly inhibitory effect on glutamatergic activity in the PFC (Puig 
and Gulledge, 2011). This inhibitory effect is driven by the 5-HT1A receptor, which 
reduces action potential generation at the cell body and axon of glutamatergic pyramidal 
neurons (Puig and Gulledge, 2011). The 5-TH1A receptor also acts as a presynaptic 
autoreceptor on projections from the dorsal raphe, inhibiting further release of serotonin 
(Li et al., 1999). Stimulation of the 5-TH1A receptor has been associated with improved 
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attentional control and decreased impulsivity (Carli et al., 2006; Puig and Gulledge, 
2011). Serotonin also binds to 5-HT2A receptors on the apical dendrites of pyramidal 
neurons, which increases membrane excitability and excitatory post-synaptic potentials 
(Puig and Gulledge, 2011). Simulation of these 5-HT2A receptors has been associated 
with worse cognitive flexibility (Carli et al., 2006), reversal learning (Boulougouris et al., 
2008; Boulougouris and Tsaltas, 2008), and impulsivity (Carli et al., 2006; Puig and 
Gulledge, 2011). These seemingly paradoxical effects result in serotonin inhibiting the 
activity of individual neurons while increasing the coherence of networks of neurons in 
the PFC (Puig and Gulledge, 2011).  
 Evidence supporting the withdrawal of estrogen modulation of these prefrontal 
monoaminergic systems as one mechanism leading to decline in executive functions will 
be discussed further below. 
 
Estradiol’s effect on executive function 
Subjective cognitive complaints, particularly in areas of memory and attention, 
are commonly reported by women transitioning through menopause (Halbreich et al., 
1995; Weber and Mapstone, 2009; Schaafsma et al., 2010; Epperson et al., 2011; 
Mitchell and Woods, 2011; Epperson et al., 2015; Shanmugan et al., 2017). Mitchell and 
Woods (Mitchell and Woods, 2011) found that 60% of their sample of menopausal 
women reported experiencing increasing memory problems while 79% of menopausal 
women in another sample reported experiencing memory loss (Weber and Mapstone, 
2009). Rodent and non-human primate studies have suggested that this midlife cognitive 
decline can be attributed to the loss of estradiol experienced during the menopause 
transition. Estrogen, alone or in combination with progesterone, has been shown to be 
successful in correcting ovariectomy induced impairments in spatial working memory 
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and recognition memory consolidation, pre-clinical proxies for executive function (Rapp 
et al., 2003; Inagaki et al., 2010). In a delayed response test of spatial working memory, 
estrogen replacement reversed cognitive impairments associated with cognitive aging in 
intact aged female rhesus monkeys, while ovariectomy worsened the same symptoms 
(Rapp et al., 2003; Shanmugan and Epperson, 2014). Enhanced performance on 
working memory tasks in ovariectomized nonhuman primates receiving estradiol is 
thought to be in part due to estradiol-induced increases in dendritic spine density and the 
number of smaller, more motile dendritic spines thought to be important for synaptic 
plasticity (Rapp et al., 2003; Hao et al., 2007).  
 
ACE effects on executive function 
Unlike other cognitive domains, the executive system undergoes a protracted 
period of development that extends into young adulthood, making it particularly 
susceptible to the effects of early life adversity (Pechtel and Pizzagalli, 2011). The high 
density of glucocorticoid receptors and dopaminergic inputs make the PFC especially 
vulnerable (Brake et al., 2000; Pechtel and Pizzagalli, 2011). Inhibitory control and 
cognitive flexibility develop more slowly in preschool-aged children with less access to 
learning resources (Clark et al., 2013; Shanmugan and Satterthwaite, 2016). 
Impairments in inhibitory control (Navalta et al., 2006; Mueller et al., 2010) and PFC 
hyperactivation (Mueller et al., 2010) have also been observed in adolescents with high 
levels of early life stress (Mueller et al., 2010) as well as adult women with a history of 
sexual abuse (Navalta et al., 2006; Pechtel and Pizzagalli, 2011). A longitudinal 
neuroimaging study found an interactive effect of socioeconomic status and sex on both 
behavior and brain function, but no effect of socioeconomic status or sex alone 
(Spielberg et al., 2015; Shanmugan and Satterthwaite, 2016), highlighting the relevance 
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of considering interactions between early adversity and estradiol on neural function. This 
study suggested that inhibitory processing in the DLPFC is less efficient in females of 
lower socioeconomic status than those of higher socioeconomic status (Spielberg et al., 
2015). The negative effects of early life stress on executive function last into adulthood. 
In healthy adults, early trauma has been associated with poorer working memory 
performance (Philip et al., 2016), executive system hyperactivation during a working 
memory task (Philip et al., 2016), and decreased functional connectivity within networks 
at rest (Philip et al., 2013). Findings from rodent studies have suggested that the impact 
of early life stress on later cognitive functions may become particularly acute during 
middle-age (Brunson et al., 2005). Significant adversity during childhood has similarly 
been associated with sub-optimal cognitive aging in human participants (Kremen et al., 
2012; Zhang et al., 2016). Together, these studies suggest that early life adversity alters 
the developmental trajectory of executive functions, which may result in heightened 
vulnerability to executive dysfunction with loss of estradiol. Reviewing the mechanisms 
by which estradiol and ACE impact monoaminergic systems is necessary to understand 
why the effects of ACE may be particularly acute during the menopause transition. 
 
Estradiol effects on prefrontal catecholamine systems 
Estradiol modulates PFC concentrations of dopamine and norepinephrine, 
catecholamines crucial for executive functioning (Arnsten, 2011). Previous studies have 
demonstrated that treatment with 17b-estradiol both improves memory consolidation and 
regulates dopaminergic and noradrenergic neurotransmission in the rodent PFC. In 
rodents, estradiol treatment improves memory consolidation and raises concentrations 
of 3-Methoxy-4-hydroxyphenylglycol (metabolite of norepinephrine) and 3,4-
Dihydroxyphenylacetic acid (metabolite of dopamine) in the PFC (Inagaki et al., 2010). 
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Estrogen benzoate or ERb agonist-induced elevations in prefrontal dopamine and 
norepinephrine metabolites are accompanied by improvements in recognition memory in 
ovariectomized rats (Jacome et al., 2010). However, treatment with significantly higher 
or lower doses of estradiol does not improve memory consolidation in ovariectomized 
rats despite increases in neurotransmitter levels observed at higher doses, indicating 
that estrogen’s effects on cognition are dose dependent (Inagaki et al., 2010). 
Estrogen also modulates these catecholaminergic systems through enzymatic 
regulation of transmitter metabolism. In female rats, OVX or treatment with tamoxifen, an 
estrogen antagonist, has been shown to elevate PFC protein expression and enzyme 
activity of catechol-o-methyl transferase (COMT), an enzyme involved in dopamine and 
norepinephrine metabolism (Schendzielorz et al., 2011). Jacobs and D’Esposito (2011) 
showed that the relationship between BOLD signal in the medial frontal gyrus (MFG) 
during performance of a working memory task (N-back task) and estradiol levels are 
dependent on catecholaminergic tone, as determined by COMT Val158Met genotype 
and enzyme activity. In this study, premenopausal women with the genotype Val/Val had 
greater COMT enzyme activity, and therefore metabolized dopamine more quickly, 
compared to women who were homozygous for the Met allele. Performance on the N-
back task as well as MFG activation exhibited an inverted U-shaped curve dependent on 
both genotype and estradiol level. Women who were homozygous for the Val allele 
showed better working memory performance and increased MFG activation when 
estradiol levels were high compared with when estradiol levels were low, presumably 
because the increase in estradiol increased dopamine to optimum levels. The opposite 
was true of women with the genotype Met/Met. In their case, the increase in estradiol 
resulted in overly heightened PFC dopamine levels, pushing them to the right side of the 
inverted U-shaped curve and impairing executive functioning (Jacobs and D'Esposito, 
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2011). This literature suggests withdrawal of estrogen modulation of prefrontal 
catecholamine systems during menopause may be one mechanism leading to decline in 
executive functions (Shanmugan and Epperson, 2014). 
 
ACE effects on prefrontal catecholamine systems 
Maternal deprivation and separation paradigms have been used to model early 
life stress in rodents. In these rodent models of early life stress, adversity results in an 
increase in PFC dopamine turnover (Matthews et al., 2001; Rentesi et al., 2013) and 
may lower dopamine levels in comparison to controls (Rentesi et al., 2013). Rodents 
exposed to early life stress are more sensitive to the effects of d-amphetamine 
(Zimmerberg and Shartrand, 1992; Rentesi et al., 2013), a stimulant that increases 
concentrations of dopamine and norepinephrine, as well as apomorphine (Daskalakis et 
al., 2012; Rentesi et al., 2013), a dopamine agonist. Early stress also decreases 
dopamine D2 receptor expression in the PFC (Rentesi et al., 2013). Similarly, in 
nonhuman primates, early and life-long stress in the form of social subordination results 
in decreased D2 receptor function accompanying stressed behaviors in female monkeys 
(Shively, 1998).  
Evidence from human participants suggests the consequences of these changes 
in neurotransmission manifest early in life. A large longitudinal study recently found that 
a child’s executive functioning is determined by the interaction between genotype for 
COMT and history of early life adversity (Blair et al., 2015). This study found that 
between the ages of 3 and 5, the presence of early life adversity was associated with 
poorer executive function. Additionally, there was a COMT genotype x early life adversity 
interaction on the trajectory of executive functioning development during this time. In 
children with low levels of adversity, Val/Val children initially performed better on 
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executive functioning tasks, but children with a Met allele improved faster. In contrast, 
children with a Met allele and high levels of adversity demonstrated the slowest 
executive development, resulting in the lowest performance levels at 5 years of age 
among the four groups (Val/Val low adversity = Val-Met/Met-Met low adversity > Val/Val 
high adversity > Val-Met/Met-Met high adversity) (Blair et al., 2015). 
These studies demonstrate that estradiol and early life adversity act on common 
molecular targets involved in catecholamine function and suggest that exposure to high 
levels of early life adversity may result in heightened vulnerability to loss of estradiol 
modulation of catecholamine function. 
 
Estradiol effects on serotonin 
Rodent and non-human primate studies have demonstrated that estradiol has 
profound impacts on serotonin function at the gene, enzyme, and receptor level. (Amin 
et al., 2005). Estradiol treatment increases serotonin concentration (Inagaki et al., 2010), 
synthesis (Cone et al., 1981), release (Cone et al., 1981) and turnover (Di Paolo et al., 
1983), increases gene expression of tryptophan hydroxylase (the rate limiting enzyme in 
serotonin synthesis) (Pecins-Thompson et al., 1998), increases serotonin transporter 
binding (Fink et al., 1999), and increases serotonin receptor 2A mRNA and binding (Cyr 
et al., 1998; Fink et al., 1999; Amin et al., 2005). Using the tryptophan depletion (TD) 
paradigm, Epperson et al. (2012) provided novel evidence for estrogen by serotonin 
interactions during working memory in menopausal women. In this study, the TD 
paradigm was used to lower central serotonin levels in healthy menopausal women 
before and after treatment with transdermal estradiol. During the 2-back task, TD was 
associated with a decrease in BOLD signal in the right and left DLPFC and middle 
frontal/cingulate gyrus prior to estradiol treatment. This attenuation in BOLD was 
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prevented by estradiol treatment, suggesting that estradiol’s effects on brain activation 
during working memory are in part via estradiol’s effects on serotonergic function 
(Epperson et al., 2012; Shanmugan and Epperson, 2014). 
 
ACE effects on serotonin 
Preclinical studies have shown that early life adversity exerts lasting effects on 
the serotonin system (Comasco et al., 2013; van der Doelen et al., 2014a; van der 
Doelen et al., 2014b; van der Doelen et al., 2015), suggesting the interaction between 
these factors may further exacerbate executive difficulties during hypogonadism. In 
rodent models of early life stress, maternal deprivation results in a decrease in serotonin 
levels in the PFC (Matthews et al., 2001; Rentesi et al., 2013) as well as an increase in 
serotonin turnover (Masis-Calvo et al., 2013; Rentesi et al., 2013; Wong et al., 2015). 
Early life adversity also decreases tryptophan hydroxylase type 2, the rate-limiting 
enzyme in serotonin synthesis (Bethea et al., 2008) and increases monoamine oxidase-
A (Wong et al., 2015), an enzyme involved in serotonin metabolism. Early life stress also 
attenuates 5-HT1A receptor function (Wong et al., 2015) and decreases 5-HT2A 
receptor expression (Rentesi et al., 2013) in the prefrontal cortex of adult rats. 
Furthermore, low serotonin levels have been shown to exacerbate the negative effects 
of early life stress on impulsivity in adult mice (Sachs et al., 2013). This literature 
indicates that estradiol and early life stress act on common serotonergic targets at the 
molecular level and suggests that one mechanism by which early life adversity increases 
risk for executive dysfunction during menopause may be via decreased serotonin 
concentration and receptor function.  
 
Overview of original research chapters  
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The overarching purpose of this dissertation is to determine whether early life 
adversity is a risk factor for executive function difficulties during menopause and to 
examine the impact of ACE on monoaminergic function during this hormonal transition. 
To answer this question, we use behavioral and neuroimaging data from 3 separate 
samples of menopausal women with high and low levels of early life adversity. 
First, we sought to determine whether ACE confers a risk for executive 
dysfunction during menopause. In chapter 2, we use behavioral data from a large 
sample of women who underwent surgical menopause to establish the impact of ACE on 
subjective and objective measures of executive function. We demonstrate that ACE is 
associated with greater symptoms of executive dysfunction as well as poorer task 
performance. Importantly, we show that these effects of ACE are partially mediated by 
anxiety and depression symptoms. 
The strong associations between ACE and mood symptoms in chapter 2 
suggested to us that ACE is likely associated with suboptimal serotonergic function. 
Given the previous work from our lab demonstrating the importance of intact 
serotonergic function to working memory function during menopause (Epperson et al., 
2012) as well as the converging effects of estradiol and early life stress on common 
serotonergic targets at the molecular level, we hypothesized that one mechanism by 
which ACE exerts a negative impact on executive function during periods of low estradiol 
may be via effects on serotonin. 
To test this hypothesis, we used functional magnetic resonance imaging and 
tryptophan depletion (TD), a paradigm used to lower central serotonin levels. We 
hypothesized that ACE would be associated with executive hyperactivation and that TD 
would exacerbate differences between ACE groups. However, given that previous 
studies have shown that TD may improve sustained attention and response inhibition 
13	
	
(Schmitt et al., 2000; Booij et al., 2005; Scholes et al., 2007), our competing hypothesis 
was that TD would attenuate differences in ACE groups. The common theme underlying 
both of these hypotheses is that, because early adversity negatively impacts multiple 
aspects of serotonergic function, the serotonin system of high ACE individuals would be 
more “vulnerable” to experimental manipulations affecting serotonin, resulting in 
differential response to TD. 
In chapter 3, we present data consistent with our competing hypothesis. We 
show that in the absence of exogenous estradiol, TD increases DLPFC activation in high 
ACE subjects but decreases DLPFC activation in low ACE subjects. Importantly, 
treatment with estradiol attenuates the effects of both ACE and TD. Given that the TD x 
ACE interaction on BOLD signal, while consistent with our competing hypothesis, was 
not as initially predicated, we chose to further probe this finding by examining whether 
ACE and TD would show similar effects on a different neural marker of executive 
function: functional connectivity. 
In chapter 4, we residualize task effects to obtain an approximate resting state 
timeseries. Using this pseudo-resting state, we examine the impact of ACE and TD on 
within-network connectivity, a measure shown to underlie executive functions across the 
lifespan (Betzel et al., 2014; Chan et al., 2014; Tsvetanov et al., 2016). We predicted 
that ACE would be associated with lower within-network connectivity. We also initially 
predicted that TD would further lower connectivity in women with high levels of early 
adversity but have no effect in in women with low levels of early adversity. However, 
given the results of chapter 3, we strongly considered the competing hypothesis that TD 
would attenuate differences between ACE groups by selectively increasing connectivity 
in the high ACE group. This was in fact what we found. We demonstrate that ACE is 
associated with lower within-network connectivity regardless of depletion condition. We 
14	
	
also show that TD increases connectivity in the high ACE group but has no effect on 
connectivity in the low ACE group. 
We first examined whether serotonergic differences contribute to ACE effects on 
executive function because results of chapter 2 indicated that ACE likely alters 
serotonergic function and because previous work from our lab (Epperson et al., 2012) 
indicated that the serotonin system may be vulnerable to additional insults during 
periods of low estradiol. However, as reviewed earlier in the introduction, ACE likely 
affects executive function via multiple mechanisms involving monoamine 
neurotransmission.  
Therefore, we next examined the impact of ACE on dopaminergic and 
noradrenergic function in menopausal women with subjective cognitive complaints. 
Because rodent studies have demonstrated that early life stress may increase sensitivity 
to amphetamine, we chose to use a stimulant medication as our pharmacological probe. 
We specifically selected lisdexamfetamine (LDX), because this medication successfully 
improves subjective measures of executive function in menopausal women with self-
reported new-onset executive difficulties (Epperson et al., 2015). 
Previous studies have shown that stimulant medications increase activation in 
executive regions, including the insula (Rubia et al., 2014) and DLPFC (Wong and 
Stevens, 2012) in subjects with attention deficit hyperactivity disorder (ADHD). 
Stimulants have also been shown to decrease glutamate levels in the PFC of children 
with ADHD (Wiguna et al., 2012). However, no brain imaging studies examining the 
effect of LDX on brain activation or neurochemistry have been performed. Therefore, 
before examining whether ACE alters response to this drug, we first characterize the 
impact of LDX on executive activation and neurochemistry in chapter 5. Results from 
chapter 5 demonstrate that LDX improves subjective symptoms of executive 
15	
	
dysfunction, increases insula activation, and decreases DLPFC glutamate. In chapter 6, 
we examine whether ACE moderates the impact of LDX on these outcomes and 
demonstrate that ACE is a moderator of both behavioral and brain response to LDX. 
 In summary, this body of work seeks to address why many healthy women with 
no history of cognitive dysfunction experience executive difficulties during the 
menopause transition. Indicators of risk for executive function difficulties at menopause 
are currently lacking, as is an understanding of the mechanisms contributing to this 
vulnerability with diminishing estradiol. Therefore, in the following chapters I will examine 
early life adversity as a risk factor for this decline and explore potential mechanisms by 
which early adversity confers this vulnerability to executive dysfunction with loss of 
estradiol. 
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Abstract 
Objective: Many women who undergo risk reduction salpingo-oophorectomy (RRSO) to 
reduce risk of breast and ovarian cancers experience onset of executive dysfunction. 
Adverse childhood experiences (ACE) may be one factor contributing to risk vs 
resilience for executive dysfunction after oophorectomy. Here the authors examined the 
effect of ACE on subjective and objective measures of executive function in women who 
underwent RRSO. The authors hypothesized that ACE would be associated with poorer 
executive function and that these effects would be mediated by mood symptoms. 
Method: The authors studied 552 women who completed cognitive testing after RRSO at 
up to two time points (857 sessions total). Cognitive tasks included the Continuous 
Performance Task and letter n-back task to probe sustained attention and working 
memory, respectively. The ACE questionnaire was used to assess early life adversity. 
ACE effects on task performance and subjective symptoms of executive dysfunction 
were examined using generalized estimating equations. Mood (anxiety/depressive) 
symptoms were evaluated as a mediator of ACE effects on these outcomes. 
Results: ACE was associated with more symptoms of executive dysfunction and worse 
performance on both cognitive tasks. Mood symptoms were a partial mediator of ACE 
effects on sustained attention and subjective report of executive dysfunction.  
Conclusions: These data suggest that early life adversity is associated with increased 
risk of executive dysfunction after RRSO and that the negative effects of early adversity 
on executive function are in part mediated by mood symptoms, highlighting the 
importance of assessing anxiety and depressive symptoms in women who have 
undergone RRSO.  
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Introduction 
Women with mutations in breast cancer type 1 or 2 susceptibility genes (BRCA1 
and BRCA2) are at increased risk for developing breast and ovarian cancers (Finch et 
al., 2012). Risk reduction salpingo-oophorectomy (RRSO) by 35 – 40 years of age is the 
standard of care (Muto, 2015) and up to 90% of BRCA carriers undergo RRSO (Finch et 
al., 2012). While this procedure reduces the risk of ovarian cancer by 85-95% and the 
risk of breast cancers by 53-68% (Guidozzi, 2016), there are several consequences of 
being hypogonadal at such an early age.  
Given that ovarian hormones such as estradiol and progesterone have numerous 
neuromodulatory and neuroprotective effects (Shanmugan and Epperson, 2014), recent 
studies have examined RRSO as a potential risk for central nervous system (CNS) 
impairment and overall decline in quality of life. For example, large cohort studies have 
shown that women who undergo oophorectomy before natural menopause are at 
increased risk of dementia (Rocca et al., 2007) and cognitive dysfunction during and 
after the seventh decade of life (Rocca et al., 2007; Ryan et al., 2014). More specifically, 
the largest declines in cognitive performance following oophorectomy occur in executive 
functioning domains (Kurita et al., 2016). This post-oophorectomy onset of executive 
difficulties may be a result of reduced estradiol modulation of brain regions such as the 
prefrontal cortex (PFC) that are critical to proper executive processes such as working 
memory, organization, focus, and sustained attention (Epperson et al., 2011; 
Shanmugan and Epperson, 2014; Epperson et al., 2015; Shanmugan et al., 2017).  
Executive functioning capacity depends on the neurochemical environment in the 
PFC. Optimal executive function is maintained by a balance of factors in this region 
including dopamine, norepinephrine, and glutamate concentration and receptor function 
(Arnsten and Jin, 2014) as well as hormonal status (Jacobs and D'Esposito, 2011; 
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Shanmugan and Epperson, 2014). However, previous research has shown that 
significant adverse childhood experiences (ACE) not only alter the developmental 
trajectory of the executive system (Shanmugan and Satterthwaite, 2016) but also have 
lasting impacts on dopaminergic (Kasanova et al., 2016), noradrenergic (Zitnik et al., 
2016), and glutamatergic (Llorente et al., 2012) function, which may leave the individual 
vulnerable to cognitive changes during periods of low estradiol such as after RRSO 
(Shanmugan and Epperson, 2014).  
Together, these studies suggest that premature, abrupt loss of estradiol with 
RRSO induces executive function difficulties in many, but not all, hypogonadal women 
and that ACE may be one factor contributing to risk vs resilience for executive 
dysfunction after oophorectomy. However, no studies examining the effect of ACE on 
executive function after RRSO have been performed. Early life adversity has also been 
shown to increase risk for mood disorders during natural menopause (Epperson et al., In 
Press), and mood symptoms have been independently associated with executive 
dysfunction (Shanmugan et al., 2016). As such, it is not clear to what extent ACE effects 
on mood symptoms drive ACE effects on executive function in hypogonadal women.  
Here we examined the effect of ACE on subjective and objective measures of 
executive function while rigorously controlling for multiple possible confounding variables 
in 552 women who underwent RRSO. We hypothesized that high levels of early life 
adversity would be associated with greater self-reported symptoms of executive 
dysfunction as well as poorer performance on neuropsychological tasks probing 
executive function. Furthermore, we hypothesized that these ACE effects on executive 
function would be partially mediated by ACE effects on mood symptoms. 
 
Method 
29	
	
Participants 
Subjects were recruited through mailings from the Cancer Risk Evaluation 
Program at the University of Pennsylvania, through local advertising, and through an 
advocacy group for women with genetic risk for breast and ovarian cancer (FORCE; 
Facing Our Risk of Cancer Empowered). Women over the age of 30 at high risk for 
breast or ovarian cancer who had undergone RRSO were eligible to participate. 
Exclusion criteria included inability to provide informed consent.  
Subjects completed online surveys through Qualtrics. These surveys assessed 
mood, subjective and objective cognition, menopausal symptoms and related quality of 
life measures, early life adversity, and medication use. Subjects were asked to repeat 
the survey after 1 year. In this report, we consider the sample of subjects from this 
cohort that completed one or more outcomes of interest at least once.  
 
Assessment of subjective executive function 
Subjective symptoms of executive dysfunction were evaluated using a modified 
version of the 40-item Brown Attention Deficit Disorder Scale (BADDS), a validated 
subjective measure of executive function (Sandra Kooij et al., 2008) that assesses the 
frequency and severity of five domains of executive dysfunction: (1) organization and 
activating for work, (2) sustaining attention and concentration, (3) sustaining alertness, 
effort, and processing speed, (4) managing affective interference, and (5) using working 
memory and accessing recall. The original version of the BADDS was adapted for online 
use. Each item is rated on a scale from 0 to 3. Higher scores are indicative of more 
dysfunction. Total BADDS score served as the primary measure of subjective executive 
function, while BADDS subscales were secondary outcome measures. 
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Assessment of objective executive function  
As part of a comprehensive computerized cognitive battery, (Gur et al., 2010) 
subjects completed two neuropsychological tasks probing executive domains. In this 
report, we specifically focused on measures related to executive functions given the 
converging evidence for the effects of estradiol and early life stress on this domain 
(Shanmugan and Epperson, 2014; Shanmugan and Satterthwaite, 2016). The Penn 
Continuous Performance Task (CPT) number and letter version (Kurtz et al., 2001) was 
used to assess sustained attention. During the task, subjects were instructed to respond 
when the image seen was a complete letter or number. The primary measure of 
sustained attention was d’, a signal detection metric that limits the influence of response 
bias.  
 A letter version of the n-back task (Ragland et al., 2002) was used to probe 
working memory function across four conditions that placed varying demands on 
working memory load: 0-back, 1-back, 2-back and 3-back. Stimuli were 4-letter non-
words without vowels. In the 0-back condition, participants responded with a button 
press to a pre-specified target 4-letter stimulus, while subjects responded to a stimulus 
“n” number of stimuli before it in all other conditions. Because the 3-back condition 
places the greatest demands on working memory load, 3-back d’ served as the primary 
measure of working memory.  
 
Assessment of early life adversity 
The Adverse Childhood Experiences (ACE) Questionnaire (Felitti et al., 1998) 
was used to assess history of child abuse, childhood neglect, and household 
dysfunction. The ACE questionnaire has been widely used to assess the association 
between early life stress and health-related outcomes in adult life (Felitti et al., 1998). 
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Using the ACE questionnaire allowed us to consider the effects of overall early life 
adversity as a predictor of cognitive dysfunction rather than examining the 
consequences of a particular trauma or stressor.  The number of exposures was 
summed to create the ACE score (range: 0–10). Based on evidence from prior studies 
indicating increased risk of depressive disorders in later life in subjects with 2 or more 
ACEs (Chapman et al., 2004; Epperson et al., In Press), we considered subjects with an 
ACE score ≥ 2 “high ACE” and subjects with an ACE score of < 2 “low ACE”.  
 
Assessment of mood symptoms 
 Presence of depressive and anxiety symptoms was assessed using the 14-item  
Hospital Anxiety and Depression Scale. This scale contains a 7-item depression 
subscale that assesses changes in mood, loss of interest, and psychomotor slowing and 
a 7-item anxiety subscale that assesses mental agitation and psychological distress. 
Each item is rated on a scale of 0 to 3. In line with prior studies of executive functions 
that have represented anxiety and depressive symptoms as a composite “mood” score 
(Shanmugan et al., 2016), total scores on the depression and anxiety subscales were 
summed to create a composite measure of mood symptoms. 
 
Statistical analyses 
Generalized estimating equations implemented using the geepack package 
(HÃ¸jsgaard et al., 2006) in R (R Core Team, 2015) were employed to evaluate the 
effect of ACE on executive outcomes. This method accommodates multiple survey 
assessments per woman, and adjusts for non-independence of these repeated 
measures.  Age, time since oophorectomy, and age at oophorectomy were assessed as 
possible covariates. However, at baseline, age was highly correlated with both age at 
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oophorectomy (r=0.85, p<0.0001) and time since oophorectomy (r=0.49, p<0.0001). To 
fully account for the effects of age on cognitive outcomes, generalized estimating 
equations with cognitive measures as the outcomes and age as the predictor were used 
to obtain age-residualized scores for the BADDS, CPT, and n-back outcomes. 
Subsequent analyses were performed on these residuals rather than raw values. Time 
without hormones (a summary of time since oophorectomy and duration of hormone 
therapy use, if any), education level, and history of chemotherapy use were included as 
covariates in all models. Significance was defined as p<=0.05. 
Mediation models were used to examine whether ACE confers a risk for 
executive dysfunction after RRSO via increased mood symptoms. The three primary 
outcome measures served as the dependent variable in 3 separate analyses. Total ACE 
served as the independent variable, while the composite mood score served as the 
mediator. The indirect effect was estimated using the Product of Coefficients approach 
followed by significance testing using a bootstrap resampling approach implemented 
with the boot package (Canty and Ripley, 2016) using ordinary nonparametric 
bootstrapping and 2,000 iterations. 
Psychotropic medication use served as an additional covariate in supplemental 
analyses of primary outcome variables. Supplementary analyses also examined the 
effects of ACE in the subset of women who had undergone oophorectomy prior to age 
47.4, 2 standard deviations (1 SD=2.26 years) below the average age (51.9 years) of 
post-menopause onset (Freeman et al., 2012). To evaluate whether timing of adversity 
was driving results, we also separately examined the effects of pre-pubertal ACE and 
post-pubertal ACE on primary outcome measures. Puberty was defined as 2 years prior 
to menstrual cycle onset. 
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Results 
Participants 
Eight hundred subjects completed cognitive testing at baseline and were eligible 
for inclusion in this report. Of these 800 subjects, 453 repeated cognitive testing after 1 
year, yielding a total of 1,253 sessions that were eligible for inclusion. Sessions included 
in analyses must have completed at least one outcome of interest (n=1,058). Sessions 
missing information regarding age at testing (n=16), hormone therapy use (n=165), ACE 
(n=12), education level (n=8), and mood symptoms (n=30) were excluded. As part of 
data quality assurance, subjects who performed below chance (<50% true positives) on 
the CPT were excluded from analyses of the CPT (n=20). Similarly, subjects who 
performed below chance (<5 true positive responses) on the 0-back control condition 
were excluded from analyses of the n-back (n=13). The final sample included in 
analyses was 552 subjects (Table 2-1; Figure 2-1). Complete data for at least one 
outcome measure and all primary covariates were obtained on 494 subjects at baseline 
and 363 subjects at the 1-year follow-up session, yielding a total of 857 sessions 
included in analyses. 
 
 ACE effects on executive function 
ACE was associated with higher total BADDS score (β= 7.1, p=0.0005) (Figure 
2-2a) as well as each BADDS subscale (organization/activation for work, β=1.7, p= 
0.002; attention/concentration, β=1.8, p=0.001; alertness/effort/processing speed, β=1.4, 
p=0.004; managing affective interference, β=1.3, p=0.0007; working memory/accessing 
recall, β=0.8 p=0.03) (Figure 2-2b). The high ace group also performed worse on both 
the n-back (β=-0.17, p=0.007) (Figure 2-3a) and CPT (β=-0.1, p=0.03) (Figure 2-3b) in 
comparison to the low ACE group. Chemotherapy use also had a negative impact on 
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sustained attention (β=-0.17, p=0.006). Time in a hypogonadal state was not significantly 
associated with any outcome measure.  
 
Mood symptoms mediate ACE effects on executive function 
We conducted mediation analyses to determine whether ACE effects on 
executive function are mediated by ACE effects on mood symptoms. Mood symptoms 
partially mediated the relationship between ACE and total BADDS score (Figure 2-4a). 
After accounting for the effects of previous chemotherapy use, education, and length of 
time hypogonadal, ACE was significantly associated with mood symptoms (β=2.1, 
p=0.0003) and mood symptoms were significantly associated with age-residualized total 
BADDS scores (β=2.1, p<0.0001). ACE continued to be associated with total BADDS 
scores when mood symptoms were included as a covariate (β=2.8, p=0.08). Mood 
symptoms mediated 62.8% (95% CI:  42.3% - 100%) of ACE effect on total BADDS 
score. 
Mood symptoms partially mediated ACE effects on sustained attention (Figure 2-
4b). ACE was significantly associated with higher mood symptoms (β=2.1, p=0.0002) 
and mood symptoms were significantly negatively associated with age-residualized CPT 
d’ (β=-0.01, p=0.001). ACE continued to be associated with CPT d’ when mood 
symptoms were included as a covariate (β=-0.09, p=0.08). Mood symptoms mediated 
21.3% (95% CI:  9.3% - 100%) of ACE effects on CPT d’. 
In contrast to the role of mood symptoms as a mediator of ACE effects on 
subjective executive function and sustained attention, mood symptoms did not mediate a 
significant proportion of the relationship between ACE and working memory performance 
(95% CI: -1.4%  – 50%) (Figure 2-4c). However, ACE effects on n-back d’ remained 
significant when mood symptoms were included as a covariate (β=-0.16, p=0.01). 
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Supplementary analyses 
ACE effects on subjective executive function (β=6.1, p=0.002), sustained 
attention (β=-0.11, p=0.03), and working memory (β=-0.16, p=0.01) were similar when 
controlling for use of psychoactive medications. Results were also similar in the subset 
of women who underwent oophorectomy before age 47.4 (total BADDS, n=353, β =8.4, 
p=0.0008; CPT d’, n=350, β = -0.12, p=0.06; n-back d’, n=382, β = -0.16, p=0.06). While 
pre-pubertal ACE was associated with significantly more subjective executive difficulties 
(β=5.6, p=0.03), post-pubertal ace was not. In contrast, post-pubertal ACE was 
associated with worse sustained attention (β=-0.24, p=0.006), while pre-pubertal ACE 
was not. Pre-pubertal ACE (β=-0.13, p=0.08) and post-pubertal ACE (β=-0.22, p=0.07) 
were both associated with poorer working memory. 
 
Discussion 
In this large study of cognitive function in women who underwent RRSO, we 
examined associations between early life adversity and subjective and objective 
measures of executive function. To account for the fact that early adversity is associated 
with increased risk of mood disorders with loss of estradiol, we conducted mediation 
analyses to determine the extent to which ACE effects on executive function result from 
concurrent mood changes. Women with high levels of early life adversity reported more 
symptoms of dysfunction across executive domains. High ACE women also performed 
worse on executive tasks probing sustained attention and working memory. While mood 
symptoms partially mediated ACE effects on sustained attention and subjective report of 
executive dysfunction, the associations between ACE and poorer subjective and 
objective measures of executive function remained present after accounting for the 
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effects of anxiety and depression symptoms. Taken together, these data emphasize that 
early life adversity is associated with increased risk of executive dysfunction after RRSO. 
 
Evidence for ACE effects on executive function 
As predicted, we found that ACE was associated with greater subjective report of 
executive dysfunction as well as poorer performance on neuropsychological tasks of 
executive function. Several studies have demonstrated early life adversity is associated 
with poorer executive function during childhood and adolescence (Hostinar et al., 2012; 
Loman et al., 2013; Heyman and Hauser-Cram, 2015) and that this negative effect 
persists into adulthood (Philip et al., 2016).  For example, a study of 90 young children 
found that early psychosocial deprivation was associated with lower composite scores of 
executive function after controlling for IQ (Hostinar et al., 2012). Such deprivation has 
been associated with slower neural responses and attentional processing in older 
children (Loman et al., 2013). Similarly, early life stress has been associated with poorer 
working memory performance and aberrant activation in associated brain regions in 
healthy adults (Philip et al., 2016). This literature suggests early life adversity likely alters 
the developmental trajectory of the executive system (Shanmugan and Satterthwaite, 
2016).  
Animal models suggest the mechanisms underlying the detrimental effects of 
early adversity on executive function development are likely multifold. For example, early 
life stress in mice has been shown to induce alterations in PFC dendritic architecture 
(Yang et al., 2015). Early adversity also alters dopaminergic (Kasanova et al., 2016), 
noradrenergic (Zitnik et al., 2016), serotonergic (Matsuzaki et al., 2009), and 
glutamatergic (Llorente et al., 2012) function in the PFC. Importantly, estradiol supports 
the normal development and maintenance of each of the above neurotransmitter 
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systems (Shanmugan and Epperson, 2014). Additionally, the effects of early adversity 
and estradiol converge on common molecular targets at the synaptic level (Shively et al., 
2003; Amin et al., 2005; Matsuzaki et al., 2009; Michopoulos et al., 2014; Shanmugan 
and Epperson, 2014). Together, this literature suggests abrupt loss of estradiol 
regulation of these neurotransmitter systems after RRSO is likely a key mechanism 
underlying the observed differences in executive function between high and low ACE 
groups (Shanmugan and Epperson, 2014).  
 
Evidence for mood as a mediator of ACE effects on executive function 
ACE effects on subjective report of executive dysfunction and ACE effects on 
sustained attention performance after RRSO were partially mediated by anxiety and 
depressive symptoms. Many healthy women experience onset of executive function 
difficulties during menopause concurrent with loss of estradiol (Epperson et al., 2011; 
Epperson et al., 2015; Shanmugan et al., 2017). During this hormonal transition, women 
with no history of depression are also at increased risk of new onset depressive 
symptoms (Freeman et al., 2014). Early life adversity has been suggested as a risk 
factor for both executive function difficulties (Shanmugan and Epperson, 2014) as well 
as mood changes (Epperson et al., In Press) during periods of waning estradiol. Mood 
symptoms are also associated with executive system dysfunction (Shanmugan et al., 
2016), highlighting the importance of jointly considering the role of early adversity and 
mood changes on executive functions after RRSO. Notably, the mediating effect of 
mood and timing of pre- vs post-pubertal adversity varied across domains, suggesting 
future studies of ACE effects on executive function would benefit from further 
dissociation between sustained attention, working memory, and subjective report of 
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executive dysfunction symptoms as well as timing of adversity onset in relation to 
puberty. 
Our results highlight that addressing concurrent mood changes is a critical step 
in treating either natural or surgical menopause-induced executive difficulties. 
Importantly, we found that ACE effects were mediated by anxiety and depressive 
symptoms, which may or may not translate to a full diagnosis of generalized anxiety 
disorder, major depressive disorder, or other mood disorder. The mediating effect of 
mood was significant even though the average anxiety and depression subscale scores 
in this sample (Table 1) were below those corresponding to full categorical diagnoses of 
anxiety (8+) or depressive disorders (8+) (Bjelland et al., 2002), further emphasizing the 
importance of screening for sub-threshold mood symptoms in this population. However, 
mood was a partial, not full, mediator of ACE effects on BADDS and CPT performance. 
Additionally, mood did not mediate ACE effects on working memory. Furthermore, ACE 
effects on working memory remained significant when accounting for the effects of mood 
symptoms, age, chemotherapy use, time since oophorectomy, hormone therapy use, 
and education. Together, these data suggest that mood symptoms are only one 
component of the mechanism underlying new onset cognitive dysfunction with loss of 
estradiol and that at least a portion of ACE-associated risk for executive difficulties is 
independent of the association between ACE and anxiety and depressive symptoms. 
Further research is necessary to determine these mood-independent mechanisms, but 
dopaminergic (Shanmugan et al., 2017), glutamatergic (Shanmugan et al., 2017), and 
serotonergic (Shanmugan and Epperson, 2014) pathways likely play a role. 
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Limitations 
 While this study had a large sample size and controlled for multiple possible 
confounds, certain limitations should be acknowledged. First, subjects completed 
cognitive testing in an uncontrolled environment, potentially reducing validity of these 
neuropsychological tests. However, excluding subjects who performed below chance on 
control conditions allowed us to limit this effect. Additionally, such a study design 
enabled us to examine the effects of early adversity on cognition post-RRSO at a scale 
that would have been much less feasible with in-office visits. Second, while a previous 
study (Ryan et al., 2014) found effects of age at oophorectomy on cognitive outcomes, 
we did not find a similar effect of time without hormones. This difference may be due to 
differences in the predictive variable examined as well as the fact that that study was 
conducted in a much older population (age at baseline > 65). Third, all subjects in this 
study were surveyed after undergoing RRSO. As such, while results demonstrate that 
ACE is associated with worse executive function after RRSO, it is not clear whether ACE 
has similar effects prior to RRSO. Longitudinal studies testing subjects before and after 
RRSO would be necessary to determine whether the impacts of RRSO and ACE on 
executive function are synergistic or additive. 
 
Conclusions 
In summary, these data provide novel evidence regarding the impact of early life 
adversity on executive function after RRSO. These results emphasize that the negative 
effects of early adversity on executive function are at least in part mediated by ACE 
effects on mood, underscoring the importance of assessing anxiety and depressive 
symptoms in women who have undergone RRSO. These results suggest that the 
neurotransmitter systems underlying these processes, including serotonin, glutamate, 
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and dopamine, may be important targets of interventions that seek to improve executive 
function in this population. Further research utilizing longitudinal study designs and multi-
modal neuroimaging would be helpful in elucidating ACE x RRSO effects on 
glutamatergic and monoaminergic function. 
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Table 2-1. Participant Characteristics 
  Low ACE High ACE 
  Mean (SD) or number 
n 350 202 
Age (years) 47.2 (7.2) 48.1 (7.9) 
Age at oophorectomy (years) 43.4 (6.0) 43.9 (7.3) 
Time since oophorectomy (months) 45.6 (46.2) 49.3 (48.3) 
Time without hormones (months) 30.8 (41.3) 33.3 (43.0) 
History of cancer 156 101 
Previous hormone therapy use 150 80 
Current hormone therapy use 98 52 
Previous chemotherapy use 94 65 
Education 
  Graduate school 155 94 
College 155 68 
Some College 34 32 
High school 3 8 
Some high school 1 0 
8th grade or less 2 0 
Race 
  Caucasian 326 181 
African American 2 4 
Asian 3 0 
Hispanic 8 6 
Other 6 3 
Unknown or preferred not to disclose 10 8 
  
  Mood symptoms 
  HADS total score 11.3 (6.7) 13.5 (7.1) 
HADS depression subscale score 5.5 (3.8) 6.7 (4.0) 
HADS anxiety subscale score 5.7 (3.6) 6.9 (3.4) 
  
  Current psychoactive medication indication or 
class 
   Attention deficit disorder 4 4 
Depression 98 62 
Anxiety 9 12 
Neurological conditions 13 7 
Narcotics 3 2 
SERM antagonist/Aromatase inhibitor 43 30 
Tamoxifen/SERM 32 16 
  
  
  
Mean ACE 0.32 (0.47) 3.4 (1.6) 
Abuse 
  Emotional abuse 6 119 
Physical abuse 4 78 
Sexual abuse 25 51 
Neglect 
  Emotional neglect 11 102 
Physical neglect 1 25 
Household dysfunction 
  Parents divorced/separated 37 107 
Witnessed domestic violence 2 26 
Drug abuse in household 10 93 
Mental illness in household 7 93 
Incarceration of family member 2 13 
 
ACE=Adverse Childhood Experiences; HADS=Hospital Anxiety and Depression Scale; 
SERM=Selective Estrogen Receptor Modulator 
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Figures 
 
Figure 2-1. Consort diagram. Eight hundred subjects completed cognitive testing at 
baseline and 453 subjects repeated cognitive testing after 1 year, yielding a total of 
1,253 sessions that were eligible for inclusion. Sessions included in analyses must have 
completed at least one outcome of interest (n=1,058). Sessions missing information 
regarding age at testing (n=16), hormone therapy use (n=165), ACE (n=12), education 
level (n=8), and mood symptoms (n=30) were excluded. Subjects who performed below 
chance (<50% true positives) on the CPT were excluded from analyses of the CPT 
(n=20). Similarly, subjects who performed below chance (<5 true positive responses) on 
the 0-back control condition were excluded from analyses of the n-back (n=13). 
Complete data for at least one outcome measure and all primary covariates were 
obtained on 494 subjects at baseline and 363 subjects at the 1-year follow-up session, 
yielding a total of 552 subjects and 857 sessions included in analyses. ACE=adverse 
childhood experiences 
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Figure 2-2. ACE effects on subjective symptoms of executive dysfunction. ACE 
was associated with higher total BADDS score (β= 7.1, p=0.0005) (a) as well as each 
BADDS subscale (b) (organization/activation for work, β=1.7, p= 0.002; 
attention/concentration, β=1.8, p=0.001; alertness/effort/processing speed, β=1.4, 
p=0.004; managing affective interference, β=1.3, p=0.0007; working memory/accessing 
recall, β=0.8 p=0.03). Bars represent means. BADDS=Brown Attention Deficit Disorder 
Scale. ACE=adverse childhood experiences  
  
44	
	
 
Figure 2-3. ACE effects on sustained attention and working memory. When 
controlling for age, time without hormones, chemotherapy use, and education level, ACE 
was associated with worse performance worse on both the CPT (β=-0.1, p=0.03) (a) and 
n-back (β=-0.17, p=0.007) (b). Bars represent means. CPT=continuous performance 
task. ACE=adverse childhood experiences. 
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Figure 2-4. Mood symptoms mediate ACE effects on executive function. a) Mood 
symptoms partially mediated the relationship between ACE and total BADDS score. 
ACE was significantly associated with total BADDS scores (β=7.2, r2=0.03, p=0.0005). 
ACE was significantly associated with mood symptoms (β=2.1, p=0.0003), mood 
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symptoms were significantly associated with age-residualized total BADDS scores 
(β=2.1, p<0.0001), and ACE was associated with BADDS scores when mood symptoms 
were included as a covariate (β=2.8, r2=0.41, p=0.08). Mood symptoms mediated 62.8% 
(95% CI:  42.3% - 100%) of ACE effect on total BADDS score. b) Mood symptoms 
partially mediated ACE effects on sustained attention. ACE was significantly associated 
with CPT performance (β=-0.1, r2=0.02, p=0.03). ACE was associated with greater mood 
symptoms (β=2.1, p=0.0002), mood symptoms were negatively associated with age-
residualized CPT d’ (β=-0.01, p=0.001), and ACE was associated with CPT d’ when 
mood symptoms were included as a covariate (β=-0.09, r2=0.04, p=0.08). Mood 
symptoms mediated 21.3% (95% CI:  9.3% - 100%) of ACE effects on CPT d’. c) ACE 
was significantly associated with working memory performance (β=-0.17, r2=0.02, 
p=0.007). Mood symptoms did not mediate a significant proportion of the relationship 
between ACE and working memory performance (95% CI: -1.4%  – 50%). However, 
ACE effects on n-back d’ remained significant when mood symptoms were included as a 
covariate (β=-0.16, r2=0.02, p=0.01). BADDS=Brown Attention Deficit Disorder Scale. 
CPT=continuous performance task. ACE=adverse childhood experiences 
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Abstract 
 
Many healthy women with no history of cognitive dysfunction experience subjective 
executive difficulties during menopause. Preclinical literature suggests latent effects of 
early life adversity on serotonin function may play a role in this phenomenon. However, 
evidence in human participants regarding the mechanisms by which loss of estradiol 
contributes to this vulnerability is lacking. Here we examined the impact of tryptophan 
depletion (TD) and adverse childhood experiences (ACE) on brain activation during a 
working memory task in menopausal women. We hypothesized that an interactive effect 
between ACE and TD would be observed when women were hypogonadal, and that 
treatment with estradiol would attenuate this effect. Thirty-three women underwent 
functional imaging at four time points (123 total scans) in this double-blind, placebo 
controlled, crossover study. The effects of TD, ACE, and TD x ACE were evaluated 
using a voxelwise, mixed-effects, 2 x 2 ANOVA. In the absence of exogenous estradiol, 
a TD by ACE interaction was observed on BOLD signal in the right DLPFC such that TD 
increased activation in high ACE subjects but decreased activation in low ACE subjects. 
While a similar interaction was observed with placebo treatment, treatment with estradiol 
attenuated the effects of ACE and TD such that no between or within group differences 
were observed. Together, these results suggest that early life adversity may have a 
lasting impact on serotonergic circuits underlying executive function that are unmasked 
by loss of estradiol during menopause. 
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Introduction 
During menopause, many healthy women experience new onset subjective 
difficulties with executive processes involving sustained attention, motivation for work, 
organization and working memory (Epperson et al., 2015; Shanmugan et al., 2017). 
Onset of these executive difficulties coincides with waning estradiol levels and may be a 
result of reduced estradiol modulation of the prefrontal cortex (PFC) (Shanmugan and 
Epperson, 2014). We previously showed that estradiol modulation of serotonergic 
function in the dorsolateral PFC (DLPFC) may be particularly important in maintaining 
intact working memory processes in menopausal women (Epperson et al., 2012). Early 
life experiences may also shape an individual’s executive function during this hormonal 
transition (Shanmugan and Epperson, 2014). Significant adversity during childhood 
alters executive system development (Bruce et al., 2013; Shanmugan and Satterthwaite, 
2016), resulting in poor working memory and executive system hyper-activation into 
adulthood (Majer et al., 2010; Bruce et al., 2013; Philip et al., 2016) as well as sub-
optimal cognitive aging (Barnes et al., 2012). Moreover, adverse childhood experiences 
(ACE) have lasting impacts on serotonergic function (Comasco et al., 2013; van der 
Doelen et al., 2015), which may leave individuals vulnerable to cognitive changes during 
periods of low estradiol such as during menopause (Epperson et al., 2011; Shanmugan 
and Epperson, 2014; Epperson et al., 2015; Shanmugan et al., 2017).   
Non-human primate studies indicate effects of early life stress and estradiol 
converge on key aspects of serotonergic function. Specifically, reduction in tryptophan 
hydroxylase type 2 (TPH2) gene expression resulting from social subordination stress in 
ovariectomized macaques is ameliorated by treatment with estradiol (Bethea et al., 
2008). In non-stressed, ovariectomized rats and macaques, chronic estradiol treatment 
not only increases serotonin synthesis via TPH2, but also enhances serotonin release 
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and turnover, increases serotonin transporter binding, and increases serotonin receptor 
2A mRNA and binding (Amin et al., 2005). Together, this preclinical literature suggests 
early life stress and estradiol act on common serotonergic targets at the molecular level. 
However, what roles early adversity and the interaction between early adversity and 
serotonin function play in conferring vulnerability to executive dysfunction during 
menopause is unknown. Human participants studies examining ACE effects on 
serotonergic function during conditions of low and high estradiol are needed to 
determine whether early adversity increases risk for executive dysfunction during 
menopause via effects on serotonin. 
We used tryptophan depletion (TD) and a double-blind, placebo-controlled, 
cross-over design in 33 healthy menopausal women with high and low levels of early life 
adversity. We hypothesized that ACE would be associated with aberrant activation in the 
DLPFC. Additionally, we predicted TD would differentially impact DLPFC activation in 
high vs low ACE hypogonadal women. Moreover, we hypothesized that estradiol 
treatment would attenuate ACE and TD effects. 
 
Methods and Materials 
Participants were healthy women ages 48-60 with no psychiatric diagnoses and 
within 10 years of their last menstrual period. Participants were right-handed and had a 
FSH > 30 IU/ml, a normal mammogram within the last year, and a clear urine toxicology. 
Exclusion criteria included use of hormone therapy within the last year, contraindications 
to hormone therapy, IQ < 95, Mini Mental Status Exam Score < 25, lifetime history of 
psychotic or bipolar disorder, other psychiatric or substance use disorder in the last year, 
Hamilton depression score > 14, psychotropic medication use within the last month, 
metallic implant, and claustrophobia. This study was approved by the Institutional 
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Review Board at the University of Pennsylvania. All participants provided written 
informed consent.  
Study design  
Participants underwent 4 test days in this double-blind, placebo-controlled, cross-
over study (Figure 3-1a). During test days 1 and 2 (phase 1), participants underwent 2 
imaging sessions: active TD or sham TD. The order of condition was counterbalanced 
and double-blind. After phase 1, participants were randomized to 17β-estradiol (Vivelle 
Dot® 0.100 mg/d) or placebo patch treatment for 10 weeks. After completing ~8 weeks 
of estradiol or placebo, participants underwent active TD and sham TD (phase 2).   
On test days, participants ingested capsules containing either amino acids 
without tryptophan (active TD) or microcellulose (sham TD). Blood was taken for free 
tryptophan analysis (Figure 3-1b) and mood ratings were completed prior to 
consumption of capsules and approximately 6 hours later, after which participants 
underwent neuroimaging. Subjects with percent change in tryptophan approximately >3 
SD from the average for the assigned depletion status were excluded to ensure that 
tryptophan levels were consistent with the assigned condition.   
 
Assessment of early life adversity 
The Adverse Childhood Experiences Questionnaire (Felitti et al., 1998) was used 
to assess history of emotional, physical, or sexual abuse, childhood neglect, and 
household dysfunction. The ACE questionnaire assesses the number of exposures 
rather than severity (Teicher and Parigger, 2015) and has been used extensively to 
assess the association between early adversity and later life health outcomes (Felitti et 
al., 1998). Number of exposures was summed to create the ACE score (range: 0–10). 
Subjects with an ACE score ≥ 2 were considered “high ACE” while subjects with ACE 
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score of < 2 were considered “low ACE”. A threshold of 2 was used to define the high 
ACE group based on studies of depression prevalence in later life that demonstrate 
increased susceptibility at this level of exposure (Chapman et al., 2004; Epperson et al., 
In Press). 
 
Assessment of mood 
Mood was measured as a possible confound using the Profile of Mood States. 
Total score and “Depression-Dejection” sub-score assessed changes in overall mood 
and depressive symptoms, respectively. Difference in mood score (AM-PM) served as 
the outcome in regression models used to assess the effects of TD and ACE on mood.  
 
Task paradigm 
A letter n-back task was used to probe executive system function during fMRI. 
The task included four conditions: 0-back, 1-back, 2-back and 3-back. Stimuli were 4-
letter non-words without vowels presented for 500 ms, followed by an interstimulus 
interval of 2500 ms. In the 0-back condition, participants responded to a target stimulus. 
In all other conditions, participants responded to a stimulus “n” number of stimuli before 
it. Each condition consisted of 3 20-trial blocks (60s; 1:2 target-foil ratio). Visual 
instructions (9s) preceded each block. Baseline rest periods occurred at the beginning 
(72s), middle (24s), and end (24s) of acquisition. Task duration was 924s. Equivalent n-
back tasks with unique stimuli were used for each session and version order was 
counter-balanced. Performance measures of interest were overall true positive count, 
false positive count, and median true positive response time.  
 
Image acquisition and processing 
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Imaging data were acquired on 3T Siemens Trio scanner. A magnetization-
prepared, rapid acquisition gradient echo T1-weighted image (TR=1810 ms, TE=3.51 
ms, FOV=180 x 241mm, matrix=192 x 256, 160 slices, effective voxel resolution of 0.94 
x 0.94 x 1 mm) was acquired to aid spatial normalization to standard space. Functional 
images were acquired using a whole-brain, single-shot gradient-echo echoplanar 
sequence with the following parameters: TR/TE=3000/32 ms, FOV=192 × 192mm, 
matrix=64 x 64, slice thickness/gap=3/0 mm, 46 slices, effective voxel resolution of 3 x 3 
x 3 mm.  
BOLD time series data were skull stripped with BET (Smith, 2002), despiked with 
AFNI’s 3dDespike (Cox, 1996), motion-corrected with MCFLIRT (Jenkinson et al., 2002), 
high pass filtered (120s), spatially smoothed (6mm FWHM), and mean-based intensity 
normalized. Subject-level timeseries analyses were carried out using FILM (FMRIB's 
Improved Linear Model) with local autocorrelation correction (Woolrich et al., 2001; 
Woolrich et al., 2009). The four condition blocks (0-back, 1-back, 2-back, and 3-back) 
and their temporal derivatives were modeled using a canonical (double-gamma) 
hemodynamic response function with standard plus extended motion parameters 
included as nuisance covariates. The rest condition (fixation point) served as the 
unmodeled baseline. Functional and anatomical volumes were co-registered using 
boundary-based registration (Greve and Fischl, 2009). The anatomical image was 
normalized to the MNI 152 T1 1mm template using diffeomorphic SyN registration in 
ANTs (Klein et al., 2009; Avants et al., 2011). Co-registration, normalization, and down-
sampling to 3 mm3 were concatenated so only one interpolation was performed. Images 
were assessed for excessive motion (mean relative displacement > 0.5 mm) and low 
temporal signal-to-noise ratio (tSNR < 2 SD). 
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Group-level analyses 
Analyses of imaging data were completed using voxelwise linear mixed-effects 
models with FSL’s FLAME1 procedure. A two-way, whole-brain, voxel-wise, mixed-
effects ANOVA was used to determine the effects of TD, ACE, and TD x ACE on brain 
activation during phase 1. The primary analysis focused on the parametric contrast; 0-, 
1-, 2-, and 3-back were weighted -3, -1, 1, and 3 to model a linear increase in activity 
across conditions. The parametric contrast is most sensitive to linear effects in signal 
associated with increasing working memory load and may not capture non-linear effects. 
Therefore, we also examined the 3-back > 0-back contrast. As prior imaging studies 
found effects of early life stress at 0-back > baseline (Philip et al., 2016), we also 
examined this contrast. To adequately control for Type I error (Eklund et al., 2016) and 
limit the probability of Type 2 error, we implemented stringent cluster correction 
procedures using 10,000 Monte-Carlo simulations executed with AFNI’s 3dClustSim 
program (Cox, 1996).  Parameters selected include voxel height threshold of z>3.1, 
cluster probability of p<0.05, non-Gaussian (long-tailed) filtering, padded simulated 
volumes to account for edge effect artifacts, 1-sided thresholding, and first-nearest 
neighbor clustering (clustering of above threshold voxels if faces touch). Smoothness 
was estimated with AFNI’s 3dFWHMx program using residuals of the group level 
analysis and spatial autocorrelation computed as a function of the radius using a mixed 
Gaussian plus mono-exponential model (Eklund et al., 2016). Mean percent signal 
change from significant voxels was extracted for further statistical testing and 
visualization. Signal was also extracted from the 1-back>0-back and 2-back>0-back 
contrasts to investigate effects of TD and ACE at varying levels of working memory load 
(Figure 3-S1). To examine whether estradiol attenuated the impact of ACE and TD on 
BOLD, signal from significant phase 1 voxels was extracted from phase 2 scans. 
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Statistical analyses 
Linear mixed-effects models implemented using the nlme package (Pinheiro et 
al., 2016) in R (R Core Team, 2015) were employed to evaluate the effect of TD, ACE 
and their interaction on mood, behavior, and BOLD signal during phase 1 as well as the 
4-way interaction between ACE group x TD status x estradiol/placebo group x study 
phase. All models accounted for repeated measures and controlled for age, estradiol 
level, and time since last menstrual period. Hypotheses regarding the impact of TD and 
ACE status under estradiol and placebo conditions on significant phase 1 outcome 
measures were then tested using this modeling framework. Test day was included as an 
additional covariate in secondary analyses of significant behavioral findings to account 
for practice effects. Difference in percent errors between 3-back and 0-back was 
included as a covariate in supplementary analyses to account for differences in task 
performance between back levels that may be reflected in the 3-back > 0-back BOLD 
contrast. The square root of the coefficient of determination from a linear mixed-effects 
model was used to estimate the partial correlation between BOLD signal within the 
DLPFC and behavior while accounting for repeated measures. Spearman’s rank 
correlation was used to examine the relationship between ACE as a continuous variable 
and BOLD signal during sham depletion. Statistical tests were two-sided with p<=0.05 
considered significant. 
 
Results 
Participants 
Sixty participants completed screening and were enrolled in this study. Two 
participants self-withdrew before the first test day and 3 were lost to follow-up. Six 
participants did not complete the first test day due to inability to complete the depletion 
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procedure (n=1), claustrophobia (n=4), and lack of space (n=1) inside the MRI scanner. 
All study procedures were otherwise well tolerated with no serious or unintended 
adverse events. Three participants self-withdrew prior to the second test day, and one 
subject was withdrawn due to artifacts produced by dental fillings. Per a priori exclusion 
criteria, participants were excluded from phase 1 analyses for excessive motion (n=0), 
having a percent change in tryptophan level approximately greater than 3 SD from the 
average for the assigned depletion status (n=3), or missing data regarding ACE (n=3), 
imaging (n=1), or tryptophan levels (n=4). The subject with the lowest tSNR (< 2 SD) 
was flagged for further inspection; independent component analysis confirmed lack of n-
back network activation and the subject was excluded. 
The final sample included in phase 1 analyses consisted of 19 low ACE and 14 
high ACE participants (Table 3-1, Table 3-S1). One of these participants was lost to 
follow-up prior to randomization. Only subjects included in phase 1 analyses were 
considered for inclusion in analyses of phase 2. Sessions during phase 2 that had 
percent change in tryptophan level approximately 3 SD from the average for each 
condition (n=2), did not complete imaging (n=1), or had missing tryptophan levels (n=4) 
were excluded from analyses of phase 2. The final sample included in phase 2 analyses 
consisted of 10 low ACE participants (19 sessions) and 11 high ACE participants (19 
sessions) randomized to estradiol and 8 low ACE participants (13 sessions) and 3 high 
ACE participants (6 sessions) randomized to placebo. 
 
Behavioral results 
Active TD significantly decreased free tryptophan concentration in comparison to 
sham TD (p<0.0001; Figure 3-1b). There was not a significant difference in percent 
change in tryptophan levels between ACE groups. As expected, increasing working 
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memory load was associated with fewer correct responses to targets and greater false 
positive responses to foils (Figure 3-1c). During phase 1 (pre-randomization), active TD 
increased true positive responses (p=0.03) in comparison to sham depletion, though had 
no effect on false positive responses or reaction time. This main effect of TD on true 
positive count remained significant (p=0.04) when accounting for non-significant practice 
effects, though was not present in the smaller subgroups randomized to estradiol or 
placebo. High ACE was associated with slower true positive reaction time in comparison 
to low ACE during phase 1 (p=0.1), but not in the smaller subgroups of phase 2. There 
was no effect of TD x ACE on behavior during either phase of the study. Similarly, there 
was no significant effect of ACE or TD on overall mood or depressive symptoms. 
 
Imaging results: phase 1 
As expected, the parametric (Figure 3-S2) and 3-back > 0-back (Figure 3-1d) 
contrasts robustly recruited the executive network (Owen et al., 2005; Loughead et al., 
2009; Loughead et al., 2010; Satterthwaite et al., 2013; Shanmugan et al., 2016). Lower 
activation during 3-back relative to 0-back in regions associated with the default mode 
network were also robust. No effects of TD or ACE on the parametric or 0-back contrasts 
survived correction, and subsequent analyses focused on the 3-back > 0-back contrast. 
A whole-brain analysis demonstrated that TD differentially altered right DLPFC activation 
in high and low ACE groups (Figure 3-2a; MNI coordinates: x=45, y=21, z=48; 
volume=108 mm3; peak z=3.94). BOLD signal in this region significantly correlated with 
true positive responses across all subjects (r=0.34, p=0.007) (Figure 3-2b). During 
sham depletion, BOLD signal in this region was significantly correlated with total ACE 
score (r=0.41, p=0.02; Figure 3-2c). When controlling for the effects of age, estradiol 
level, and time since last menstrual period, the interaction between ACE and TD 
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remained significant (p=0.0001). Post-hoc comparisons revealed the following effects: 
higher BOLD signal in low ACE participants on active TD compared to sham TD 
(p=0.03), lower BOLD signal in high ACE participants on active TD compared to sham 
TD (p=0.0003), and higher BOLD in high ACE participants compared to low ACE 
participants during sham TD (p=0.007). During active TD, there was no difference 
between ACE groups.  This interactive effect of TD and ACE on DLPFC BOLD remained 
significant when true positive count was included as an additional covariate (p=0.0002). 
Similarly, this interaction remained significant (p=0.0002) when controlling for the 
difference in percent errors between 3-back and 0-back. Post-hoc comparisons revealed 
the following effects: higher BOLD signal in low ACE participants on active TD compared 
to sham TD (p=0.03), lower BOLD signal in high ACE participants on active TD 
compared to sham TD (p=0.0007), and higher BOLD in high ACE participants compared 
to low ACE participants during sham TD (p=0.005). There was no difference between 
ACE groups during active TD. 
 
Imaging results: phase 2  
 Within the right DLPFC cluster from phase 1, a 4-way interaction between ACE 
group x TD status x estradiol/placebo group x study phase was detected (p=0.03). A 
comparable interactive effect to that observed in phase 1 between ACE and TD on 
BOLD was present in the participants randomized to placebo (Figure 3-3b; p=0.07).  As 
in phase 1, lower BOLD signal was observed in high ACE participants on active TD 
compared to sham TD (p=0.08) and higher BOLD was observed in high ACE 
participants compared to low ACE participants during sham TD (p=0.04). However, in 
participants randomized to estradiol, there was no effect of ACE or TD on BOLD (Figure 
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3-3c). In these participants, estradiol attenuated differences between high and low ACE 
groups during sham TD as well as BOLD response to active TD in the high ACE group. 
Results were similar when controlling for differences in percent errors between 3-
back and 0-back. The 4-way interaction between ACE group x TD status x 
estradiol/placebo group x study phase remained significant (p=0.03). An ACE x TD 
interaction was observed in participants randomized to placebo (p=0.09); lower BOLD 
signal was observed in high ACE participants on active TD compared to sham TD 
(p=0.1) and higher BOLD was observed in high ACE participants compared to low ACE 
participants during sham TD (p=0.04). No effect of ACE or TD was observed in 
participants randomized to estradiol. 
 
Discussion 
This double-blind, placebo-controlled, cross-over study examined whether TD 
differentially impacted brain activation in high vs low ACE hypogonadal women in the 
presence and absence of exogenous estradiol. In the absence of exogenous estradiol, 
TD increased right DLPFC BOLD signal and improved working memory performance in 
women who experienced low levels of early life adversity. In contrast, TD decreased 
right DLPFC activation without worsening performance in high ACE women. However, 
treatment with estradiol attenuated the effects of ACE and TD such that no between or 
within group differences were observed. Together, these results suggest that ACE has 
lasting impacts on serotonergic circuits supporting executive function that are unmasked 
by loss of estradiol during menopause. 
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Evidence for TD x ACE effects on executive function 
As expected, we found main effects of ACE and TD as well as an ACE by TD 
interaction on DLPFC activation in hypogonadal women. The DLPFC is part of the 
frontoparietal network responsible for goal-directed executive functions (Cortese et al., 
2012) and dysfunction of this region contributes to executive deficits across multiple 
psychiatric disorders (Shanmugan et al., 2016).  During sham depletion, the high ACE 
group exhibited significantly greater activation in this region and a trend for slower 
reaction time than the low ACE group This finding suggests early adversity is associated 
with inefficient hyperactivation of the DLPFC in hypogonadal menopausal women. Our 
findings are globally convergent with the only other study that used a whole-brain 
approach to examine early adversity effects on brain activation during the n-back in 
healthy adults, which found that early adversity was associated with hyperactivation of 
several brain regions (Philip et al., 2016). While that study found effects of early life 
adversity during 0-back, differences in results between our study and theirs are likely 
due to differences in correction methods employed and instruments used to assess early 
adversity. 
While the high ACE group demonstrated inefficient hyperactivation of the DLPFC 
during sham TD, this ACE effect was not present during active TD. That TD ameliorates 
this ACE-associated inefficiency in DLPFC activation suggests that serotonergic 
differences likely contribute to baseline differences in BOLD between ACE groups 
observed during the sham condition. This finding is in agreement with two other n-back 
studies demonstrating TD-induced decreases in DLPFC activation in the absence of 
performance changes (Allen et al., 2006; Epperson et al., 2012). In contrast, TD 
increased activation and task performance in the low ACE group. Similar TD-induced 
improvements in performance (Schmitt et al., 2000; Booij et al., 2005; Scholes et al., 
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2007) have been reported during tasks requiring focused attention and response 
inhibition (Mendelsohn et al., 2009). These studies may not be directly relevant to our 
results as they examined executive domains other than working memory. The 
combination of group differences observed during sham depletion and the differential 
direction of response to active depletion highlight that the effects of ACE should be 
accounted for in future neuroimaging studies utilizing neurotransmitter manipulations. 
Failure to account for this moderating effect is likely a major factor contributing to the 
inconclusive supporting literature regarding TD’s effects on executive function. 
In combination, these results suggest that ACE has lasting impacts on serotonin 
function and that hypogonadal middle-aged women with high and low levels of early 
adversity respond differently to experimental manipulations of the serotonergic system. 
As early adversity negatively impacts serotonin synthesis (Shively et al., 2003), 
metabolism (Wong et al., 2015), and signaling (Murrough et al., 2011), the mechanism 
contributing to differential TD response in low and high ACE participants is likely 
multifold. A human participants study found that low socioeconomic status is associated 
with lower serotonergic activity (Matthews et al, 2000), suggesting differences in 
baseline serotonin concentration may play a role. Animal studies demonstrating that 
early life stress lowers TPH2 expression (Shively et al., 2003) and increases monoamine 
oxidase-A (Wong et al., 2015) support this hypothesis. However, early adversity also 
reduces 5-HT1B expression (Murrough et al., 2011) and attenuates 5-HT1A function 
(Matsuzaki et al., 2009). This suggests alterations in feedback inhibition or receptor 
sensitivity may also contribute to differences in BOLD response to TD between high and 
low ACE individuals. 
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Evidence for estradiol modulation of TD x ACE effects on executive function 
 As predicted, treatment with estradiol attenuated ACE and TD effects on BOLD 
signal in the DLPFC. In contrast to the ACE by TD interaction seen in the absence of 
exogenous estradiol during phase 1 and participants randomized to placebo, no 
between or within group differences were observed in participants randomized to 
estradiol. This finding is in agreement with our previous study demonstrating that 
estradiol prevented TD-induced alterations in brain activation (Epperson et al., 2012). 
These data support the hypothesis that early adversity has long-term effects on 
serotonergic circuits involved in working memory that are revealed by loss of estradiol 
during menopause. Given that TD results in decreased serotonin synthesis, and the 
animal literature demonstrating effects of early adversity and estradiol on TPH2 gene 
expression (Shively et al., 2003), one likely mechanism by which ACE is exerting these 
latent effects on working memory may be via TPH2.  However, the converging effects of 
early trauma (Matsuzaki et al., 2009) and estradiol (Michopoulos et al., 2014) on 5-HT1A 
make the presynaptic autoreceptor another promising alternative.  
 
Limitations 
While this study leveraged a unique study design with several levels of rigorous 
controls, certain limitations merit discussion. First, given the association between ACE 
and many adverse health-related outcomes (Felitti et al., 1998), the resilient sample of 
highly educated, physically and psychologically healthy hypogonadal women studied 
here reduces generalizability to the typical menopausal population, particularly those 
with substantial early life stress. However, using this sample allowed us to examine the 
effects of early life adversity on serotonin system function while limiting the potentially 
confounding impacts of comorbid psychiatric symptomatology and psychotropic 
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medication use. Second, no parametric effects of ACE or TD survived correction, and 
results are based on a post-hoc analysis of the 3-back > 0-back contrast. However, 
results using this contrast indicate ACE and TD effects are present when high demands 
are placed on working memory. Third, the sample size of 33 is relatively small. It is 
possible that lack of ACE and TD effects in the estradiol group could be driven by 
diminished power in the sub-sample of phase 1 participants. However, these findings are 
unlikely due to lack of power given the significant 4-way interaction as well as the ACE 
and ACE x TD effects observed in the smaller sub-sample randomized to placebo. 
Additionally, the double-blind, placebo-controlled, cross-over study design using 
repeated-measures allowed for decreased variance in estimates of treatment effects and 
increased power to detect between group differences using > 100 fMRI scans, a 
comparatively large data set for an imaging study employing a pharmacologic 
manipulation in a healthy population. Furthermore, the stringent Type 1 error correction 
method applied to our whole brain analysis highlights the robust nature of these findings. 
 
Conclusions 
In summary, these data imply that early life adversity exerts enduring effects on 
serotonergic circuits underlying executive processes that are unmasked by loss of 
estradiol during menopause. To confirm this effect of menopause, a longitudinal study of 
women pre- to postmenopause would be ideal. Our results emphasize serotonin’s role in 
executive function and highlight that the moderating effects of early adversity must be 
accounted for when manipulating serotonin levels. Further, they provide preliminary 
mechanistic evidence as to why some, but not all, women experience executive 
difficulties during menopause and that brain responses to estradiol vary. Further 
research in a larger sample would be helpful in elucidating the impact of timing of early 
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life adversity on serotonin system function across brain networks, whether sex-
differences exist with regard to TD x ACE interactions, and finally whether early life 
adversity alters the risk-benefit profile of peri- and postmenopausal estrogen treatment. 
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Table 3-1. Participant characteristics at admission 
 
  Low ACE High ACE 
  Mean (SD) or number (%) 
n 19 14 
Age (years) 55.4 (3.6) 54.8 (2.9) 
Months since last menstrual period 52.9 (33.4) 62.5 (32.1) 
Follicle-stimulating hormone (IU/L)  93.4 (35.6) 75.7 (42.8) 
Estradiol (pg/mL) 26.5 (18.8) 24.1 (10.5) 
Education     
Graduate 11 (58) 2 (14) 
Some Graduate 1 (5) 3 (21) 
College 4 (21) 4 (29) 
Some College 2 (11) 5 (36) 
High School 1 (5) 0 (0) 
Race     
Caucasian 16 (84) 9 (64) 
African American 2 (11) 4 (29) 
Asian 1 (5) 1 (7) 
Employment     
Full time 14 (64) 9 (64) 
Part time 1 (12) 4 (29) 
Retired 2 (11) 0 (0) 
Unknown or preferred not to disclose 0 (0) 1 (7) 
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Figure Legends 
 
Figure 3-1. Study design, tryptophan levels, working memory performance, 
contrast of interest. a. This study used a double-blind, placebo-controlled, cross-over 
design. Each participant underwent 4 test days. During test days 1 and 2 (phase 1), 
each participant underwent 2 imaging sessions: active TD or sham TD. The order of 
condition (active TD vs sham TD) was counterbalanced and double-blind. After 
completing phase 1, participants were randomized to 17β-estradiol 0.100 mg/d or look-
alike placebo patch treatment for a total of 10 weeks. Randomization was assigned by 
the research pharmacist and was blocked and stratified with a block size of 3 to maintain 
a 2:1 ratio of estrogen to placebo within each stratum. Randomization allocation 
sequence was generated using a random sequence generator in Excel. Lot and 
expiration information were withheld by investigational drug services to conceal 
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sequence and randomization status. After completion of approximately 8 weeks of 
estradiol treatment or placebo treatment, each participant again underwent active TD 
and sham TD on two separate test days (phase 2). On test days, participants presented 
to the Penn Center for Women’s Behavioral Wellness (PCWBW) at 7:30 am after an 
overnight fast and ingested 70 capsules containing either 31.5g of amino acids without 
tryptophan (active TD) or 31.5g of microcellulose (sham TD). The active capsules 
consisted of L-isoleucine 4.2g, L-leucine 6.6g, L-lysine 4.8g, L-methionine 1.5g, L-
phenylalanine 6.6g, L-threonine 3.0g and L-valine 4.8g. Enrollement and post-test day 
follow-up (24 hours for placebo, 3 weeks for estradiol) was conducted by research 
coordinators at PCWBW. b. Blood was taken for free tryptophan analysis prior to 
consumption of the study capsules (morning) and approximately 6 hours later 
(afternoon). The effect of active vs sham depletion was assessed using a linear mixed 
model with percent change in free tryptophan concentration as the outcome. Active TD 
resulted in a significant decrease in tryptophan level in comparison to sham TD 
(p<0.0001). There was not a significant difference in percent change in tryptophan levels 
between ACE groups. Bars represent means and error bars represent standard error. c. 
Increased working memory load was associated with fewer correct responses to targets 
and more false positive responses to foils d. The Bonferonni corrected group mean of 
the 3-back > 0- back contrast across the 123 scans included in analyses activated 
executive regions and de-activated default mode network regions.  Images were 
displayed using caret. TD=tryptophan depletion. 
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Figure 3-2. Phase 1 imaging results. a. A whole-brain mixed-effects 2 x 2 ANOVA 
demonstrated that TD differentially altered right DLPFC activation in high and low ACE 
groups (MNI coordinates: x=45, y=21, z=48; volume=108 mm3; peak z=3.94). b. BOLD 
signal in this region significantly correlated with true positive responses across all 
subjects (r=0.34, p=0.007). This relationship remained significant when excluding the 
two sessions with the lowest BOLD signal (r=0.30, p=0.02). c. During sham depletion, 
BOLD signal in this region was significantly correlated with total ACE score (r=0.41, 
p=0.02) d. Signal from the region displayed in Figure 2a was extracted for visualization. 
In the low ACE group, active TD increased BOLD relative to sham TD (β=0.20, 95% CI: -
0.16 – 0.21, p=0.03). In the high ACE group, active TD decreased activation relative to 
sham TD (β=-0.43, 95% CI: -0.65 – -0.22, p=0.0003). During sham depletion, high ACE 
was associated with greater activation relative to low ACE (β=0.49, 95% CI: 0.15 – 0.82, 
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p=0.007). During active TD, there was no difference between ACE groups. Bars 
represent means and error bars represent standard error. TD=tryptophan depletion. 
ACE=adverse childhood experiences. *p<0.1, **p<0.05, ***p<0.01, ****p<0.001 
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Figure 3-3. Phase 2 imaging results. a. TD and ACE exerted an interactive effect on 
right DLPFC BOLD during phase one. This panel is identical to Figure 2c. b. Within this 
cluster, a 4-way interaction between ACE group x TD status x estradiol/placebo group x 
study phase was detected (β=1.1, 95% CI: 0.12 – 2.1, p=0.03). A comparable interactive 
effect to that observed in phase 1 between ACE and TD on BOLD was present in the 
participants randomized to placebo. Active TD decreased activation in the high ACE 
group in comparison to sham TD (β=-0.62, 95% CI: -1.4 – 0.12, p=0.08) and high ACE 
was associated with increased activation in comparison to low ACE during sham TD 
(β=0.59, 95% CI: 0.12 – 1.1, p=0.04). c. Estradiol attenuated differences between high 
and low ACE groups during sham TD as well as BOLD response to active TD in the high 
ACE group. There was no effect of ACE or TD on BOLD after estradiol treatment. Bars 
represent means and error bars represent standard error. TD=tryptophan depletion. 
ACE=adverse childhood experiences. *p<0.1, **p<0.05, ***p<0.01, ****p<0.001 
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Table 3-S1. Occurrence of Individual ACEs in Study Sample 
 
  Low ACE High ACE 
Mean ACE 0.32 ± 0.48 3.79 ± 1.25 
Abuse     
Emotional abuse 0 8 
Physical abuse 0 5 
Sexual abuse 1 5 
Neglect     
Emotional neglect 0 8 
Physical neglect 0 0 
Household dysfunction     
Parents divorced/separated 2 7 
Witnessed domestic violence 0 8 
Drug abuse in household 2 6 
Mental illness in household 1 7 
Incarceration of family member 0 0 
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Figure 3-S1. TD and ACE effects on DLPFC activation across n-back levels. a. A 
whole-brain mixed-effects 2 x 2 ANOVA demonstrated that TD differentially altered right 
DLPFC activation in high and low ACE groups (MNI coordinates: x=45, y=21, z=48; 
volume=108 mm3; peak z=3.94). This panel is identical to Figure 2a. b. Signal from the 
region depicted in part a was extracted from the 1-back > 0-back, 2-back > 0-back, and 
3-back > 0-back contrasts to investigate the effects of TD and ACE across varying levels 
of working memory load.  
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Figure 3-S2. Mean parametric contrast. The Bonferonni corrected group mean of the 
parametric contrast across the 123 scans included in analyses activated executive 
regions. Decreasing activation with increasing working memory load was observed in 
default mode network regions.   
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Abstract 
During the menopause transition, women are at increased risk of subjective 
symptoms of executive dysfunction. Evidence from animal and human participant 
studies suggests adverse childhood experiences (ACE) may be a risk factor for 
executive complaints during this hormonal transition. Preclinical literature indicates early 
life adversity effects on serotonin function may play a role in this increased susceptibility. 
However, the mechanisms underlying this increase in vulnerability in human participants 
remain relatively unknown. Here we examined the impact of ACE and tryptophan 
depletion (TD) on functional network connectivity in discovery and replication datasets. 
We hypothesized that ACE would be associated with decreased within-network 
connectivity. We predicted that TD would further lower connectivity in women with high 
levels of early adversity, but have no effect in in women with low levels of early 
adversity. Forty women underwent two functional imaging sequences at two time points 
(141 total scans) in a double-blind, placebo controlled, crossover study. The effects of 
ACE and TD were evaluated using generalized estimating equations (GEE). As 
predicted, ACE was associated with lower within-network connectivity. While TD had no 
effect on connectivity in the low ACE group, TD increased connectivity in the high ACE 
group. The robust main effect of ACE remained significant in the replication dataset, 
though the ACE x TD interaction did not. Together, these results suggest that early life 
adversity has lasting impacts on large-scale functional networks underlying executive 
function.  Alterations in functional network connectivity may be one mechanism by which 
early life adversity increases the risk of cognitive disorders during menopause.  
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1. Introduction 
The menopause transition is associated with increased susceptibility to 
subjective symptoms of cognitive dysfunction (Shanmugan and Epperson, 2014). 
Several reports have suggested that healthy women with no history of cognitive 
dysfunction experience increased difficulty with everyday tasks requiring executive 
processes such as working memory, focus, attention, organization, and planning 
(Epperson et al., 2015; Shanmugan and Epperson, 2014; Shanmugan et al., 2017). 
There is preliminary evidence for adverse childhood experiences (ACE) such as abuse, 
neglect, and household dysfunction as a risk factor for executive dysfunction during this 
hormonal transition (Shanmugan and Epperson, 2014). 
Significant adversity during childhood alters normal trajectories of brain 
maturation (Bruce et al., 2013; Hanson et al., 2015; Shanmugan and Satterthwaite, 
2016) resulting in heightened vulnerability to executive dysfunction (Philip et al., 2016) in 
adult life. Neuroimaging studies have demonstrated that early adversity alters activation 
in brain regions subserving executive processes. In healthy adults, early trauma has 
been associated with executive system hyperactivation during working memory (Philip et 
al., 2016). In healthy menopausal women, estradiol treatment attenuates this ACE-
associated executive hyperactivation (Shanmugan et al., 2016), suggesting the effects of 
ACE may be magnified when women are hypogonadal.  
While these studies demonstrate that ACE has effects on activation in particular 
brain regions, the impact of ACE on functional network architecture is less clear. There 
is growing evidence that the functional connectivity between brain regions as part of 
larger cognitive systems is critical to maintaining intact executive function (reviewed by 
Vaidya and Gordon, 2013).  A recent large neuroimaging study in healthy adults ages 
18-88 demonstrated that the degree of connectivity between and within large-scale brain 
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networks becomes increasingly important to maintaining cognitive performance as we 
age (Tsvetanov et al., 2016). Additionally, altered neural connectivity has been 
suggested as a potential marker of menopausal women who may be at risk of late-life 
cognitive dysfunction (Vega et al., 2016). As such, understanding whether early 
adversity alters connectivity among these functional networks is particularly relevant in 
this middle-aged population.  
During development, networks supporting cognitive processes segregate: brain 
regions become more connected with regions of the same network (increased within-
network connectivity) and less connected with regions of other networks (decreased 
between-network connectivity) (Dosenbach et al., 2010; Fair et al., 2007a; Power et al., 
2010; Satterthwaite and Baker, 2015; Shanmugan and Satterthwaite, 2016). Adversity-
induced disruptions in this trajectory of network segregation have been observed as 
early as preschool (Demir-Lira et al., 2016) and last into adulthood (Philip et al., 2013). 
In healthy adults, early life trauma is associated with decreased connectivity between 
regions within the same network as well as increased connectivity between regions in 
different networks (Philip et al., 2013). Such patterns of dysconnectivity are associated 
with poorer working memory across the lifespan (Tsvetanov et al., 2016). 
Together these studies suggest that early life adversity may confer a risk for 
executive dysfunction during menopause by altering connectivity between and within 
neural networks. However, the effects of ACE on functional network connectivity during 
this hormonal transition have not been studied. Converging evidence from animal and 
human studies suggests one mechanism by which ACE may alter brain function during 
periods of low estradiol may be via effects on serotonin. In non-human primates, both 
ovariectomy and social subordination stress are associated with reductions in tryptophan 
hydroxylase type 2 (TPH2) gene expression (Shively et al., 2003) and 5-HT1A binding 
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potential (Michopoulos et al., 2014). Similarly, lowering central serotonin levels 
differentially impacts prefrontal cortex activation in menopausal women with high and 
low levels of early life adversity (Shanmugan et al., 2016). However, whether ACE and 
sertononin exhibit a similar interactive effect on functional networks is not known.  
Accordingly, we tested the hypothesis that ACE adversely impacts functional 
network connectivity during menopause via alterations in serotonin function. Forty 
healthy menopausal women with high and low levels of early life adversity underwent 
tryptophan depletion (TD) and performed two cognitive tasks during functional magnetic 
resonance imaging. Task effects were regressed to obtain discovery and replication 
timeseries approximate to the resting state (Fair et al., 2007b). The impact of ACE, TD, 
and the interaction between ACE and TD on within-network connectivity were examined 
in both datasets. We predicted that within-network connectivity would be lower in the 
high ACE group compared to the low ACE group during both active TD and sham TD. 
We also predicted that TD would further lower this measure in the high ACE group, but 
have no effect on connectivity in the low ACE group.  
 
2. Methods 
2.1. Participants 
Participants were healthy menopausal women ages 48-60 with no current 
psychiatric diagnoses and within 10 years of their last menstrual period. Participants 
were right-handed and had a FSH > 30 IU/ml, a normal mammogram and pap smear 
within the last year, and a clear urine toxicology. Exclusion criteria included use of 
estrogen or hormone therapy within the last year, contraindications to hormone therapy, 
IQ less than 95, Mini Mental Status Exam Score less than 25, lifetime history of DSM-V 
psychotic or bipolar disorder, other psychiatric or substance use disorder in the last year, 
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Hamilton depression score > 14, psychotropic medication use within the last month, 
metallic implants, and claustrophobia. The sample considered here constitutes a 
superset of participants previously included in a report focusing on the impact of early 
adversity on prefrontal cortex activation during working memory (Shanmugan et al., 
2016).  
 
2.2 Study design 
This study used a double-blind, placebo-controlled, cross-over design. Each 
participant underwent 2 imaging sessions: active TD or sham TD. The order of condition 
(active TD vs sham TD) was counterbalanced and double-blind. On each test day, 
participants presented after an overnight fast and ingested 70 capsules containing either 
31.5g of amino acids without tryptophan (active TD) or 31.5g of microcellulose (sham 
TD). The active capsules consisted of L-isoleucine 4.2g, L-leucine 6.6g, L-lysine 4.8g, L-
methionine 1.5g, L-phenylalanine 6.6g, L-threonine 3.0g and L-valine 4.8g. Blood was 
taken for free tryptophan analysis and mood ratings were completed prior to 
consumption of the capsules and approximately 6 hours later, after which participants 
underwent cognitive testing and neuroimaging. 
 
2.3 Assessment of early life adversity 
The Adverse Childhood Experiences (ACE) Questionnaire (Felitti et al., 1998) 
was used to assess history of emotional, physical, or sexual abuse, childhood neglect, 
and household dysfunction. The ACE questionnaire assesses the number of exposure 
categories and has been used extensively to assess the association between early life 
adversity and later life health-related outcomes. The number of exposures was summed 
to create the ACE score (range: 0–10). Participants with an ACE score greater than or 
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equal to 2 were considered “high ACE” while participants with ACE score of less than 2 
were considered “low ACE”. A threshold of 2 was used to define the high ACE group 
based on studies of depression prevalence in later life that demonstrate increased 
susceptibility at this level of exposure (Chapman et al., 2004; Epperson et al., In Press). 
The continuous effects of ACE were explored in secondary analyses utilizing total ACE 
score.  
 
2.4 Assessment of mood 
Mood was measured as a possible confound. Participants completed the Profile 
of Mood States prior to TD procedure and again before fMRI. Total score and the 
“Depression-Dejection” sub-score were used to assess changes in overall mood and 
depressive symptoms, respectively. Difference in mood score (morning - afternoon) 
served as the outcome variable in regression models used to assess the effects of TD 
and ACE on mood.  
 
2.5 Task paradigms 
A letter version of the n-back task was used to probe working memory and 
executive system function during fMRI scans. The task consisted of four conditions: 0-
back, 1-back, 2-back and 3-back. Stimuli were 4-letter non-words without vowels 
presented for 500 ms, followed by an interstimulus interval of 2500 ms. During the 0-
back, participants responded to a target 4-letter stimulus with a button press. During 
other conditions, participants responded to a stimulus “n” number of stimuli before it. 
Each condition consisted of a 20-trial block (60s) and each class of blocks was repeated 
three times. A target-foil ratio of 1:2 was maintained in all blocks. Visual instructions (9s) 
preceded each block. The task began with a 48s baseline rest period. Additional 24s 
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baseline rest periods occurred at the beginning, middle, and end of the acquisition. Total 
task duration was 924s. Equivalent n-back tasks with unique stimuli were used for the 
four sessions and version order was counter-balanced.  
An emotional identification task was used to probe emotional bias and affective 
processing. The task consisted of 60 faces displaying neutral, happy, sad, angry or 
fearful expressions presented in a fast event-related design. Each face was displayed for 
5.5 seconds followed by a variable inter-stimulus interval (0.5–18.5 seconds) during 
which a complex crosshair (matched to the faces’ perceptual qualities) was displayed. 
Participants were asked to select one of five labels (happy, sad, anger, fear, neutral) for 
each face presented using a scroll wheel. Equivalent versions of the task with unique 
stimuli were used for the four sessions and version order was counter-balanced. Total 
task duration was 630s.  
 
2.6 Image acquisition  
Imaging data were acquired on 3T Siemens Trio scanner. A magnetization-
prepared, rapid acquisition gradient echo T1-weighted image (TR = 1810 ms, TE = 3.51 
ms, FOV = 180 x 241 mm, matrix = 192 x 256, 160 slices, effective voxel resolution of 
0.94 x 0.94 x 1 mm) was acquired to aid spatial normalization to standard space. 
Functional images were acquired using a whole-brain, single-shot gradient-echo (GE) 
echoplanar sequence with the following parameters: TR/TE = 3000/32 ms, FOV= 192 × 
192 mm, matrix = 64 x 64, slice thickness/gap = 3/0 mm, 46 slices, effective voxel 
resolution of 3 x 3 x 3 mm.  
 
2.7 Network construction and visualization  
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We examined the effects of ACE and TD on functional connectivity using a 
system of functional networks described by Power et al. (Power et al., 2011). In this 
system, networks are composed of spheres with a 5-mm radius (264 nodes) (Figure 4-
1) and the connections between these nodes (34,716 unique edges). These nodes 
compose 14 functional network modules that correspond to brain networks that are 
present during both task performance and at rest (Power et al., 2011). This node system 
provides good coverage of the whole brain (Power et al., 2011) and has been used to 
examine functional connectivity between and within brain networks during cognitive 
tasks and at rest (Dosenbach et al., 2010; Satterthwaite et al., 2013b).  
 
Image registration 
Subject-level functional and anatomical T1 images were co-registered using 
boundary-based registration (Greve and Fischl, 2009). The anatomical image was 
normalized to the MNI 152 T1 1mm template using the top-performing diffeomorphic 
SyN registration in ANTs (Avants et al., 2011; Klein et al., 2009). Co-registration, 
normalization, and down-sampling of network nodes to subject space were 
concatenated so only one interpolation was performed.  
 
2.8 Image Processing 
BOLD time series data were skull stripped with BET (Smith, 2002), despiked with 
AFNI’s 3dDespike (Cox, 1996), motion-corrected with MCFLIRT (Jenkinson et al., 2002), 
high pass filtered (120 s), spatially smoothed (6 mm FWHM), and mean-based intensity 
normalized. The event related emotion identification task time series were also slice-time 
corrected. Subject-level time series analyses were carried out using FILM (FMRIB's 
Improved Linear Model) with local autocorrelation correction (Woolrich et al., 2009). 
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Task condition (0-back, 1-back, 2-back, and 3-back blocks for the n-back or happy, sad, 
anger, fear, and neutral events for emotion identification) and their temporal derivatives 
were modeled using a canonical (double-gamma) hemodynamic response function with 
24 motion parameters (Friston et al., 1996; Yan et al., 2013a) included as nuisance 
covariates. The rest condition (fixation point) served as the unmodeled baseline. Images 
were assessed for excessive motion (mean relative displacement > 0.3 mm) 
(Satterthwaite et al., 2013b). Time series were extracted from each of the 264 nodes in 
subject space using the residuals of this subject-level analysis that modeled task and 
motion. Task regression has been shown to aide test-retest reliability of connectivity 
measurements obtained during tasks (Cao et al., 2014).  
 
2.9 Graph construction and analyses of network topology 
 For each participant, pair-wise Pearson correlations were calculated using the 
time series extracted from the 264 nodes. These values were then transformed using a 
Fisher-Z transformation to construct a 264 x 264 symmetric connectivity matrix for each 
participant. Our primary outcome of interest was within-network connectivity. Within-
network connectivity is the mean strength of edges between nodes within a network, 
averaged across all networks. We also calculated total network strength to account for 
potential motion artifact (Saad et al., 2013; Yan et al., 2013b). Total network strength is 
the average strength of the connectivity matrix (Saad et al., 2013; Yan et al., 2013b). 
 
2.9 Discovery and replication data sets 
Prior studies have demonstrated that removing the effects of task from BOLD 
data acquired during cognitive tasks produces “resting-state” timeseries that are 
qualitatively similar to “true” resting-state data (Fair et al., 2007b). Several groups have 
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used these residual timeseries to examine the effect of pathology on “resting-state” 
functional connectivity (Fleisher et al., 2009; Weisberg et al., 2014). However, given that 
differences between task-regressed residuals and “true” resting-state timeseries have 
been noted (Fair et al., 2007b), we tested our hypotheses in both a discovery and 
replication dataset. We obtained these two approximate resting-state timeseries by 
regressing task effects during working memory and emotion identification tasks. Given 
the differences in both task design (block vs event-related) and task demands, 
consistency of results across timeseries would suggest differences due to intrinsic 
functional network architecture rather than task performance. 
We defined the timeseries obtained during the n-back as the discovery 
timeseries for several reasons. First, the n-back task was longer and provided an 
additional 98 volumes for calculation of correlations between network nodes. Second, 
Cao et al. (2014) demonstrated that the test-retest reliability of graph-based connectivity 
measures calculated from residual timeseries was higher for the n-back than for an 
emotional face-processing task. Third, as described below in the results (section 3.1 
Participants), a greater number of timeseries were available for the n-back than the 
emotional identification task. Given these differences, we chose to first examine the 
impact of ACE and TD in the residuals of the n-back timeseries, which may be more 
consistent and a closer approximate to resting-state. The main effect of task on within-
network connectivity was evaluated using generalized estimating equations to assess 
the validity of using residual timeseries from a separate task as the replication dataset. 
 
2.9 Statistical analysis 
Generalized estimating equations implemented using the geepack package 
(HÃ¸jsgaard et al., 2006) in R (R Core Team, 2015) were employed to evaluate the 
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effect of ACE, TD, and their interaction on within-network connectivity. This method 
accommodates multiple assessments per participant and adjusts for non-independence 
among these repeated measures. All models controlled for age, estradiol level, and time 
since last menstrual period. As previous studies have demonstrated that the impact of 
TD on brain function varies with estradiol level in menopausal women (Epperson et al., 
2012), we also controlled for this interaction in our analyses. Both mean relative 
displacement (Power et al., 2015; Satterthwaite et al., 2013a) and mean network 
strength (Saad et al., 2013; Yan et al., 2013a; Yan et al., 2013b) were included as 
covariates to minimize the impact of motion. The effect of the number of ACEs 
(continuous) on functional connectivity was evaluated in supplementary analyses that 
examined interactions between TD and total ACE score. Statistical tests were two-sided 
with p<=0.05 considered significant. 
 
3. Results 
3.1 Participants 
Sixty participants completed screening and were enrolled in the present study. Of 
these 60 participants, 2 withdrew from the study before the first test day, and 3 were lost 
to follow up. Six participants did not complete the first test day due to inability to 
complete the depletion procedure (n=1), claustrophobia (n=4), or lack of space (n=1) 
inside the MRI scanner. Three participants withdrew prior to the second test day, and 
one participant was excluded due to artifacts produced by dental fillings. Participants 
were excluded from analyses for excessive motion (n-back n=1; emotion identification 
n=2), having a percent change in tryptophan level approximately greater than 3 SD from 
the average for the assigned depletion status (n=3), or missing data regarding ACE 
(n=3), imaging (n-back n=1; emotion identification n=5), or tryptophan levels (n=4). The 
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final sample included in the discovery dataset consisted of 24 low ACE participants (43 
sessions) and 16 high ACE participants (30 sessions; see Table 4-1 and Table 4-S1). 
Four of these participants did not complete the emotional identification task; the final 
sample included in the replication dataset consisted of 24 low ACE participants (40 
sessions) and 15 high ACE participants (28 sessions). 
 
3.1 Tryptophan level and mood results 
Blood was taken for free tryptophan analysis before consumption of the study 
capsules (morning) and approximately 6 hours later (afternoon). The effect of active 
depletion vs sham depletion was assessed using a generalized estimating equation with 
percent change in free tryptophan concentration as the outcome. Active TD resulted in a 
significant decrease in tryptophan level in comparison to sham TD (p<0.0001). There 
was no significant difference in percent change in tryptophan levels between ACE 
groups. There was no significant effect of ACE, TD, or ACE x TD on mood.  
 
3.2 Validation of discovery and replication timeseries 
As expected, nodes demonstrated greater connectivity with nodes of the same 
network than with nodes of different networks in both the discovery (Figure 4-2a) and 
replication (Figure 4-2b) data sets. The mean symmetric connectivity matricies from 
these two timeseries qualitatively appeared very similar. However, prior to testing our 
hypotheses regarding the impact of ACE and TD on functional connectivity, we 
evaluated the main effect of cognitive task performed on within-network connectivity to 
assess the validity of using residual timeseries from a separate task as the replication 
dataset. There was no significant effect of task (n-back vs emotional identification) on 
within-network connectivity. This effect remained non-significant when accounting for 
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total network strength as well as motion and was not evaluated further. The lack of 
significant task effect supported our use of these two sets of timeseries as discovery and 
replication datasets. 
 
3.3 Discovery timeseries results  
To test our hypotheses that ACE would be associated with lower within-network 
connectivity and that tryptophan depletion would selectively further lower connectivity 
only in the high ACE group, we used a model that evaluated the impact of ACE group, 
TD status, and ACE group x TD status on within-network connectivity. The effect of ACE 
in this model was robust; as predicted, connectivity was significantly lower in the high 
ACE group than in the low ACE group during sham depletion (p=0.002). In line with our 
hypothesis that TD would selectively impair the high ACE group, TD had no effect on 
connectivity in the low ACE group. Also as predicted, an interaction between ACE group 
and depletion status on within-network connectivity was observed at a trend level 
(p=0.1). However, contrary to our hypothesis that active TD would exacerbate the effect 
of ACE observed during sham TD, active depletion actually increased connectivity in the 
high ACE group (p=0.02; Figure 4-3a). This attenuated the effect of ACE during active 
TD. As in the sham condition, the high ACE group also displayed lower within-network 
connectivity during active TD, though this trend did not reach statistical significance 
(p=0.1).  
Previous studies using the ACE questionnaire to evaluate the impact of early life 
adversity on mental health outcomes in adult life have used a threshold of ≥ 2 to define 
the high ACE group (Epperson et al., In Press). As such, our primary analysis utilized 
the same binary definitions of ACE. However, it is not clear whether such a threshold 
applies to ACE effects on functional network connectivity. Therefore, we also examined 
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the effect of the number of ACEs (continuous) using a model that evaluated the impact 
of total ACE score, TD status, and ACE score x TD status. As hypothesized and in 
agreement with our results using ACE group, there was a robust effect of ACE score as 
ACE score was significantly negatively associated with within-network connectivity 
during sham depletion (p=0.004; Figure 4-3b). Additionally, there was a significant ACE 
score x TD status interaction on within-network connectivity (p=0.04). Consistent with 
our TD x ACE group analysis, active TD diminished the impact of ACE score; there was 
no association between total ACE score and within-network connectivity during active 
TD (p=0.2). 
 
3.3 Replication timeseries results  
 To probe the validity of our results, we tested our hypotheses regarding the 
impact of ACE and TD on functional connectivity using a separate set of task-regressed 
timeseries data acquired in a subsample of our participants. As in the discovery data set, 
we used a model that evaluated the impact of ACE group, TD status, and ACE group x 
TD status on within-network connectivity to test our hypotheses that ACE would be 
associated with lower connectivity and that tryptophan depletion would selectively lower 
connectivity only in the high ACE group. The effect of ACE group was robust and 
consistent with discovery results. Within-network connectivity was significantly lower in 
the high ACE group during both sham TD (p=0.002) and active TD (p=0.05; Figure 4-
4a). The effect of TD in the low ACE group was also replicated and remained non-
significant. However in contrast to discovery results, there was no significant ACE group 
x TD status interaction and no effect of TD in the high ACE group. 
 We also attempted to replicate our findings regarding the continuous effects of 
ACE using a model that evaluated the impact of total ACE score, TD status, and ACE 
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score x TD status. Consistent with our hypothesis and analyses using ACE group, total 
ACE score was significantly negatively associated with within-network connectivity 
during sham TD (p=0.008; Figure 4-4b). As in the discovery dataset, this association did 
not reach significance during active TD. However, it was present at a trend level (p=0.1), 
and the interaction between ACE score and TD status was not significant. 
 
4. Discussion 
 In this double-blind, placebo-controlled, cross-over study, we examined the 
effects of ACE and TD on functional network connectivity in healthy menopausal women. 
In our discovery dataset, high ACE women displayed lower within-network connectivity 
than low ACE women regardless of depletion status. Similarly, total ACE score was 
negatively associated with within-network connectivity. Additionally, active TD increased 
within-network connectivity in women with high levels of early adversity but had no effect 
in women with low levels of early adversity. While the robust effects of both ACE group 
and ACE score were replicated, the more marginal ACE x TD interaction was not. These 
results indicate early life adversity has lasting impacts on intrinsic large-scale functional 
networks and provide preliminary evidence that serotonin’s effect on these networks 
may be task-dependent. 
  As expected, we found a main effect of ACE on functional connectivity. High ACE 
participants displayed lower within-network connectivity in both the discovery and 
replication datasets. Connectivity within functional networks has been shown to underlie 
multiple cognitive domains including working memory (Dosenbach et al., 2007; Fair et 
al., 2007a; Power et al., 2010; Tsvetanov et al., 2016). Decrements in working memory 
are associated with lower connectivity within default and cingulo-opercular networks 
(Vaidya and Gordon, 2013). Decreases in within-network connectivity have been 
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observed in psychiatric disorders exhibiting dysfunction in executive domains 
(Satterthwaite and Baker, 2015; Shanmugan and Satterthwaite, 2016). While the impact 
of ACE on similar measures of within-network connectivity has not been examined, our 
findings are globally convergent with seed-based resting-state connectivity studies 
examining the impact of early life stress on functional connectivity in healthy adults 
(Philip et al., 2013) and adult women with posttraumatic stress disorder (Bluhm et al., 
2009). Although seed regions selected and networks examined vary, these studies 
found that early adversity is associated with lower connectivity between regions within 
the same network (Bluhm et al., 2009; Philip et al., 2013). 
 The mechanisms by which ACE imparts this negative impact on connectivity are 
likely multifold. While we hypothesized that TD would selectively impair connectivity in 
the high ACE group, we found that TD instead selectively improved connectivity in the 
high ACE group. Though contrary to our hypothesis, this result is consistent with 
previous findings demonstrating that tryptophan depletion attenuates ACE effects on 
dorsolateral prefrontal cortex activation during the n-back in menopausal women 
(Shanmugan et al., 2016). That TD attenuated the negative effects of ACE on 
connectivity suggests that serotonergic differences may be contributing to baseline 
differences in functional connectivity between ACE groups. However, we were not able 
to replicate this ACE x TD interaction in our replication timeseries. This discordance may 
be due to differences in task duration, task design, or variations in non-linear effects of 
task remaining in the residual timeseries (Fair et al., 2007b). However, this lack of ACE x 
TD interaction in our replication timeseries as well as the consistent effects of ACE 
regardless of depletion status or cognitive task highlight the importance of considering 
other mechanisms by which early adversity exerts enduring effects on functional 
connectivity.  
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Given that functional connections may be reflective of underlying structural 
connections (Damoiseaux and Greicius, 2009), the effects of early adversity on neuronal 
development during childhood and adolescence likely also play a role. During 
development, within-network connectivity increases while between-network connectivity 
decreases (Satterthwaite and Baker, 2015; Shanmugan and Satterthwaite, 2016). 
Significant adversity during this developmental period may preclude this network 
segregation (Vaidya and Gordon, 2013), possibly via structural changes. Early life stress 
in mice has been shown to induce alterations in PFC dendritic architecture (Yang et al., 
2015). Female mice that experience peripubertal stress also display increases in PFC 
myelin basic protein gene expression and proteolipid protein gene expression, both of 
which are indicators of myelination (Morrison et al., 2016). Importantly, estradiol 
supports the normal development and maintenance of serotonergic function (Epperson 
et al., 2012), dendritic morphology (Shanmugan and Epperson, 2014), and neuronal 
myelination (Luo et al., 2016). 
 
4.1 Limitations 
Certain limitations of the present study should be noted. First, we focused on 
middle-aged females who were within 10 years of their final menstrual period, as women 
are at risk of executive dysfunction during the menopause transition (Epperson et al., 
2015; Shanmugan and Epperson, 2014; Shanmugan et al., 2017). Given the impact of 
estradiol on prefrontal cortex structure and function (Shanmugan and Epperson, 2014) 
as well as evidence for sex differences in the effects of early adversity (Shanmugan and 
Satterthwaite, 2016) on neural response, these data cannot be extrapolated to similar-
aged males or pre-menopausal females. Similarly, while results demonstrate that ACE is 
associated with maladaptive connectivity patterns during menopause, it is not clear 
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whether ACE has comparable effects prior to menopause. Longitudinal studies testing 
women pre- and post-menopause would be necessary to determine whether the impacts 
of ACE and menopause on functional connectivity are synergistic or additive. Second, 
given the association between ACE and many adverse health-related outcomes (Felitti 
et al., 1998), the resilient sample of highly educated, healthy hypogonadal women 
without psychiatric disorders studied here reduces generalizability to the typical 
menopausal population, particularly those with substantial early life adversity. However, 
this sample allowed us to examine the impact of early adversity on functional network 
connectivity while limiting the confounding effects of psychiatric symptomatology and 
psychotropic medication use. Third, residuals from task-regressed timeseries, while 
similar, are not identical to true resting state data (Fair et al., 2007b). However, that ACE 
results were replicated in a separate set of residual timeseries lends confidence to our 
results. Third, the sample size of 40 is relatively small. However, the double-blind, 
placebo-controlled, cross-over study design using repeated-measures allowed for 
decreased variance in estimates of condition effects and increased power to detect 
between group differences.  
 
4.2 Conclusions 
In summary, these data suggest that early life adversity has lasting impacts on 
functional network connectivity in healthy menopausal women. These results provide 
preliminary evidence regarding the mechanisms by which early life adversity confers a 
vulnerability for executive dysfunction during menopause. Further research in a larger 
sample would be helpful in elucidating the impact of timing of early life adversity on brain 
networks and whether sex-differences exist with regard to TD and ACE effects on 
connectivity. 
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Table 4-1. Participant characteristics 
  Low ACE High ACE 
  Mean (SD) or number (%) 
n 24 16 
Age (years) 55.5 (3.3) 55.1 (3.1) 
Months since last menstrual period 53.7 (33.0) 62.3 (30.9) 
Follicle-stimulating hormone (IU/L)  93.5 (32.5) 74.0 (40.8) 
Estradiol (pg/mL) 27.1 (17.7) 22.7 (11.3) 
Education     
Graduate 14 (58) 2 (13) 
Some Graduate 1 (4) 3 (29) 
College 4 (17) 6 (38) 
Some College 2 (8) 5 (31) 
Associates 1 (4) 0 (0) 
High School 2 (8) 0 (0) 
Race     
Caucasian 19 (79) 11 (69) 
African American 3 (13) 4 (25) 
Asian 1 (4) 1 (6) 
Other 1 (4)   
Employment     
Full time 16 (67) 10 (63) 
Part time 2 (8) 5 (31) 
Unemployed 1 (4) 0 (0) 
Retired 2 (8) 0 (0) 
Unknown or preferred not to disclose 0 (0) 1 (6) 
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Figures 
 
Figure 4-1. Power nodes. Nodes in the system of functional networks described by 
Power et al. (Power et al., 2011). In this system, networks are composed of spheres with 
a 5-mm radius (264 nodes) and the connections between these nodes (34,716 unique 
edges). These nodes compose 14 functional network modules that correspond to brain 
networks that are present during both task performance and at rest. This node system 
provides good coverage of the whole brain and has been used to examine functional 
connectivity between and within brain networks during cognitive tasks and at rest. Time 
series were extracted from each of the 264 nodes in subject space using the residuals of 
this subject-level analysis that modeled task and motion. Time series were extracted 
from each of these nodes in subject space. Image is displayed using BrainNet Viewer. 
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Figure 4-2. Mean symmetric connectivity matrices. The mean symmetric connectivity 
matrix of discovery (a) and replication (b) timeseries confirmed nodes demonstrated 
greater connectivity with nodes of the same network than with nodes of different 
networks. The mean symmetric connectivity matrices from these two timeseries 
qualitatively appeared very similar. We evaluated the main effect of cognitive task 
performed on within-network connectivity to assess the validity of using residual 
timeseries from a separate task as the replication dataset. There was no significant 
effect of task (n-back vs emotional identification) on within-network connectivity. This 
effect remained non-significant when accounting for total network strength as well as 
motion. Values displayed are Fisher Z transformed pair-wise Pearson’s correlations. 
Color bars to the left and bottom of connectivity matrices indicate community 
membership. 
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Figure 4-3. ACE and TD effects on within-network connectivity in discovery 
timeseries. a. To test our hypotheses that ACE would be associated with lower within-
network connectivity and that tryptophan depletion would selectively further lower 
connectivity only in the high ACE group, we used a model that evaluated the impact of 
ACE group, TD status, and ACE group x TD status on within-network connectivity. The 
effect of ACE in this model was robust; as predicted, connectivity was significantly lower 
in the high ACE group than in the low ACE group during sham depletion (p=0.002). In 
line with out hypothesis that TD would selectively impair the high ACE group, TD had no 
effect on connectivity in the low ACE group. Also as predicted, an interaction between 
ACE group and depletion status on within-network connectivity was observed at a trend 
level (p=0.1). However, contrary to our hypothesis that TD would exacerbate the effect of 
ACE observed during sham TD, active depletion actually increased connectivity in the 
high ACE group (p=0.02). This attenuated the effect of ACE during active TD. As in the 
sham condition, the high ACE group also displayed lower within-network connectivity 
during active TD, though this trend did not reach statistical significance (p=0.1). Bars 
represent least-square means adjusted for age, time since last menstrual period, 
estradiol level, total network strength, and motion. Error bars represent standard error. b. 
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We also examined the effect of the number of ACEs (continuous) using a model that 
evaluated the impact of total ACE score, TD status, and ACE score x TD status. As 
hypothesized and in agreement with our results using ACE group, there was a robust 
effect of ACE score as ACE score was significantly negatively associated with within-
network connectivity during sham depletion (p=0.004). Additionally, there was a 
significant ACE score x TD status interaction on within-network connectivity (p=0.04). 
Consistent with our TD x ACE group analysis, active TD diminished the impact of ACE 
score; there was no association between total ACE score and within-network 
connectivity during active TD (p=0.2). The effect of all covariates included in analyses 
have been regressed from the connectivity values depicted. ACE= adverse childhood 
experiences; TD = tryptophan depletion; *p ≤ 0.1, **p ≤ 0.5, ***p ≤ 0.01 
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Figure 4-4. ACE and TD effects on within-network connectivity in replication 
timeseries. a. To probe the validity of our results, we tested our hypotheses regarding 
the impact of ACE and TD on functional connectivity using a separate set of task-
regressed timeseries data acquired in a subsample of our participants. As in the 
discovery dataset, we used a model that evaluated the impact of ACE group, TD status, 
and ACE group x TD status on within-network connectivity to test our hypotheses that 
ACE would be associated with lower connectivity and that tryptophan depletion would 
selectively lower connectivity only in the high ACE group. The effect of ACE group was 
robust and consistent with discovery results. Within-network connectivity was 
significantly lower in the high ACE group during both sham TD (p=0.002) and active TD 
(p=0.05). The effect of TD in the low ACE group was also replicated and remained non-
significant. However in contrast to discovery results, there was no significant ACE group 
x TD status interaction and no effect of TD in the high ACE group. Bars represent least-
square means adjusted for age, time since last menstrual period, estradiol level, global 
connectivity, and motion. Error bars represent standard error. b. We also attempted to 
replicate our findings regarding the continuous effects of ACE using a model that 
evaluated the impact of total ACE score, TD status, and ACE score x TD status. 
Consistent with our hypothesis and analyses using ACE group, total ACE score was 
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significantly negatively associated with within-network connectivity during sham TD 
(p=0.008). As in the discovery dataset, this association did not reach significance during 
active TD. However, it was present at a trend level (p=0.1), and the interaction between 
ACE score and TD status was not significant. The effect of all covariates included in 
analyses have been regressed from the connectivity values depicted. ACE= adverse 
childhood experiences; TD = tryptophan depletion; *p ≤ 0.1, **p ≤ 0.5, ***p ≤ 0.01 
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Table 4-S1. Occurrence of Individual ACEs in Study Sample 
	
  Low ACE High ACE 
Mean ACE 0.29 ± 0.46 3.75 ± 1.18 
Abuse     
Emotional abuse 0 10 
Physical abuse 0 5 
Sexual abuse 1 5 
Neglect     
Emotional neglect 0 9 
Physical neglect 0 1 
Household dysfunction     
Parents divorced/separated 2 8 
Witnessed domestic violence 0 8 
Drug abuse in household 3 6 
Mental illness in household 1 9 
Incarceration of family member 0 0 
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Executive Activation and 
Neurochemistry in Menopausal 
Women with Executive Difficulties  
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Abstract 
Many women with no history of executive dysfunction report difficulties in this 
domain during the menopause transition. Lisdexamfetamine (LDX) has been suggested 
to be a safe and effective treatment option for these women. However, the mechanisms 
by which LDX improves executive functioning in these women is not known. Here we 
investigated the effects of LDX on brain activation and neurochemistry, hypothesizing 
that LDX would be associated with increased activation and decreased glutamate in 
executive regions. Fourteen women underwent multi-modal neuroimaging at 7T at three 
time points in this baseline-corrected, double-blind, placebo controlled, crossover study. 
Effects of LDX on symptom severity, BOLD signal, and DLPFC glutamate + glutamine 
(Glx) were measured using a clinician-administered questionnaire, fMRI during 
performance of a fractal n-back task, and 1H-MRS, respectively. The effect of treatment 
(LDX minus baseline vs. placebo minus baseline) on these behavioral and neural 
markers of executive function was examined using repeated measures mixed-effects 
models. LDX treatment was associated with decreased symptom severity, increased 
activation in the insula and DLPFC, and decreased DLPFC Glx. Additionally, magnitude 
of LDX-induced improvement in symptom severity predicted both direction and 
magnitude of LDX-induced change in insular and DLPFC activation. Moreover, symptom 
severity was positively correlated with Glx concentration in the left DLPFC at baseline. 
These findings provide novel evidence that the neural mechanisms by which LDX acts to 
improve self-reported executive functioning in healthy menopausal women with midlife 
onset of executive difficulties include modulation of insular and DLPFC recruitment as 
well as decrease in DLPFC Glx concentration.  
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Introduction 
During the menopause transition, many women with no history of executive 
functioning deficits report cognitive difficulties in domains including working memory, 
organization, focus, and attention (Epperson et al., 2011). This midlife onset of executive 
difficulties may be a result of reduced estradiol modulation of the executive system 
(Shanmugan and Epperson, 2014). Proper executive functioning depends on the 
neurochemical environment of executive regions including the dorsolateral prefrontal 
cortex (DLPFC), the region of the prefrontal cortex (PFC) critical for attention and 
working memory (Arnsten and Jin, 2014). PFC function has been characterized as an 
inverted U-shaped curve such that optimal executive function (EF) depends on a 
balance of factors including baseline monoaminergic and glutamatergic function 
(Arnsten and Jin, 2014) as well as hormonal status (Jacobs and D'Esposito, 2011). In 
such a model, a decrease in estradiol levels during menopause could cause executive 
difficulties in women whose genetics or previous life experiences make them susceptible 
to such a cognitive decline (Kudielka et al., 2009; Shanmugan and Epperson, 2014; 
Culpepper, 2015) (Figure 5-1). 
Estradiol affects working memory through modulation of PFC dopamine activity. 
In women who metabolize dopamine more quickly, low estradiol levels result in improper 
PFC activation during working memory tasks (Jacobs and D'Esposito, 2011). Preclinical 
models have suggested estradiol modulation of glutamatergic function may be an 
additional mechanism by which estradiol loss induces changes in cognition. Estradiol 
loss reduces the density of healthy dendritic spines in the DLPFC (Bailey et al., 2011) 
that are necessary for communication between delay cells (Wang and Arnsten, 2015), 
neurons capable of maintaining representations across a delay in the absence of 
sensory input. Loss of this regulation could lead to disinhibition of neurons that fire in 
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response to a stimulus, potentially resulting in higher DLPFC glutamate levels and worse 
EF (Wang and Arnsten, 2015). 
 As such, interventions that increase dopamine and decrease glutamate may 
improve executive difficulties induced by loss of estradiol input to the PFC during 
menopause. We have shown lisdexamfetamine (LDX), a stimulant medication, 
successfully improves subjective measures of EF in menopausal women with self-
reported new onset executive difficulties (Epperson et al., 2015). In addition to 
increasing extracellular dopamine and norepinephrine, stimulants also have direct and 
indirect effects on striatal and cortical glutamate critical to optimal PFC function 
(Paspalas and Goldman-Rakic, 2005). 
Previous studies have shown that stimulant medications increase blood oxygen 
level dependent (BOLD) signal in executive regions, including the insula (Rubia et al., 
2014) and DLPFC (Wong and Stevens, 2012) in subjects with ADHD. Additionally, 
stimulants also decrease glutamate levels in the PFC of children with ADHD (Wiguna et 
al., 2012). However, no neuroimaging studies examining the effect of LDX on brain 
activation or neurochemistry have been performed. Additionally, whether stimulants 
improve executive deficits in populations other than ADHD with similar cognitive 
difficulties by analogous mechanisms is not known. Furthermore, while preclinical 
studies suggest glutamatergic tone may mediate executive capabilities (Wang and 
Arnsten, 2015), information regarding the role that DLPFC glutamate levels play in EF in 
human subjects is limited. Thus, human subject studies evaluating the effect of 
stimulants on neural markers of executive dysfunction in populations other than ADHD 
are necessary to determine the mechanisms by which such medications improve 
executive deficits in these populations. 
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 Accordingly, here we used multi-modal neuroimaging and a baseline corrected, 
double-blind, placebo controlled, crossover design to examine the effects of LDX on 
executive system recruitment and neurochemistry in 14 healthy menopausal women with 
midlife onset executive dysfunction. We hypothesized LDX would increase executive 
activation during a working memory task and decrease glutamate + glutamine (Glx) 
levels in the DLPFC at rest. Furthermore, we predicted baseline DLPFC Glx levels would 
be reflective of the degree of executive dysfunction.  
 
Methods 
Participants 
Subjects in this study represent a subset of women who participated in a clinical 
trial investigating the effects of LDX on EF (Epperson et al., 2015) and were recruited 
from the parent trial to participate in this neuroimaging adjunct study. Women ages 45 to 
60 with EF difficulty onset during menopause and were within 5 years of their last 
menstrual period (LMP) were eligible to participate. Perimenopausal women had 
irregular menstrual cycles for ≥12 months, no period for ≥ 3 months, and serum follicle 
stimulating hormone (FSH) level of ≥ 20 IU/L. LMP of ≥12 months and serum FSH levels 
≥35 IU/L indicated postmenopausal status. Subjective EF symptom severity was 
assessed using the Brown Attention Deficit Disorder Scale (BADDS) (Brown, 1996). 
BADDS score of ≥ 20 and onset of symptoms coinciding with the initiation of menstrual 
cycle irregularity were required.  
Women with a lifetime history of a DSM-IV psychotic disorder or psychostimulant 
abuse, substance abuse disorder in the previous year, or present Axis I psychiatric 
disorder were excluded. Psychotropic medication use, ET use within the previous 6 
months, positive pregnancy test, Mini-mental Status Examination score < 26, IQ ≤ 90, 
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history of seizures, cardiac disease, active hypertension, claustrophobia, abnormal 
electrocardiogram at screening, left-handedness, and metallic implants were all 
exclusionary. Subjects were excluded from ROI analyses for poor co-registration (n=2). 
Excessive motion (mean relative displacement > 0.5 mm; n=1) was an additional 
exclusionary criterion in whole-brain analyses. 
 
Study Design 
 This study was a double-blind, placebo controlled, crossover study. After 
screening, subjects underwent neuroimaging and cognitive assessment at three time 
points. After baseline, subjects were randomized to one pill of study medication (LDX 20 
mg or placebo) daily for the first week, two pills daily for the second week, and, if 
tolerated, three pills daily for the final 2 weeks of each trial.  Participants were allowed to 
remain in the study if they could tolerate at least 1 pill per day throughout the study. 
Upon completion of the first 4-week trial, participants underwent a 2-week washout and 
were crossed over to the other treatment condition. Testing and imaging were conducted 
approximately 2 – 6 hours after last LDX dose. 
 
Assessment of Executive Function 
Assessment of subjective EF was as previously reported (Epperson et al., 2015). 
Briefly, subjects completed the BADDS, a validated subjective measure of EFs (Sandra 
Kooij et al., 2008). The BADDS is a clinician-administered questionnaire that assesses 
the frequency and severity of five clusters of executive dysfunction: (1) organization and 
activating for work, (2) sustaining attention and concentration, (3) sustaining alertness, 
effort, and processing speed, (4) managing affective interference, and (5) using working 
memory and accessing recall. Subjects rate symptoms on a scale from 0 to 3, with 0 
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meaning the problem described does not relate to them and 3 indicating the problem 
occurs almost daily. Subjects also completed an out-of-scanner cognitive battery 
consisting of a letter n-back task, NYU paragraph recall task, and Penn Continuous 
Performance Task to assess working memory, verbal memory, and sustained attention, 
respectively (See Epperson et al, 2015 for further detail).  
 
fMRI Task paradigm 
Subjects completed a fractal n-back task (Ragland et al., 2002) with 3 conditions 
(0-, 2-, and 3-back) during each scan to probe working memory. Subject performance 
was monitored to ensure adequate task engagement. See Supplementary Methods for 
further detail. 
 
Image Processing 
Imaging data were acquired on 7T Siemens Trio scanner (Supplementary 
Methods). In comparison to 3T, the higher signal to noise ratio and greater sensitivity to 
BOLD signal at 7T allows for increased ability to distinguish differences between 
conditions, though 7T is more sensitive to distortion and artifacts.  
Timeseries were analyzed with FEAT (fMRI Expert Analysis Tool) 
(Supplementary Methods). To determine the effect of treatment (active-baseline vs. 
placebo-baseline), mean signal change for the 3-back contrast was extracted from 
functionally defined ROIs in the right and left DLPFC, medial frontal/cingulate gyrus 
(MF/CG), right and left insula, right and left parietal cortex, and posterior cingulate 
cortex. ROI masks for these regions were functionally defined using the parametric 
contrast of the group mean of all sessions (baseline, active, and placebo). The activation 
map of the group mean of the parametric contrast was cluster corrected at a voxel 
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threshold of z>4.5 and cluster probability of p <0.001 (Woolrich et al., 2009). ROI masks 
were transformed into subject space using FLIRT. An exploratory whole brain analysis 
using a two sample paired t-test in FSL was also performed on the 3-back contrast to 
characterize the effect of treatment (active vs. placebo). Type I error control was 
provided by cluster correction using Gaussian Random Field Theory (voxel height of z 
>1.6; cluster probability of p <0.05).  
 
MRS and Quantification of Glutamate 
Water reference single voxel spectroscopy (SVS) and water suppressed SVS 
scans were obtained on a voxel placed in the left DLPFC (15x30x20 mm3) 
(Supplementary Figure 5-1a). Voxels were placed approximately 1 cm from the skull to 
avoid lipid contamination. Automated shimming of the B0 field was performed on the 
voxel to obtain localized water line width of ~20 Hz or less using FASTMAP. Variable 
power RF pulses with optimized relaxation delays (Tkac et al., 1999) were used to obtain 
water suppression spectra (Cai et al., 2012).  SVS for Glx were obtained using short TE 
SVS with modified Point-Resolved Spectroscopy sequence (PRESS) having the 
following parameters: spectral width=4kHz, number of points=2048, averages=16 (water 
reference) or 64 (water suppressed), TE=20 ms, TR=3000 ms. Chemical shift artifact for 
Glx was minimized by setting water acquisition spectrum excitation and refocusing 
pulses in resonance with the water peak at 4.7ppm, and also setting water suppressed 
spectrum excitation and refocusing pulses in resonance with the Glx peak at 2.35ppm. 
Water reference data were used to obtain channel wise time dependent phase 
shifts due to eddy current and amplitude scale factors. Using a fitting method validated 
by Cai et al. (Cai et al., 2012) metabolite peaks from water suppressed spectrum were 
fitted as Lorentzian functions with non-linear least squares fitting using lsqcurvefit in 
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MATLAB. This procedure accounted for amplitudes, line widths and peak positions for 8 
macromolecular and 14 metabolite peaks. Normalization by water reference signal 
allowed for quantification of Glx (Supplementary Figure 5-1b). See Supplementary 
Information for goodness of fit assessment.  
 
Statistical Analysis 
Mixed effects models were employed to compare the BADDS scores, cognitive 
task performance, BOLD in ROIs, and glutamate levels measured at the end of the 
active trial minus baseline vs. those measured at the end of the placebo minus baseline 
for each participant to account for repeated measures. While the parametric activation 
map used to identify ROIs was corrected for multiple comparisons using Gaussian 
Random Field Theory (Woolrich et al., 2009), we did not further correct for the number of 
ROIs examined and p-values reported are uncorrected.  BMI was included as a 
covariate in models examining the effect of LDX on BOLD and glutamate to ensure LDX-
induced change in BMI did not affect results. Age and the proportion of grey matter in 
the spectroscopy voxel were included as covariates in a model examining the drug effect 
on glutamate (Supplementary Results).   
Spearman rank-order correlations were used to compare 1) BADDS scores to 
glutamate levels at baseline and 2) change in BADDS scores between active and 
baseline to change in BOLD between active and baseline. Association between 
glutamate and BOLD was evaluated with linear regression. Measures of anxiety, 
depression, sleep, and overlap between BOLD and spectroscopy voxels were controlled 
for in supplementary analyses (Supplementary Methods). The effect of LDX on n-back 
performance was evaluated using mixed effects models with condition as a 3-level 
predictor variable to minimize the effect of missing data.   
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Results 
Participants 
Eighteen subjects from the parent clinical trial were enrolled in this neuroimaging 
adjunct study. Of these 18 subjects, 14 subjects completed all 3 imaging session. One 
subject was unable to see the screen during the fMRI task and did not complete the 
baseline session, two subjects withdrew after the baseline session, and one subject was 
unable to tolerate being in the scanner during her final scan due to nasal congestion. 
Baseline characteristics for the 14 women who completed both active LDX and placebo 
conditions are depicted in Table 5-1. The order of active and placebo visits across these 
14 women was counterbalanced: 7 received active first and 7 received placebo first. The 
14 subjects who completed imaging had higher total BADDS scores at baseline than 
subjects from the parent clinical trial who did not participate in this imaging adjunct study 
(imaging: 44.7 ± 17.8; other: 28.6 ± 12.3; t=-3.01, DF=30, p=0.005) but were similar in 
terms of age, race, education (See Supplementary Information for Methods). All but two 
participants finished each trial taking three pills per day.  One participant experienced 
jitteriness and increased heart rate after increasing from one to two pills and remained 
on one pill for the remainder of the trial (Active LDX).  The other experienced an 
increase in blood pressure upon increasing from two to three pills and remained on two 
pills for the remainder of that trial (Placebo).   
 
Behavioral Results 
LDX significantly decreased total BADDS (F=26.6, DF=13, p<0.0002) (Figure 5-
2a, Supplementary Figure 5-2a) and each BADDS subscale (organization/activation for 
work, F=14.3, DF=13, p=0.002; attention/concentration, F=31.7, DF=13, p<0.0001; 
alertness/effort/processing speed, F=12.3, DF=13, p=0.004; managing affective 
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interference, F=4.8, DF=13, p=0.05; working memory/accessing recall, F=14.4, DF=13, 
p=0.002) (Figure 5-2b, Supplementary Figure 5-2b). While there was a trend towards 
an effect of LDX in decreasing out-of-scanner 2-back true positive reaction time (F=3.2, 
DF=10, p=0.1), no significant effect of LDX was observed on delayed paragraph recall, 
continuous performance task, or in-scanner n-back performance (p>0.05) 
(Supplementary Figure 5-3). 
 
BOLD Results 
As expected, the n-back task robustly activated executive network regions and 
deactivated non-executive regions (Figure 5-3a). ROI analyses demonstrated LDX 
increased activation in the right Insula/IFG (F=20.7, DF=11, p=0.0008) and left DLPFC 
(F=2.9, DF=11, p=0.12) (Figure 5-3b, Supplementary Table 5-1) during the 3-back. 
This robust insular finding remained significant in an exploratory whole-brain analysis 
(MNI coordinates: x=48, y=52, z=18; k=1416) (Figure 5-3c). 
 LDX-induced change in right insula activation was positively associated with 
LDX-induced decrease in total BADDS score (r=0.95, p=<0.0001, t=9.88, DF=11), 
BADDS subscale 1 (r=0.86, p=0.0004, t=5.22, DF=11), and BADDS subscale 3 (r=0.83, 
p=0.0008, t=4.70, DF=11). Similar results were obtained for correlation between LDX-
induced change in activation in the left DLPFC and total BADDS score (r=0.78, p=0.003, 
t=3.90, DF=11), BADDS subscale 1 (r=0.78, p=0.0028, t=3.93, DF=11), and BADDS 
subscale 3 (r=0.81, p=0.0014, t=4.38, DF=11) (Figure 5-3d). Correlations remained 
significant when controlling for measures of anxiety, depression, and sleep 
(Supplementary Results).  
 
Spectroscopy Results 
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LDX was associated with decreased Glx concentration in left DLPFC (F=4.6, 
DF=13, p=0.052) (Figure 5-4a, Supplementary Figure 5-4). Glx values (mean mM ± 
SD) at baseline, active, and placebo were 9.14 ± 0.81, 8.4 ± 1.03, and 8.91 ± 0.86, 
respectively. At baseline, left DLPFC Glx concentration was positively correlated with 
total BADDS (r=0.64, p=0.01, t=2.90, DF=13), BADDS subscale 1 (r=0.70, p=0.005, 
t=3.43, DF=13), and BADDS subscale 3 (r=0.58, p=0.03, t=2.47, DF=13) (Figure 5-4b). 
There were no other significant correlations between Glx and BADDS or between Glx 
and DLPFC BOLD (p>0.05). 
 
Discussion 
 In this double-blind, placebo controlled, cross-over study, we examined the effect 
of LDX on behavioral and neural markers of EF at 7T. To account for the inherent 
variability in the BOLD signal, a repeated measures, baseline corrected study design 
was used. LDX treatment was associated with improved self-reported EF in comparison 
to placebo, as shown by a significant reduction in BADDS scores. Furthermore, LDX 
treatment significantly increased recruitment of executive regions during performance of 
a working memory task. Additionally, LDX treatment decreased Glx concentrations in the 
left DLPFC at rest. Taken together, these data provide novel evidence for the neural 
mechanisms by which this drug acts to improve self-reported EF in previously healthy 
menopausal women with midlife onset of executive difficulties. 
 
Evidence for psychostimulant effects on EF  
  As in the parent clinical trial (Epperson et al., 2015), we found that LDX 
improved EF in this subset of women as measured by self-reported symptom severity. 
We did not, however, find an effect of LDX on working memory task performance. While 
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the task used in this study was validated in a large sample of healthy volunteers (Gur et 
al., 2010), education level has been shown to be correlated with performance on 
executive tasks, particularly the n-back (Gur et al., 2010). Given the large portion of our 
sample that had at least a college degree (79%) and graduate degree (35%), ceiling 
effects from the high performance at baseline likely rendered these tests unable to 
detect any objective improvements in EF.  
 
Evidence for psychostimulant effects on executive activation  
 The most robust finding in the present study is evidence of LDX’s effect of 
increasing activation in the insula/IFG region. This was observed in both an ROI analysis 
at all levels of the n-back task performed as well as in a whole-brain analysis. These 
results accord with a copious literature of neuroimaging studies of stimulant effects in 
individuals with ADHD (Rubia et al., 2014), and moreover highlight the mechanism of 
this drug’s action in a population that exhibits similar executive deficits but who do not 
meet criteria for ADHD. 
A meta-analysis of 14 fMRI data sets found stimulants relative to placebo/off-
medication most consistently increase activation in the insula/IFC (Rubia et al., 2014). 
This finding is present during tasks probing executive domains of interference inhibition 
(Rubia et al., 2014), time discrimination (Rubia et al., 2014) and working memory 
(Spencer et al., 2013). The insula is part of the cinglo-opercular control network critical 
for cognitive control, and is particularly important in the maintenance of task sets and 
error monitoring (Power et al., 2011).  
While the DLPFC is a part of the frontoparietal network supporting goal-directed 
executive processes (Cortese et al., 2012) and is an area implicated in the pathogenesis 
of executive deficits seen in ADHD (Cortese et al., 2012), the effect of stimulants on the 
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DLPFC is inconsistent. Studies have found stimulants increase (Wong and Stevens, 
2012), decrease (Cubillo et al., 2014), or have no effect (Kobel et al., 2009; Rubia et al., 
2014) on DLPFC activation. Such inconsistency may be due in part to the type or 
dosage of medication used and level of working memory load probed (Cubillo et al., 
2014). 
We also found the magnitude of LDX-induced improvement in symptom severity 
predicted both the direction and magnitude of LDX-induced change in both insular and 
DLPFC activation. While subjects with the greatest improvements in BADDS scores 
demonstrated less task-induced activation, subjects with the least improvements in 
BADDS scores demonstrated greater task-induced activation, suggesting that other 
factors such as genetics, adverse childhood experiences, baseline activation and 
symptom severity, and time since last menstrual period impact the relationship between 
LDX treatment and brain and behavioral response. Our observation that LDX treatment 
resulted in an overall increase in DLPFC and insular cortex BOLD (Figures 5-3b – 5-3c) 
was likely driven by the greater proportion of individuals who experienced an increase 
rather than a decrease in activation from baseline (Figure 5-3d). One study found no 
correlation between activation during a stop-signal task and symptom severity after 
controlling for psychostimulant use in adults with ADHD (Congdon et al., 2014). 
However, no studies have looked at the correlation between stimulant-induced changes 
in brain activation during working memory and stimulant-induced changes in symptom 
severity in adults. Thus, our findings make an important step towards understanding 
factors that impact stimulant effects on brain activation and may in part explain the 
contradictory findings (Kobel et al., 2009; Wong and Stevens, 2012; Cubillo et al., 2014; 
Rubia et al., 2014) of stimulants on brain activation in the literature.  
 
129	
	
Evidence for psychostimulant effects on neurochemistry 
A third important finding in this study was that LDX significantly decreases Glx 
concentrations in the DLPFC from baseline in comparison to placebo. Results of the few 
studies that have examined the effect of stimulants on left PFC glutamate levels are 
inconsistent and have shown that stimulants either decrease (Wiguna et al., 2012) or 
have no effect (Carrey et al., 2002; Husarova et al., 2014b) on glutamate concentrations. 
Differential effects of stimulants on glutamate levels have been attributed to differences 
in medication formulation, treatment duration, or a combination of both (Husarova et al., 
2014b). 
Importantly, we found that left DLPFC Glx levels at baseline positively correlated 
with self-reported executive function symptom severity. Only one other study has 
examined the relationship between DLPFC glutamate concentration and subjective 
executive dysfunction symptom severity (Husarova et al., 2014a). While this study found 
no correlation between left DLPFC glutamate and parent-reported symptom severity, 
associations between executive symptom severity and other neurometabolites including 
N-acetylaspartate/creatine, glutamate + glutamine/creatine, and choline/creatine in the 
DLPFC or white matter behind the DLPFC were observed.  However, it is important to 
note that subjects in that study were children who met criteria for ADHD combined 
subtype and almost one-third of subjects also had comorbid oppositional defiant 
disorder.  
 Interestingly, we did not find an association between treatment-induced change 
in Glx and treatment-induced change in symptom severity. This would seem to indicate 
that LDX disrupts the relationship between Glx and symptom severity seen at baseline. 
The implications of the lack of association between these variables with placebo 
treatment is less clear, but could indicate that either placebo also causes a change in 
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neurochemistry, prior LDX treatment alters the relationship between Glx and symptom 
severity, or that the washout period was not of sufficient duration to return the 
relationship between these variables to baseline. Glutamate antagonists have been 
shown to improve symptoms of anxiety and depression in preclinical models (Gerhard et 
al., 2016), suggesting the moderating effect of glutamate on mood symptoms could be a 
confounding factor when evaluating the relationship between glutamate and executive 
symptom severity. However, we found that correlations between Glx and total BADDS 
score remained significant even when controlling for measures of depression and sleep, 
indicating that this relationship is not simply a reflection of the effect of LDX on mood.  
No other studies have directly examined the correlation between stimulant-induced 
changes in left DLPFC Glx and stimulant induced changes in symptom severity.  
 We did not find an association between Glx concentration and BOLD signal in 
the left DLPFC. Interestingly, both of these measures were correlated with the same 
measures of symptom severity: total BADDS, Subscale 1, and Subscale 3. There was 
not, however, an association between neural outcome measures and other BADDS 
subscales even though LDX significantly improved symptoms in all domains, suggesting 
certain subscales may be more sensitive to neural markers of EF in this population. The 
relationship between glutamate concentration and BOLD signal is not well established. 
One study found a positive correlation between dorsal anterior cingulate cortex (ACC) 
glutamate and BOLD during a cognitive control task in several regions including the 
retrosplenial cortex, orbitofrontal cortex, inferior parietal lobule, and basal ganglia 
(Falkenberg et al., 2012). Another study found a positive correlation between 
dorsomedial PFC glutamate and pregenual ACC BOLD during emotional processing 
(Stan et al., 2014). In contrast, another study found no correlation between glutamate 
and BOLD in the ACC or inferior frontal gyrus before, during, or after performance of an 
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interference inhibition task (Kuhn et al., 2015) even though voxel placement was guided 
by individual’s BOLD activity. However, no studies have examined the relationship 
between DLPFC glutamate concentration and activation during a working memory task 
at baseline or with psychostimulant treatment. 
 
Limitations 
 Certain limitations of the present study should be noted. First, the sample size is 
relatively small. However, the repeated-measures design allowed for decreased 
variance in estimates of treatment effects and increased power to detect between group 
differences. Additionally, while the BOLD signal is inherently variable, this study included 
a baseline session allowing comparisons between active and placebo to be baseline 
corrected. Doing so contrasted the minimal differences in behavior, executive activation, 
and Glx concentrations between placebo and baseline with the significant differences 
between active and baseline. Furthermore, the high signal to noise ratio at 7T allows for 
increased ability to distinguish differences between conditions.  
 A second limitation of this study is that 1H-MRS does not distinguish between 
intra- and extracellular glutamate levels. Preclinical studies show the extracellular pool of 
glutamate is between 1-4 micromoles (Lerma et al., 1986). Glutamate measured using 
1H-MRS is between 8-12 millimoles, suggesting our findings are based primarily on the 
intracellular pool of glutamate. Another limitation is the inability to resolve glutamate from 
glutamine, even at 7T, due to spin-spin coupling. However, the small values in Glx fit 
uncertainty (<0.1) and strong intraclass correlation (0.6) between Glx values at baseline 
and placebo suggest robust goodness of fit and test-retest reliability, respectively.  
 Third, current substance abuse could affect both behavioral and imaging 
outcomes and subjects were not required to undergo a drug screen on each test day. 
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However, a clear urine toxicology during screening was required for inclusion in the 
study. Additionally, because these subjects did not have any history of substance abuse, 
substance abuse during the study was unlikely. Fourth, we did not formally assess 
whether participants could accurately guess when they were on active LDX or placebo.  
However, we did examine carry-over effects in the larger clinical trial and did not find any 
order effects on behavioral outcome measures (Epperson et al, 2015) suggesting that if 
participants accurately identified the active LDX from placebo trials, this knowledge did 
not unduly impact our outcomes.    
 
Conclusions 
In summary, these data provide novel evidence regarding the neural 
mechanisms by which stimulants act to improve executive functioning in healthy 
menopausal women with midlife onset of executive difficulties. Further research is 
needed to determine if other factors such as genetics or adverse childhood experiences 
modulate the effect of LDX on glutamate and executive system recruitment. Such 
information could serve as markers of women who may experience cognitive difficulties 
upon entering menopause and of women who would benefit from early intervention. 
Furthermore, the mechanisms by which loss of estradiol and healthy dendritic spines as 
well as higher cortical glutamate concentrations contribute to worse executive 
functioning in human subjects are yet to be elucidated, and future research should 
consider the role of such factors in promoting neuroinflammation and oxidative stress 
(Kitamura et al., 2009). Additional research in a larger sample would be helpful in 
ascertaining whether there is a three-way interaction between symptom severity, BOLD, 
and Glx. A larger sample may also reveal an effect of menopause stage on these 
measures. Executive function has been shown to decline between early and late post-
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menopause (Elsabagh et al., 2007), though declines observed in other cognitive 
domains such as verbal memory (Epperson et al., 2013) suggest executive dysfunction 
may begin earlier. Moreover, it would be important to confirm whether LDX acts by 
similar mechanisms after surgery- or chemotherapy-induced menopause. 
  
134	
	
Table 5-1.   Participant Characteristics 
  Mean (SD) or number (%) 
Age (years) 53.1 (3.0) 
Time since last menstrual period (months) 31.8 (18.1) 
IQ 115.9 (11.3) 
Mini-mental status exam 28.8 (1.1) 
Marital status   
Single 2 (14.3) 
Married 9 (64.3) 
Divorced/separated 2 (14.3) 
Widowed 0 (0) 
Did not disclose 1 (7.1) 
Menopause status   
Perimenopause 2 (14.3) 
Postmenopause 12 (85.7) 
Race   
Caucasian 9 (64.3) 
African American 3 (21.4) 
American Indian/Alaska native 1 (7.1)  
Others 1 (7.1) 
Ethnicity   
Hispanic 0 (0) 
Non-Hispanic 14 (100) 
Education   
High school 1 (7.1) 
Some college/vocational 2 (14.3) 
College graduate/some graduate school 6 (42.9) 
Graduate/professional degree 5 (35.7) 
Household income   
Unknown or did not disclose 4 (28.6) 
< $50,000 2 (14.3) 
$50,000 to $100,000 3 (21.4) 
$100,000 to $200,000 4 (28.6) 
> $200,000 0 (0) 
Employed    
Full time 14 (100) 
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Figure 5-1. Model for effects of estradiol and LDX on executive function. Executive 
functioning capacity depends on the neurochemical environment in the PFC. Within the 
optimum range of neurotransmitter concentrations, represented by the grey 
crosshatching in the figure, normal executive functioning is maintained by a balance of 
factors including dopamine, norepinephrine, and glutamate concentrations as well as 
estradiol level. Where a woman falls on this curve depends on her genetics for 
catecholaminergic and glutamatergic metabolism and signaling as well as hormonal 
status and stress level. Response to stress is modified by numerous factors such as 
age, hormonal and reproductive status, current or previous use of medications such as 
glucocorticoids or psychoactive drugs, smoking, coffee and alcohol consumption, caloric 
intake, genetics, exposure to prenatal stress, birth weight, gestational age, level of early 
family adversity, and position in social hierarchy indicating individual lifestyle choices 
and adverse childhood experiences may impact an individual’s executive functioning 
capacity before and during menopause [reviewed by Kudielka et al., 2009]. Additionally, 
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factors such as depressive symptoms (Culpepper, 2015), substance use, and 
medication side effects (Kudielka et al, 2009) may also contribute to an individual’s 
executive functioning capacity. During menopause, women whose combination of such 
factors place them toward the left of the optimal range may experience executive 
functioning difficulties due to loss of estradiol modulation of prefrontal systems. LDX may 
improve executive functioning in these women by increasing dopamine and 
norepinephrine as well as decreasing glutamate in the PFC, though response to LDX 
should be considered in the context of underlying genetic variability in catecholaminergic 
and glutamatergic neurotransmission. 
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Figure 5-2. LDX improves subjective measures of executive function. The decrease 
in BADDS scores from baseline was significantly greater with LDX versus placebo for 
both (a) total BADDS (F=26.6, DF=13, p<0.0002) as well as (b) each BADDS subscale 
(organization/activation for work, F=14.3, DF=13, p=0.002; attention/concentration, 
F=31.7, DF=13, p<0.0001; alertness/effort/processing speed, =12.3, DF=13, p=0.004; 
managing affective interference, F=4.8, DF=13, p=0.05; working memory/accessing 
recall, F=14.4, DF=13, p=0.002). Error bars represent standard error.  
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Figure 5-3. LDX increases executive activation during working memory. (a) The n-
back task robustly activated executive network regions and deactivated non-executive 
regions, as depicted by the parametric contrast (z>4.5, p<0.001). (b) Recruitment of the 
right insula, and left DLPFC increased with increasing levels of working memory load. 
Values plotted represent mean difference in activation from baseline at each task level. 
Error bars represent standard deviations. (c) Whole-brain analysis using a paired t-test 
(z>1.6, p <0.05) of the 3-back contrast demonstrated that activation in the right insula 
(MNI coordinates: x=48, y=52, z=18; k=1416) was significantly greater than placebo. (d) 
LDX-induced increase in both right insula and left DLPFC BOLD signal from baseline 
during the 3-back was positively correlated with LDX-induced decrease in total BADDS 
Scores as well as BADDS subscales measuring organization/activation for work and 
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alertness/effort/processing speed. Subjects with the greatest improvements in BADDS 
scores demonstrated less task-induced activation with LDX while subjects with the least 
improvements in BADDS scores demonstrated greater task-induced activation with LDX. 
Right insula: total BADDS (r=0.95, p=<0.0001, t=9.88, DF=11); organization/activation 
for work (r=0.86, p=0.0004, t=5.22, DF=11); alertness/effort/processing speed (r=0.83, 
p=0.0008, t=4.70, DF=11). Left DLPFC: total BADDS (r=0.78, p=0.003, t=3.90, DF=11); 
organization/activation for work (r=0.78, p=0.0028, t=3.93, DF=11); 
alertness/effort/processing speed (r=0.81, p=0.0014, t=4.38, DF=11).  
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Figure 5-4. Left DLPFC Glx concentrations. (a) Decrease in left DLPFC Glx 
concentration from baseline was greater with LDX vs placebo (F=4.5, DF=12, p=0.056). 
Error bars represent standard error. (b) At baseline, left DLPFC Glx concentration was 
positively correlated with total BADDS (r=0.64, p=0.01, t=2.90, DF=13) as well as 
BADDS subscales measuring organization/activation for work (r=0.70, p=0.005, t=3.43, 
DF=13) and alertness/effort/processing speed (r=0.58, p=0.03, t=2.47, DF=13).  
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Supplementary Information 
Supplementary Methods 
fMRI Task Paradigm 
Subjects completed a fractal version of the n-back task during each fMRI scan. 
During the task, a fractal was presented for 500 ms followed by a 2500 ms interstimulus 
interval. This task was used to probe working memory and had 3 conditions: 0-, 2-, and 
3-back. Each condition consisted of three 20-trial blocks, each preceded by a 9s 
instruction period, with a target to foil ratio of 1:3. The task included a total of 45 targets 
and 135 foils, as well as three 24 s blocks of rest during which a fixation crosshair was 
displayed. Analyses on in-scanner n-back performance focused on true positives, false 
positives, and reaction time. 
 
Image Acquisition 
Structural and functional images were acquired on 7T Siemens Trio scanner. 
Structural image acquisition sequence consisted of a gradient echo localizer, a 3D 
Magnetization Prepared Rapid Gradient Echo (MPRAGE) whole brain acquisition (TR, 
2110 ms; TE, 3.17 ms; TI, 1500 ms; FOV, 240×180 mm; matrix, 256×192; 160 slices; 
slice thickness, 1 mm; flip angle, 10°; effective voxel resolution, 0.9×0.9×1 mm), and 3D 
reformatting of the MPRAGE data. Functional images were obtained using a whole-
brain, single-shot, multislice, gradient-echo echoplanar sequence (239 volumes; TR, 
3000; TE, 27 ms; flip angle, 70°; FOV, 220×220 mm; matrix 110×110; 37 slices; slice 
thickness 2.2 mm; effective voxel resolution, 2×2×2.2 mm). 
 
Image Processing 
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BOLD timeseries data were analyzed with FEAT (fMRI Expert Analysis Tool) in 
FSL, using skull removal with BET (Smith, 2002), motion-correction with MCFLIRT 
(Jenkinson et al., 2002), high pass filtering, spatial smoothing (6 mm FWHM), and mean-
based intensity normalization. Subject-level timeseries analyses were carried out using 
FILM (FMRIB's Improved Linear Model) with local autocorrelation correction (Woolrich et 
al., 2009). The three condition blocks (0-back, 2-back, and 3-back) were modeled using 
a canonical (double-gamma) hemodynamic response function with standard plus 
extended motion parameters included as nuisance covariates. The rest condition 
(crosshair) served as the unmodeled baseline. The median functional and anatomical 
volumes were co-registered using boundary-based registration (Greve and Fischl, 2009). 
The anatomical image was normalized to the MNI 152 T1 2 mm template using linear 
registration with 12 degrees of freedom. Statistical maps for the contrasts of interest (3-
back) were used in group-level analyses.   
 
MRS and Quantification of Glutamate 
Goodness of fit for the fitting method used to quantify Glx was evaluated on all 
scans for all subjects. Using residuals and the Jacobian matrix  (dYi/dPj) where Yi 
represents the fitted result at point i and Pj represents the parameter j, 90% confidence 
limits were determined for all parameters. Upper and lower integral limits and 
concentrations for Glx were calculated using the amplitude and width limits for these two 
metabolites. Goodness of fit was estimated from these integral limits. Fit uncertainty was 
conservatively represented by the higher of these values. Additionally, test-retest 
reliability of acquisition and fitting methods were evaluated using intraclass correlation, 
which assessed agreement between Glx concentrations at baseline and placebo. An F-
test was used to test whether intraclass correlation is different from zero. 
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Statistical Analysis 
We examined how representative subjects who completed this neuroimaging 
adjunct study were of subjects who participated in the parent clinical trial in terms of age, 
race, education, and baseline BADDS scores. Age and BADDS were assessed using 
pooled t-tests while race and education were assessed using Fisher’s Exact Test. 
Modulation of glutamate has been shown to effectively reduce symptoms of 
depression and anxiety (Gerhard et al., 2016). Primary analyses also included 
Spearman rank-order correlations to compare 1) BADDS scores to Glx levels at baseline 
and 2) change in BADDS scores between active and baseline to change in BOLD signal 
between active and baseline. Therefore, we also included measures of anxiety, 
depression, and sleep in models examining the change in BADDS scores between 
active and baseline to change in BOLD signal between active and baseline in subsets of 
subjects for whom data were available. Anxiety, depression, and sleep were assessed 
using the Beck Anxiety Inventory, Beck Depression Inventory, and Pittsburgh Sleep 
Quality Index, respectively. Baseline scores for these indices were used as covariates in 
the model examining correlations between BADDS scores to Glx levels at baseline.  
BMI was included as a covariate in models examining the effect of LDX on BOLD 
and Glx to ensure LDX-induced change in BMI did not affect results.  
Separate linear regression models were used to test for association between Glx 
and BOLD signal at each condition (baseline, active, placebo). These models were 
repeated with distance between peak of the BOLD signal and the center of the 
spectroscopy voxel was included as a covariate to account for variations in overlap 
between the functionally defined DLPFC ROI and DLPFC spectroscopy voxel. The 
functionally defined left DLPFC ROI is superficial with respect to cortical tissue making 
voxel placement for spectroscopy somewhat of a challenge, as any overlap of the voxel 
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with skull would introduce lipid contamination and partial voluming, obscuring results. 
While we measured Glx before individuals performed the n-back in order to avoid any 
potential impact of task activation effecting Glx levels, we could not ensure the voxel 
used for MRS of Glx always completely overlapped with the functionally defined ROI 
used for BOLD analyses. However, distance between peak of the BOLD signal and the 
center of the spectroscopy voxel was included as a covariate to account for variations in 
overlap between the functionally defined DLPFC ROI and DLPFC spectroscopy voxel. 
This metric was calculated as follows. The group level DLPFC ROI was transformed into 
subject space using FLIRT and binarized with fslmaths. This mask was multiplied by the 
subject’s zstat image to isolate the subject’s BOLD signal within the DLPFC voxel. This 
image was then transformed to the same T1 space as the subject’s spectroscopy voxel. 
Fslstats was then used to obtain the coordinates of the peak of the bold signal and the 
center of the spectroscopy voxel.  
The volume of grey matter in the spectroscopy voxel relative to the total volume 
of grey matter, white matter, and CSF was determined as follows. FAST was used to 
segment each skull-stripped T1 image into grey matter, white matter, and CSF. Each 
segmented image was then multiplied by a mask of the subject’s spectroscopy voxel to 
obtain the number of volumes of grey matter, white matter, and CSF in this voxel. Age 
and proportion of grey matter volume in the spectroscopy voxel were included as 
covariates in a model examining the effect of LDX on Glx. 
 
Supplementary Results 
BOLD Results 
In the right insula, results were similar to the unadjusted model (F=20.7, DF=11, 
p=0.0008) when controlling for the effects of BMI (F=17.6, DF=9, p=0.0023), anxiety 
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(F=9.1, DF=7, p=0.019), depression (F=24.0, DF=9, p=0.0009), and sleep (F=14.1, 
DF=9, p=0.0046). In the left DLPFC, results were similar to the unadjusted model 
(F=2.9, DF=11, p=0.12) when controlling for the effects of BMI (F=2.2, DF=9, p=0.17), 
anxiety (F=2.1, DF=7, p=0.19), depression (F=4.8, DF=9, p=0.06), and sleep (F=2.5, 
DF=9, p=0.15). 
As stated in the primary manuscript, significant correlations were observed 
between LDX-induced change in activation in the right insula and total BADDS score, 
BADDS subscale 1, and BADDS subscale 3. The correlation between LDX-induced 
change in activation and LDX-induced change in total BADDS score remained significant 
when controlling for measures of anxiety (p<0.0004, t=7.07, DF=8), depression 
(p<0.0001, t=7.04, DF=10), and sleep (p<0.0001, t=9.05, DF=10). Correlations also 
remained significant for BADDS subscale 1 (anxiety p<0.008, t=3.99, DF=8; depression 
p<0.005, t=3.09, DF=10; sleep p<0.002, t=4.71, DF=10) and BADDS subscale 3 (anxiety 
p<0.02, t=3.58, DF=8; depression p<0.02, t=3.13, DF=10; sleep p<0.003, t=4.41, 
DF=10). Likewise, the correlation between LDX-induced change in left DLPFC activation 
and LDX-induced change in total BADDS score remained significant when controlling for 
measures of anxiety (p=0.0007, t=6.42, DF=8), depression (p<0.03, t=2.64, DF=10), and 
sleep (p<0.007, t=3.65 DF=10). Results were similar for BADDS subscale 1 (anxiety 
p<0.005, t=3.99, DF=8; depression p<0.03, t=2.81, DF=10; sleep p<0.006, t=3.72, 
DF=10) and BADDS subscale 3 (anxiety p<0.002, t=5.31, DF=8; depression p<0.007, 
t=3.66, DF=10; sleep p<0.003, t=4.22, DF=10). 
 
 
Spectroscopy Results 
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The SNR for NAA, Glx, Cho, and Cr is ~110, ~20, 60, and 90, respectively. 
fWHM for NAA and Cr are ~18 Hz (We used line broadening of 6Hz when processing 
raw data). Glx fit uncertainty (mean ± SD) was 0.096 ± 0.082, 0.095 ± 0.068, and 0.093 
± 0.087 at baseline, placebo and active conditions, respectively. The intraclass 
correlation between baseline and placebo was 0.63 (F(6,7)=4.35, p=0.038). 
As stated in the main manuscript, significant correlations were observed between 
baseline Glx concentration in the left DLPFC and total BADDS score, BADDS subscale 
1, and BADDS subscale 3. The correlation between Glx and total BADDS score 
remained significant when controlling for measures of sleep (p<0.04, t=2.49, DF=10) but 
not measures of anxiety or depression (p>0.05). Correlations also remained significant 
for BADDS subscale 1 when measures of sleep (p<0.01, t=3.05, DF=13) and depression 
(p<0.03, t=2.60, DF=13) were included, though correlations between Glx and BADDS 
subscale 3 were no longer significant. 
To examine whether variations in voxel placement in relation to the BOLD peak 
could be affecting results, we calculated a distance metric that was a measure of the 
distance between the peak of the BOLD signal and the center of the spectroscopy voxel. 
However, including this distance metric as a covariate did not alter results and 
correlations between Glx and BOLD did not reach significance.  
To ensure LDX-induced decreases in Glx were not due to changes in the amount 
of grey matter in the spectroscopy voxel, we examined the proportion of grey matter in 
the voxel at each time point. A mixed model was used to determine whether the 
proportion of grey matter within this voxel differed by condition. There was no significant 
difference in this ratio across conditions (F=0.27, Numerator DF=2, Denom DF = 26; 
p=0.77) (Supplementary Figure 5). This proportion (mean ± SD) was 0.17 ± 0.06, 0.17 ± 
0.07, and 0.16 ± 0.05 at baseline, active, and placebo, respectively. Results were 
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consistent with the original model examining the effect of LDX on Glx concentration 
when the change in this proportion between baseline and condition was included as a 
covariate (F=4.72, Num DF=1, Denom Df=12, p=0.051). 
Effects of LDX on Glx concentration were similar when BMI (p=0.058, t=-2.10, 
DF=12) and age (p=0.056, t=-2.10, DF=13) were included as covariates.  
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Supplementary Tables 
 
Region k Peak z x y z 
  
    
  
Activation 
    
  
Frontal Pole, Right DLPFC 1935 6.55 36 40 18 
Precentral Gyrus, Left DLPFC 1360 6.03 -34 -6 42 
MF/CG 897 6.14 2 8 54 
Right Parietal lobe 473 5.89 42 -48 46 
Right Insular Cortex 379 6.49 30 22 6 
Left Insular Cortex 356 5.96 -28 22 4 
Left Parietal lobe 320 6.31 -50 -48 40 
  
    
  
Deactivation 
    
  
Occipital Pole, PCC 5243 5.6 -18 -94 26 
            
 
Supplementary Table 5-1. Effect of n-back task on executive and non-executive 
regions. Performance of the n-back task robustly activated executive regions (z>4.5, 
p<0.001) and deactivated non-executive regions (z>1.9, p<0.05).  Values displayed for 
mean of parametric contrast for all sessions.  
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Supplementary Figures 
 
 
Supplementary Figure 5-1. 1H-MRS of left DLPFC voxel. (a) Localization of 
spectroscopy voxel in the left DLPFC. (b) Representative water suppressed raw 
spectrum, fitted spectrum, and difference spectrum from one scan session.  
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Supplementary Figure 5-2. BADDS scores across the study. BADDS scores 
measured across the study for total BADDS (a) and BADDS subscales (b) Error bars 
represent standard error.  
 
 
 
 
Supplementary Figure 5-3. In-scanner n-back performance across the study. 
Accuracy (% correct) (a) and true positive reaction time (b) measured across the study. 
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Supplementary Figure 5-4. Glx measurements across the study. Left DLPFC Glx 
concentrations measured across the study. Error bars represent standard error.  
 
 
 
 
Supplementary Figure 5-5. Proportion of grey matter volume in Left DLPFC 
spectroscopy voxel across the study. The proportion of grey matter in the 
spectroscopy voxel did not significantly differ at any time point. This value (mean ± SD) 
was 0.17 ± 0.06, 0.17 ± 0.07, and 0.16 ± 0.05 at baseline, active, and placebo, 
respectively. Error bars represent standard error. 
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CHAPTER 6  
	
Early Adversity as a Moderator of 
Lisdexamfetamine’s Effects on 
Executive Function in Menopausal 
Women: An Addendum to Chapter 5 
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Rodent studies have indicated that early life stress may increase sensitivity to 
amphetamine (Zimmerberg and Shartrand, 1992; Rentesi et al., 2013). Therefore, in this 
addendum to chapter 5, we examined whether adverse childhood experiences (ACE) 
altered brain and behavioral response to lisdexamfetamine (LDX) in menopausal women 
with subjective cognitive complaints. We hypothesized that women with high levels of 
early life adversity would demonstrate greater response to LDX vs placebo in 
comparison to women with low levels of early life adversity. Specifically, we predicted 
that high ACE women would report greater symptom improvement with LDX than low 
ACE women. We also predicted that high ACE women would show a greater increase in 
insula activation and a greater decrease in dorsolateral prefrontal cortex (DLPFC) 
glutamate concentration from baseline with LDX than low ACE women. 
 
Methods 
Inclusion and exclusion criteria, study design, assessment of executive function, 
image acquisition and processing, and quantification of glutamate were as described in 
chapter 5 (Shanmugan et al., 2017) but are reproduced below for completeness. 
 
Participants 
Subjects in this addendum represent a subset of women who participated in a 
clinical trial investigating the effects of LDX on executive function (Epperson et al., 
2015). Women ages 45 to 60 with EF difficulty onset during menopause and were within 
5 years of their last menstrual period (LMP) were eligible to participate. Perimenopausal 
women had irregular menstrual cycles for ≥12 months, no period for ≥ 3 months, and 
serum follicle stimulating hormone (FSH) level of ≥ 20 IU/L. LMP of ≥12 months and 
serum FSH levels ≥35 IU/L indicated postmenopausal status. Subjective EF symptom 
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severity was assessed using the Brown Attention Deficit Disorder Scale (BADDS) 
(Brown, 1996). BADDS score of ≥ 20 and onset of symptoms coinciding with the 
initiation of menstrual cycle irregularity were required. 
Women with a lifetime history of a DSM-IV psychotic disorder or psychostimulant 
abuse, substance abuse disorder in the previous year, or present Axis I psychiatric 
disorder were excluded. Psychotropic medication use, ET use within the previous 6 
months, positive pregnancy test, Mini-mental Status Examination score < 26, IQ ≤ 90, 
history of seizures, cardiac disease, active hypertension, and abnormal 
electrocardiogram at screening were all exclusionary. Left-handedness, metallic 
implants, and claustrophobia were additional exclusion criteria for subjects who 
underwent neuroimaging. Subjects were excluded from ROI analyses for poor 
coregistration (n = 2).  
 
Study Design 
This study was a double-blind, placebo-controlled, crossover study. After 
screening, subjects underwent neuroimaging	 and cognitive assessment at three time 
points. After baseline, subjects were randomized to one pill of study medication (LDX 20 
mg or placebo) daily for the first week, two pills daily for the second week, and, if 
tolerated, three pills daily for the final 2 weeks of each trial. Participants were allowed to 
remain in the study if they could tolerate at least 1 pill per day throughout the study. 
Upon completion of the first 4-week trial, participants underwent a 2-week washout and 
were crossed over to the other treatment condition. Testing and imaging were conducted 
∼ 2–6 h after last LDX dose. 
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Assessment of Executive Function 
Assessment of subjective EF was as previously reported (Epperson et al., 2015). 
Briefly, subjects completed the BADDS, a validated subjective measure of EFs (Sandra 
Kooij et al., 2008). The BADDS is a clinician-administered questionnaire that assesses 
the frequency and severity of five clusters of executive dysfunction: (1) organization and 
activating for work, (2) sustaining attention and concentration, (3) sustaining alertness, 
effort, and processing speed, (4) managing affective interference, and (5) using working 
memory and accessing recall. Subjects rate symptoms on a scale from 0 to 3, with 0 
meaning the problem described does not relate to them and 3 indicating the problem 
occurs almost daily.  
 
Assessment of early life adversity 
The Adverse Childhood Experiences Questionnaire (Felitti et al., 1998) was used 
to assess history of emotional, physical, or sexual abuse, childhood neglect, and 
household dysfunction. Number of exposures was summed to create the ACE score 
(range: 0–10). Subjects with an ACE score ≥ 2 were considered “high ACE” while 
subjects with ACE score of < 2 were considered “low ACE”. A threshold of 2 was used to 
define the high ACE group based on studies of depression prevalence in later life that 
demonstrate increased susceptibility at this level of exposure (Chapman et al., 2004; 
Epperson et al., In Press). 
 
fMRI Task Paradigm 
Subjects completed a fractal version of the n-back task during each fMRI scan. 
During the task, a fractal was presented for 500 ms followed by a 2500 ms interstimulus 
interval. This task was used to probe working memory and had 3 conditions: 0-, 2-, and 
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3-back. Each condition consisted of three 20-trial blocks, each preceded by a 9s 
instruction period, with a target to foil ratio of 1:3. The task included a total of 45 targets 
and 135 foils, as well as three 24 s blocks of rest during which a fixation crosshair was 
displayed. Analyses on in-scanner n-back performance focused on true positives, false 
positives, and reaction time. 
 
Image Acquisition 
Structural and functional images were acquired on 7T Siemens Trio scanner. 
Structural image acquisition sequence consisted of a gradient echo localizer, a 3D 
Magnetization Prepared Rapid Gradient Echo (MPRAGE) whole brain acquisition (TR, 
2110 ms; TE, 3.17 ms; TI, 1500 ms; FOV, 240×180 mm; matrix, 256×192; 160 slices; 
slice thickness, 1 mm; flip angle, 10°; effective voxel resolution, 0.9×0.9×1 mm), and 3D 
reformatting of the MPRAGE data. Functional images were obtained using a whole-
brain, single-shot, multislice, gradient-echo echoplanar sequence (239 volumes; TR, 
3000; TE, 27 ms; flip angle, 70°; FOV, 220×220 mm; matrix 110×110; 37 slices; slice 
thickness 2.2 mm; effective voxel resolution, 2×2×2.2 mm). 
 
Image Processing 
BOLD timeseries data were analyzed with FEAT (fMRI Expert Analysis Tool) in 
FSL, using skull removal with BET (Smith, 2002), motion-correction with MCFLIRT 
(Jenkinson et al., 2002), high pass filtering, spatial smoothing (6 mm FWHM), and mean-
based intensity normalization. Subject-level timeseries analyses were carried out using 
FILM (FMRIB's Improved Linear Model) with local autocorrelation correction (Woolrich et 
al., 2009). The three condition blocks (0-back, 2-back, and 3-back) were modeled using 
a canonical (double-gamma) hemodynamic response function with standard plus 
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extended motion parameters included as nuisance covariates. The rest condition 
(crosshair) served as the unmodeled baseline. The median functional and anatomical 
volumes were co-registered using boundary-based registration (Greve and Fischl, 2009). 
The anatomical image was normalized to the MNI 152 T1 2 mm template using linear 
registration with 12 degrees of freedom.  
 
Functional ROI analysis 
Functional ROIs were defined using the parametric contrast of the group mean of 
all sessions (baseline, active, and placebo) for subjects who completed the 
neuroimaging adjunct study (Shanmugan et al., 2017). The activation map of the group 
mean of the parametric contrast was cluster corrected at a voxel threshold of z > 4.5 and 
cluster probability of p<0.001 (Woolrich et al., 2009). While this analysis identified 8 
functionally defined regions, we limited our analysis of ACE x LDX effects specifically to 
outcomes where the effect of LDX was significant in chapter 5. However, in chapter 5, 
we examined the effect of LDX on BOLD in 8 regions and therefore restricted statistical 
tests on BOLD to the 3-back condition to limit multiple comparisons. Because we focus 
only on the right insula in this chapter, we evaluated the effect of ACE x LDX at each 
condition of working memory load. Therefore, mean signal change for the 0-back, 2-
back, and 3-back contrast was extracted from this functionally defined right insula ROI. 
The ROI mask was transformed into subject space using FLIRT.  
 
MRS and Quantification of Glutamate 
Water-reference single voxel spectroscopy (SVS) and water- suppressed SVS 
scans were obtained on a voxel placed in the left DLPFC (15×30×20mm3). Voxels were 
placed ~1cm from the skull to avoid lipid contamination. Automated shimming of the B0 
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field was performed on the voxel to obtain localized water line width of ~ 20 Hz or less 
using FASTMAP. Variable power RF pulses with optimized relaxation delays (Tkac et 
al., 1999) were used to obtain water suppression spectra (Cai et al., 2012). SVS for 
glutamate + glutamine (Glx) was obtained using short TE SVS with modified point-
resolved spectroscopy sequence (PRESS) having the following parameters: spectral 
width = 4 kHz, number of points = 2048, averages = 16 (water reference) or 64 (water 
suppressed), TE = 20 ms, TR = 3000 ms. Chemical shift artifact for Glx was minimized 
by setting water acquisition spectrum excitation and refocusing pulses in resonance with 
the water peak at 4.7 p.p.m., and also setting water-suppressed spectrum excitation and 
refocusing pulses in resonance with the Glx peak at 2.35 p.p.m. 
Water-reference data were used to obtain channel-wise time-dependent phase 
shifts due to eddy current and amplitude scale factors. Using a fitting method validated 
by Cai et al (2012), metabolite peaks from water-suppressed spectrum were fitted as 
Lorentzian functions with nonlinear least squares fitting using lsqcurvefit in MATLAB. 
This procedure accounted for amplitudes, line widths, and peak positions for 8 
macromolecular and 14 metabolite peaks. Normalization by water-reference signal 
allowed for quantification of Glx. 
 
Statistical analysis 
In chapter 5, we demonstrated that, relative to baseline, LDX (vs placebo) 
decreased scores on the Brown Attention Deficit Disorder Scale (BADDS), increased 
activation in the insula, and decreased glutamate in the DLPFC. Here we examined the 
impact of ACE as a moderator of the effect of LDX specifically on these outcomes where 
the effect of LDX was significant. Linear mixed effects models implemented using the 
nlme (Pinheiro et al, 2016) in R (R Core Team, 2015) were employed to test the effect of 
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ACE, LDX, and ACE x LDX on BADDS scores, insula BOLD, and DLPFC glutamate 
measured at the end of the active trial minus baseline vs those measured at the end of 
the placebo trial minus baseline for each participant to account for repeated measures. 
Spearman’s rank-order correlations were used to compare (1) change in BOLD between 
active and baseline to ACE scores, (2) glutamate concentration at baseline to ACE 
score, and (3) change in glutamate concentration between active and baseline to ACE 
score. Statistical tests were two-sided with p<=0.05 considered significant. 
 
Results 
Participants 
The effect of ACE on BADDS scores was evaluated using the sample of 
participants who completed the clinical trial examining the effect of LDX on executive 
function (Epperson et al., 2015). Of the 32 participants who completed this clinical trial, 3 
subjects did not complete the ACE questionnaire and were excluded from analyses. The 
final sample included in analyses of ACE x LDX effects on BADDS (n=29) consisted of 
18 low ACE participants and 11 high ACE participants. The mean +/- SD ACE score in 
the high ACE group was 3.8 +/- 1.6. The effect of ACE on BOLD and glutamate was 
evaluated using the sample of participants who completed the neuroimaging adjunct 
study described in chapter 5 (Shanmugan et al., 2017). One subject in that sample did 
not complete the ACE questionnaire and was excluded from analyses. The final sample 
included in analyses of ACE x LDX effect on BOLD (n=12) consisted of 8 low ACE 
subjects and 4 high ACE subjects. The mean +/- SD ACE score in the high ACE group 
was 3.3 +/- 1.3. The final sample included in analyses of ACE x LDX effect on glutamate 
(n=13) consisted of 8 low ACE subjects and 5 high ACE subjects. The mean +/- SD ACE 
score in the high ACE group was 3.8 +/- 1.6. 
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Behavioral results 
Linear mixed-effects models were used to test the hypothesis that the high ACE 
group would show a greater reduction in symptom severity with LDX vs placebo than the 
low ACE group. A significant ACE x LDX interaction was detected on BADDS scores 
relating to organization and activation for work (p=0.01). Post-hoc comparisons revealed 
that low ACE subjects demonstrated a greater response to placebo than high ACE 
subjects (p=0.03). While there was no significant difference between LDX vs placebo 
treatment in the low ACE group, the high ACE group showed a significantly greater 
reduction in symptoms with LDX treatment in comparison to placebo (p=0.0002; Figure 
6-1). There was no significant effect of ACE or ACE x LDX on total BADDS or other 
BADDS subscales. There was an effect of LDX vs placebo in decreasing total BADDS 
score (low ACE p=0.004; high ACE p=0.02) as well as BADDS subscales assessing 
attention and concentration (low ACE p=0.01; high ACE p=0.09) and alertness, effort, 
and processing speed (low ACE p=0.008; high ACE p=0.07). At a trend level, LDX 
decreased symptoms related to managing affective interference in the high ACE group 
(p=0.09), but had no effect in the low ACE group (p=0.16). In contrast, LDX decrease 
symptoms related to working memory/accessing recall in the low ACE group (p=0.002) 
but had no effect in the high ACE group (p=0.15). These differences in LDX effects 
between ACE groups where the interaction was not significant are likely due to 
insufficient power to detect the drug effect in the small sub-samples. 
 
BOLD results 
In chapter 5, we saw that LDX resulted in an increase in activation in the right 
insula during the 3-back condition (Shanmugan et al., 2017). Given that previous 
literature has indicated that early life stress may increase sensitivity to amphetamine 
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(Zimmerberg and Shartrand, 1992; Rentesi et al., 2013), we tested the hypothesis that 
higher ACE would be associated with a greater increase in BOLD in this ROI with LDX. 
As predicted, an ACE x LDX interaction was present at a trend level in the 0-back 
condition (p=0.06). In the high ACE group, the difference in BOLD between LDX and 
baseline was significantly higher than the difference in BOLD between placebo and 
baseline (p=0.01). In contrast, in the low ACE group, LDX did not significantly change 
BOLD from baseline in comparison to placebo. There was no significant ACE x LDX 
interaction at either 2-back or 3-back. The increase in BOLD signal from baseline was 
significantly greater with LDX than with placebo during both 2-back (low ACE p= 0.006, 
high ACE=0.02) and 3-back (low ACE p=0.009, high ACE p=0.01). The high ACE group 
exhibited greater change in BOLD from baseline with LDX in comparison to the low ACE 
group during the 2-back (p=0.08) and 3-back (p=0.09). While a similar ACE effect was 
present with LDX during the 3-back (p=0.09), there was no difference between ACE 
groups during placebo (p=0.02) (Figure 6-2). 
The above analyses demonstrated that LDX-induced change in BOLD from 
baseline was higher in the high ACE group than in the low ACE group at the higher 
levels of working memory load. To further probe this finding, we examined the 
association between the number of ACEs (continuous) and LDX-induced change in 
BOLD signal. At each level of working memory load, change in BOLD signal was 
correlated with total ACE score, though this correlation only reached significance during 
the 2-back (0-back r=0.47, p=0.1; 2-back r=0.58, p=0.05; 3-back r=0.51, p=0.09; Figure 
6-3). 
 
Spectroscopy results 
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There is preliminary evidence that individuals with a history of early adversity 
may have higher PFC glutamate levels (Duncan et al., 2015), though it is unclear 
whether adversity would moderate the effect of stimulant medications on prefrontal 
glutamate concentration. Based on evidence from rodent studies suggesting increased 
sensitivity to amphetamines with early life stress (Zimmerberg and Shartrand, 1992; 
Rentesi et al., 2013), we hypothesized the difference in LDX-induced change from 
baseline vs placebo-associated change from baseline would be greater in the high ACE 
group compared to the low ACE group. Contrary to this hypothesis, we did not find an 
effect of ACE or an ACE x LDX interaction on DLPFC glutamate concentration. The 
effect of LDX was present at a trend level in this subsample of subjects who completed 
the ACE questionnaire (p=0.1). There was also no significant correlation between total 
ACE score and either baseline glutamate concentration or change in glutamate between 
baseline and active. 
 
Conclusions 
In this double-blind, placebo-controlled, crossover study, we examined whether 
ACE moderates the effect of LDX on behavioral and neural markers of executive 
function. In the high ACE group, LDX (vs placebo) reduced symptoms related to difficulty 
with organization and activation for work. However, response to LDX was not 
significantly different from placebo in the low ACE group. Additionally, the extent to 
which LDX increased activation in the insula increased linearly with total ACE score. 
These findings are in agreement with animal studies indicating that early adversity may 
increase sensitivity to amphetamine. In contrast, there was no effect of ACE or ACE x 
LDX on glutamate concentration in the left DLPFC. Given the literature suggesting that 
early adversity has multiple, complex effects on PFC glutamate systems including 
168	
	
increases in glutamate concentration (Duncan et al., 2015), alterations in NMDA 
receptor subunit composition (Kinnunen et al., 2003), and decreases in glutamatergic 
dendritic spine density in the PFC (Michelsen et al., 2007), this finding is likely due to 
insufficient power in this small sample.  Behavioral and BOLD results provide preliminary 
evidence that early adversity may also have lasting effects on catecholaminergic 
neurotransmission. Furthermore, they emphasize the importance of considering ACE 
when treating executive difficulties with stimulant medications during menopause. 
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Figures
 
Figure 6-1. ACE x LDX effect on BADDS. Linear mixed-effects models were used to 
test the hypothesis that the high ACE group would show a greater reduction in symptom 
severity with LDX vs placebo than the low ACE group. A significant ACE x LDX 
interaction was detected on BADDS scores relating to organization and activation for 
work (p=0.01). Post-hoc comparisons revealed that low ACE subjects demonstrated a 
greater response to placebo than high ACE subjects (p=0.03). While there was no 
significant difference between LDX vs placebo treatment in the low ACE group, the high 
ACE group showed a significantly greater reduction in symptoms with LDX treatment in 
comparison to placebo (p=0.0002). There was no significant effect of ACE or ACE x LDX 
on total BADDS or other BADDS subscales. There was an effect of LDX vs placebo in 
decreasing total BADDS score (low ACE p=0.004; high ACE p=0.02) as well as BADDS 
subscales assessing attention and concentration (low ACE p=0.01; high ACE p=0.09) 
and alertness, effort, and processing speed (low ACE p=0.008; high ACE p=0.07). At a 
trend level, LDX decreased symptoms related to managing affective interference in the 
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high ACE group (p=0.09), but had no effect in the low ACE group (p=0.16). In contrast, 
LDX decrease symptoms related to working memory/accessing recall in the low ACE 
group (p=0.002) but had no effect in the high ACE group (p=0.15). These differences in 
LDX effects between ACE groups where the interaction was not significant are likely due 
to insufficient power to detect the drug effect in the small sub-samples.  
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Figure 6-2. ACE x LDX effect on insular activation. We tested the hypothesis that 
higher ACE would be associated with a greater increase in BOLD in the right insula with 
LDX. As predicted, an ACE x LDX interaction was present at a trend level in the 0-back 
condition (p=0.06). In the high ACE group, the difference in BOLD between LDX and 
baseline was significantly higher than the difference in BOLD between placebo and 
baseline (p=0.01). In contrast, in the low ACE group, LDX did not significantly change 
BOLD from baseline in comparison to placebo. There was no significant ACE x LDX 
interaction at either 2-back or 3-back. The increase in BOLD signal from baseline was 
significantly greater with LDX than with placebo during both 2-back (low ACE p= 0.006, 
high ACE=0.02) and 3-back (low ACE p=0.009, high ACE p=0.01). The high ACE group 
exhibited greater change in BOLD from baseline with LDX in comparison to the low ACE 
group during the 2-back (p=0.08). While a similar ACE effect was present with LDX 
during the 3-back (p=0.09), there was no difference between ACE groups during 
placebo (p=0.2). 
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Figure 6-3. LDX-induced change in activation correlates with ACE score. Figure 2 
demonstrated that LDX-induced change in BOLD from baseline was higher in the high 
ACE group than in the low ACE group at the higher levels of working memory load. To 
further probe this finding, we examined the association between the number of ACEs 
(continuous) and LDX-induced change in BOLD signal. At each level of working memory 
load, change in BOLD signal was correlated with total ACE score, though this correlation 
only reached significance during the 2-back (0-back r=0.47, p=0.1; 2-back r=0.58, 
p=0.05; 3-back r=0.51, p=0.09). 
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CHAPTER 7  
	
Overall Discussion and Future 
Directions 
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Synthesis of results and overall discussion 
During the menopause transition, many healthy women with no history of 
cognitive dysfunction experience subjective difficulties with sustained attention, 
motivation for work, organization and working memory (Epperson et al., 2011; 
Shanmugan and Epperson, 2014; Epperson et al., 2015; Shanmugan et al., 2017). 
Indicators of risk for cognitive decline during menopause are lacking, as is an 
understanding of the mechanisms contributing to this vulnerability with waning estradiol. 
Results of this dissertation support the hypothesis that adverse childhood experiences 
(ACE) is a risk factor for this cognitive decline and that ACE increases the risk of 
executive dysfunction during menopause via alterations in monoaminergic 
neurotransmission. 
In chapter 2, we examined the impact of ACE on subjective and objective 
measures of executive function in a large sample of women who underwent surgical 
menopause. We found that high ACE women reported more subjective symptoms of 
executive dysfunction and performed worse on neuropsychological tasks probing 
working memory and sustained attention. To account for the fact that early adversity is 
associated with increased risk of mood disorders with loss of estradiol (Epperson et al., 
In Press), we conducted mediation analyses to determine the extent to which ACE 
effects on executive function result from concurrent mood (anxiety and depressive 
symptoms) changes. We determined that mood symptoms were a partial mediator of 
ACE effects on subjective symptoms of executive dysfunction and sustained attention. 
However, mood did not mediate ACE effects on working memory. Moreover, ACE 
effects on working memory remained significant when accounting for the effects of mood 
symptoms, age, chemotherapy use, time since oophorectomy, hormone therapy use, 
and education. Together, results of chapter 2 suggest that mood symptoms are one 
177	
	
component of the mechanism underlying new onset cognitive dysfunction with loss of 
estradiol but that at least a portion of ACE-associated risk for executive difficulties is 
independent of the association between ACE and anxiety and depressive symptoms. 
We next pursued these mood-independent mechanisms in chapters 3 through 6. 
Given the strong associations between ACE and mood symptoms in chapter 2, 
we hypothesized that an additional mechanism by which ACE exerts a negative impact 
on executive function during periods of low estradiol may be via effects on serotonin. In 
chapter 3, the effects of tryptophan depletion (TD), ACE, and TD x ACE were evaluated 
using a voxelwise, whole-brain analysis. In the absence of exogenous estradiol, a 
significant TD by ACE interaction was observed on BOLD signal in the right DLPFC such 
that TD increased activation in high ACE subjects but decreased activation in low ACE 
subjects. While a similar interaction was observed with placebo treatment, treatment with 
estradiol attenuated the effects of ACE and TD such that no between or within group 
differences were observed. In chapter 4, we observed a similar ACE x TD interaction on 
within-network connectivity in the absence of exogenous estradiol. While ACE was 
robustly associated with lower within-network connectivity regardless of depletion 
condition, TD increased connectivity in the high ACE group but had no effect on 
connectivity in the low ACE group.  
 Overall, results from chapters 3 and 4 suggest that early life adversity has lasting 
impacts on serotonergic circuits underlying executive function that are unmasked by loss 
of estradiol during menopause. These results also emphasize serotonin’s role in 
executive function and highlight that the moderating effects of early adversity must be 
accounted for when manipulating serotonin levels. Further research targeting specific 
components of the serotonin system would be necessary to pinpoint the molecular 
targets of ACE. In animal models, early life stress is associated with lower tryptophan 
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hydroxylase type 2 gene expression (Shively et al., 2003), higher monoamine oxidase-A 
expression (Wong et al., 2015), and attenuated 5-HT1A function (Matsuzaki et al., 
2009), indicating that future research in human participants should focus on 
understanding how ACE affects serotonin synthesis, metabolism, and signaling during 
menopause. 
While the TD x ACE interactions on DLPFC activation and functional connectivity 
seen in chapters 3 and 4 provided evidence for ACE effects on serotonergic function, the 
robust effects of ACE on functional connectivity that were significant regardless of 
depletion status highlight that ACE effects on serotonin are only part of the story. Given 
the preclinical literature suggesting that ACE negatively impacts other monoaminergic 
systems (Shively, 1998; Matthews et al., 2001; Rentesi et al., 2013), we next examined 
the impact of ACE on dopaminergic and noradrenergic function in menopausal women 
with subjective cognitive complaints.  
We probed catecholaminergic function in women with high and low levels of early 
adversity using lisdexamfetamine (LDX), a stimulant medication that has been shown to 
improve subjective measures of executive function in menopausal women with self-
reported new-onset executive difficulties (Epperson et al., 2015). Because no previous 
imaging studies had utilized LDX, before examining whether ACE altered response to 
this drug, we first characterized the impact of LDX on executive activation and 
neurochemistry in chapter 5. We found that relative to baseline, LDX (vs placebo) 
decreased scores on the Brown Attention Deficit Disorder Scale (BADDS), increased 
activation in the insula, and decreased glutamate in the DLPFC. In chapter 6, we 
examined whether ACE moderated the effect of LDX on these outcomes. A significant 
ACE x LDX interaction was observed on subjective report of executive difficulties related 
to organization and activation for work. In the high ACE group, LDX (vs placebo) 
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reduced these symptoms from baseline while response to LDX was not significantly 
different from placebo in the low ACE group. Additionally, LDX-induced change in insular 
activation correlated with ACE score across varying levels of working memory load. 
These findings are in agreement with animal studies indicating that early adversity may 
increase sensitivity to amphetamine (Zimmerberg and Shartrand, 1992; Rentesi et al., 
2013). Given that stimulants increase dopamine and norepinephrine levels in the PFC 
(Arnsten, 2009, 2011), lower baseline concentrations of catecholamines in the high ACE 
group may play a role in the differential treatment response to LDX. Animal studies 
demonstrating that early adversity is associated with increased dopamine transporter 
(DAT) expression (Novick et al., 2015), increased catechol-o-methyl transferase (COMT) 
expression (Grissom et al., 2015), and increased D2 autoreceptor expression (Lovic et 
al., 2013) and activity (Watt et al., 2014) support this hypothesis. 
In sum, chapters 5 and 6 suggest that early adversity may have lasting effects on 
catecholaminergic neurotransmission. Furthermore, they emphasize the importance of 
considering ACE when treating executive difficulties with stimulant medications during 
menopause. 
In contrast to our findings regarding ACE x LDX effects on subjective symptoms 
of executive dysfunction and brain activation in the insula, there was no effect of ACE x 
LDX effect on glutamate concentration in the left DLPFC. The lack of ACE x LDX 
interaction was surprising given that prior studies have demonstrated that individuals 
with high levels of early adversity have higher PFC glutamate concentrations (Duncan et 
al., 2015). Evidence from rodent studies indicates that early life stress alters the 
composition of N-methyl-D-aspartic acid (NMDA) receptor subunits in the prefrontal 
cortex (Kinnunen et al., 2003), which are important for the persistent firing of 
glutamatergic neurons during working memory and sustained attention (Arnsten and 
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Wang, 2016). Early stress in mice has also been shown to decrease mGluR2 and 
mGluR3 mRNA and protein levels in the frontal cortex (Matrisciano et al., 2012), which 
are important for anxiolytic and anti-psychotic drug response (Marek, 2010). Additionally, 
chronic postnatal stress has been shown to decrease dendritic spine density in the PFC 
of rats (Michelsen et al., 2007). This negative impact of early life stress on dendritic 
spine density is particularly intriguing given that executive functioning is dependent on 
the number of prefrontal small spines (Hara et al., 2012) and the substantial literature 
demonstrating negative effects of ovariectomy and positive effects of estradiol on 
dendritic spine morphology (Shanmugan and Epperson, 2014). Estrogen treatment has 
been shown to reverse both the decreases in PFC dendritic spine density and number 
as well as the impairments in PFC dependent functions caused by ovariectomy in both 
rodents and nonhuman primates (Rapp et al., 2003; Tang et al., 2004; Hao et al., 2007; 
Chen et al., 2009). In particular, long-term 17b-estradiol administration following 
ovariectomy increases apical and basal dendritic spine density and the number of 
smaller, more motile spines thought to be important for synaptic plasticity (Hao et al., 
2007). Enhanced performance on working memory tasks in ovariectomized nonhuman 
primates receiving estradiol is thought to be at least in part due to these changes in 
spine density (Rapp et al., 2003; Hao et al., 2007). This literature suggests that our lack 
of ACE x LDX effect on glutamate levels may be due to insufficient power in the small 
sample of n=13. It is also possible that ACE predominantly impacts other aspects of 
glutamate system function (per above) which cannot be assessed with magnetic 
resonance spectroscopy. Clearly, the impact of ACE and the interaction between ACE 
and LDX on glutamatergic function in hypogondal women warrant further study in a 
larger sample.  
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Future directions 
 In the preceding chapters, we provided evidence that ACE confers a vulnerability 
for executive dysfunction during menopause via alterations in monoaminergic 
neurotransmission. However, there are likely several other mechanisms by which ACE 
impacts executive function that merit further investigation.  
In chapter 4, we found that ACE was robustly associated with lower within-
network connectivity. Given that functional connectivity may be reflective of underlying 
structural connections, impairments in neuronal development during childhood and 
adolescence may be one mechanism by which ACE predisposes individuals to executive 
dysfunction. As discussed above, early life stress in mice has been shown to induce 
alterations in PFC dendritic architecture (Yang et al., 2015). Female mice that 
experience peripubertal stress also display increases in PFC myelin basic protein gene 
expression and proteolipid protein gene expression, both of which are indicators of 
myelination (Morrison et al., 2016). Importantly, estradiol supports the normal 
development and maintenance dendritic morphology (Shanmugan and Epperson, 2014) 
and neuronal myelination (Luo et al., 2016). Future neuroimaging studies utilizing 
diffusion tensor imaging would be helpful in determining whether ACE effects on white 
matter integrity mediate the relationship between ACE and executive function during 
menopause. 
Immune markers may also mediate the effects of early adversity on later life 
cognitive function. In healthy adults, early life stress has been associated with increases 
in pro-inflammatory cytokines such as IL-6, IL1-beta, and TNF-alpha (Hartwell et al., 
2013). Elevated inflammatory markers have been implicated in the associations between 
early adversity and increased risk of major depressive disorder (Miller and Cole, 2012; 
Grosse et al., 2016), schizophrenia (Khandaker and Dantzer, 2016), and posttraumatic 
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stress disorder (Eraly et al., 2014). There is preliminary evidence that such chronic 
inflammation and oxidative stress may play a role in the pathogenesis of executive 
dysfunction seen in ADHD (Buske-Kirschbaum et al., 2013; Verlaet et al., 2014). As 
such, whether immune dysregulation contributes to the increased vulnerability for 
executive dysfunction seen with ACE should be investigated.  
This work has also generated several hypotheses with implications for clinical 
practice. In chapter 2, we have provided evidence that ACE is a risk factor for executive 
dysfunction after surgical menopause. However, the majority of our sample completed 
cognitive testing shortly after oophorectomy. This limited our ability to separate the 
effects of current age from those of age at oophorectomy. Future studies should 
examine whether the impact of ACE is moderated by age at oophorectomy. Given that 
estradiol attenuates the effects of ACE on working memory (as seen in chapter 3) and 
greater duration of endogenous estrogen exposure may be beneficial for PFC 
dependent cognitive functions (Shanmugan and Epperson, 2014), one could 
hypothesize that the negative effects of ACE on executive function may be magnified by 
earlier age at oophorectomy. If future research in a sample with greater variability in the 
relationship between age and age at oophorectomy supported this hypothesis, 
physicians may be more informed when counseling patients who are high ACE as to the 
risks and benefits of undergoing vs postponing oophorectomy as a way to mitigate the 
negative effects of ACE on cognitive function. 
In chapter 3, we demonstrated that neural response to estradiol treatment varies 
depending on levels of early adversity. This finding supports the hypothesis that 
individual biological and environmental differences contribute to risk vs resilience for 
executive dysfunction with waning estradiol. Failure to account for this moderating effect 
of ACE is likely a major factor contributing to the inconclusive literature regarding 
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estradiol’s effects on executive function in human participants. Future studies examining 
the efficacy of estradiol in alleviating menopause-associated cognitive dysfunction 
should account for history of early adversity. Validation of ACE as a moderator of 
estradiol’s impact on executive functions would support the use of ACE as a potential 
indicator of a patient’s response to estrogen therapy. 
However, many perimenopausal and postmenopausal women are not candidates 
for estrogen therapy due to medical contraindications or family history (Shifren and 
Schiff, 2010). Our results regarding ACE x monomanine interactions provide preliminary 
evidence for the use of serotonergic and catecholaminergic medications to treat 
menopause-associated executive dysfunction. In addition to psychotherapy, selective 
serotonin reuptake inhibitors (SSRIs) may be an appropriate treatment for the ACE-
associated anxiety and depressive symptoms contributing to executive dysfunction. 
Because decreases in serotonin concentration may be one mechanism by which ACE 
confers a vulnerability for executive difficulties in healthy women without associated 
mood symptoms, future clinical trials should examine whether SSRIs could also 
ameliorate cognitive dysfunction in this population. Previous studies have indicated that 
serotonin-norepinephrine reuptake inhibitors (Epperson et al., 2011) and stimulants 
(Epperson et al., 2015; Shanmugan et al., 2017) are successful in reducing subjective 
symptoms of executive dysfunction in women who have undergone natural menopause. 
Here we provided preliminary evidence that ACE moderates treatment response to LDX. 
Given that this research into catecholaminergic agents as an alternative to hormone 
therapy for the alleviation of executive dysfunction is particularly relevant to women who 
are BRCA1/BRCA2 positive, future studies in a larger sample would be helpful in 
determining whether ACE moderates both brain and behavioral response to 
catecholaminergic medications after surgery- or chemotherapy-induced menopause. 
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Conclusions 
In summary, this body of work supports the hypothesis that ACE is a risk factor 
for executive function difficulties during menopause and that ACE increases the risk of 
executive dysfunction with loss of estradiol via alterations in monoaminergic 
neurotransmission. Our results highlight that addressing concurrent mood changes is a 
critical step in treating menopause-induced executive difficulties. They also suggest that 
early life adversity has latent effects on serotonergic circuits underlying executive 
function that are unmasked by loss of estradiol during menopause. Additionally, our 
findings indicate that early adversity may have lasting effects on catecholaminergic 
neurotransmission and may alter treatment response to stimulant medications. Together, 
they emphasize the importance of considering ACE in neuroimaging studies utilizing 
neurotransmitter manipulations and when treating executive function difficulties during 
menopause. 
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ABSTRACT 
Objective: Disruption of executive function is present in many neuropsychiatric 
disorders.  However, determining the specificity of executive dysfunction within these 
disorders is challenging given high comorbidity of conditions. Here we investigated 
executive system deficits in association with dimensions of psychiatric symptoms in 
youth using a working memory paradigm, hypothesizing that common and dissociable 
patterns of dysfunction would be present. 
Methods: We studied 1,129 youths who completed a fractal n-back task during fMRI at 
3T as part of the Philadelphia Neurodevelopmental Cohort. Factor scores of clinical 
psychopathology were calculated using an itemwise confirmatory bifactor model, 
describing overall psychopathology as well as four orthogonal dimensions of symptoms 
including anxious-misery (mood / anxiety), behavioral disturbance (ADHD / conduct), 
psychosis-spectrum symptoms, and fear (phobias). The impact of psychopathology 
dimensions on behavioral performance and executive system recruitment (2-back > 0-
back) were examined using both multivariate (matrix regression) and mass-univariate 
(linear regression) analyses. 
Results: Overall psychopathology was associated with both abnormal multivariate 
patterns of activation and a failure to activate executive regions within the cingulo-
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opercular control network including the frontal pole, cingulate cortex, and anterior insula. 
Additionally, psychosis-spectrum symptoms were associated with hypo-activation of left 
dorsolateral prefrontal cortex, whereas behavioral symptoms were associated with hypo-
activation of fronto-parietal cortex and cerebellum. In contrast, anxious-misery symptoms 
were associated with widespread hyper-activation of the executive network. 
Conclusions: These findings provide novel evidence that common and dissociable 
deficits within the brain’s executive system are present in association with dimensions of 
psychopathology in youth. 
 
INTRODUCTION 
Deficits of executive function are present in a wide range of psychiatric disorders 
including attention deficit hyperactivity disorder (ADHD) (1), conduct disorder (2), and 
psychotic disorders such as schizophrenia (3,4). Executive deficits negatively impact 
everyday functioning (5), and contribute to diminished quality of life in many clinical 
populations (6,7). Consequences of executive deficits may be particularly acute in 
childhood and adolescence, and include increased interpersonal conflict, decreased 
academic achievement, and risk-taking behavior (7,8).  
 Many studies have investigated the neural basis of executive impairments in 
individual psychiatric disorders. Working memory is one of the most commonly studied 
components of executive function. For example, meta-analyses in patients with ADHD 
demonstrate hypoactivation within a network of regions including the dorsolateral 
prefrontal cortex, anterior cingulate cortex, thalamus, superior parietal lobule, and 
precuneus (9,10). Patients with schizophrenia also fail to recruit portions of the executive 
network including the dorsolateral prefrontal cortex (11-13). Likewise, conduct disorder is 
associated with a failure to activate a similar network of regions (14). Taken together, 
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these studies suggest there are likely overlapping effects across disorders, with 
hypoactivation of the executive system being a common underlying brain phenotype. 
However, evidence exists for dissociable abnormalities among psychiatric disorders.  
For example, hyperactivation of executive regions have been reported in major 
depressive disorder and anxiety disorders (15-17). Nonetheless, some heterogeneity in 
results exists, and such hyperactivation has also frequently been reported in 
schizophrenia (18). 
A case-control design in a single disorder is the predominant approach in the 
studies reviewed above, and thus most studies are unable to directly evaluate whether 
common executive deficits exist across disorders. Furthermore, while the incidence of 
psychiatric co-morbidity is quite high, studies typically do not explicitly evaluate its 
impact. In epidemiological studies, approximately 40% of individuals meeting criteria for 
one diagnosis met criteria for at least one additional disorder in a different class (19). 
Thus, studies that use subjects with “pure” single diagnoses may not be representative.  
More recently, the neural basis of executive deficits across disorders have been 
investigated in an attempt to isolate regions of dysfunction specific to each diagnosis 
(20). However, studies comparing multiple clinical groups are typically hampered by 
small sample size, and few prior studies compared more than two disorders at a time. 
Furthermore, as psychiatric symptomatology exists on a continuum of normal to 
abnormal, dimensional analyses that cut across categorical clinical diagnoses may both 
enhance power and improve biological interpretability (21). Thus, studies in large 
samples evaluating the impact of multiple dimensions of psychopathology on executive 
functioning are necessary.   
Accordingly, here we used a dimensional approach to examine executive 
dysfunction with a working memory fMRI task in a sample of 1,129 youth imaged as part 
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of the Philadelphia Neurodevelopmental Cohort (22,23). Notably, the ascertainment 
strategy used in the Philadelphia Neurodevelopmental Cohort differs substantially from 
studies using clinical help-seeking samples, instead employing a population-based 
approach that examines symptoms in non-help seeking youth. While such a design will 
likely have lower symptom severity than clinical samples, a population-based approach 
may nonetheless be valuable for investigating dimensions of psychopathology. We 
hypothesized that there would be both common and dissociable deficits in executive 
recruitment associated with different dimensions of psychopathology. Specifically, we 
predicted that general psychopathology would be associated with executive hypo-
activation regardless of clinical diagnosis. Furthermore, we predicted that specific 
dimensions of psychopathology would be linked to dissociable regional patterns of 
impairment within the executive network.   
 
METHODS 
Participants 
As previously described, the Philadelphia Neurodevelopmental Cohort is a 
collaboration between the Center for Applied Genomics at the Children’s Hospital of 
Philadelphia and the Brain Behavior Laboratory at the University of Pennsylvania 
(22,23). The current report considers the entire cross-sectional sample of 1,601 subjects 
imaged as part of the Philadelphia Neurodevelopmental Cohort; of these, 1,462 
completed the n-back task described below. Following subject exclusions including 
medical co-morbidity, task non-performance, and image quality assurance (see 
Supplementary Methods), the final sample included in analyses was n=1,129 (mean age 
= 15.5 years; SD = 3.4 years; 520 males). This sample thus constitutes a super-set of 
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subjects previously included in reports that focused on effects of working memory 
performance (24) and psychosis-spectrum symptoms (25).  
 
Clinical assessment 
As previously detailed (26,27), psychopathology symptoms were evaluated using 
a structured screening interview (GOASSESS).  Computerized algorithms used 
endorsement of symptoms, their frequency and duration, and the presence of distress or 
impairment to determine whether DSM-IV criteria were met (see Supplementary 
Methods). The frequency and relevant demographic data for each screening diagnosis 
considered are detailed in Table 1. As in large-scale epidemiologic datasets (19), co-
morbidity was quite common, with more subjects meeting criteria for more than one 
category (n=529) than a single category (n=249).    
 
Psychopathology factor analysis 
In order to parse this co-morbidity into orthogonal dimensions of 
psychopathology, we performed factor analyses of item-level data from GOASSESS. To 
produce stable factor scores, analyses utilized all subjects for whom clinical data were 
available (n=9,498) rather than only the subset who completed neuroimaging (26,27). As 
initial exploratory factor analyses indicated correlated traits of psychopathology, we used 
a bifactor confirmatory model, which can produce orthogonal scores from correlated 
traits (28).  
Methods regarding estimation of the bifactor model will be presented in detail 
elsewhere (also see Supplementary Methods). Briefly, the confirmatory bifactor model 
(Figure 1A) was estimated using a Bayesian estimator in Mplus. As predicted by theory 
and supported by initial exploratory models, the four factors primarily represent anxious-
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misery (mood & anxiety) symptoms, psychosis-spectrum symptoms, behavioral 
symptoms (conduct and ADHD), and fear symptoms (phobias). Additionally, the bifactor 
model estimated a general psychopathology factor, representing the overall burden of 
psychopathology while controlling for the presence of specific symptom dimensions. 
Importantly, all five factors (including general psychopathology) from the bifactor model 
are orthogonal and can be considered jointly in analysis of imaging data. Factors scores 
within each of the categorical screening categories were as expected given item-level 
loading (Figure 1B). 
 
Task paradigm, image acquisition and image processing 
 Task paradigm, image acquisition, and pre-processing methods were as 
previously reported (24). Briefly, a fractal version of the n-back task (29) was used to 
probe executive system function across three levels of working memory load (Figure 
2A). The primary behavioral measure was d’, a signal detection metric that limits the 
influence of response bias.  Task performance (d’) across all levels of working memory 
load was related to categorical diagnosis from GOASSESS and dimensional factor 
scores using linear models while controlling for age and sex.  Testing five dimensions of 
psychopathology were accounted for using Bonferroni correction. 
 fMRI, T1, and B0 images were acquired on the same scanner (Siemens 3T Tim 
Trio) for all subjects (see Supplementary Methods). Timeseries analysis of subject-level 
imaging data used FSL (30) to model three condition blocks (0-back, 1-back, and 2-
back); the primary contrast was 2-back > 0-back, which robustly recruits the executive 
network (24). Subject-level statistical maps were distortion corrected, co-registered to 
the T1 image using boundary-based registration, and normalized to the MNI 152 1mm 
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template using ANTs (31) and then downsampled to 2mm. All transformations were 
concatenated so only one interpolation was performed.   
 
Multivariate group-level analysis: Global associations with psychopathology  
 As a first step, we evaluated the degree to which dimensions of psychopathology 
from the factor analysis impacted overall multivariate patterns of activation (see Figure 
S1). To do this, we used multivariate distance-based matrix regression, a statistical 
technique developed originally for large-scale ecologic datasets that has recently been 
used in image analysis (32); this was implemented using the vegan package in R (33).  
Subject-level activation maps are compared on a pairwise basis (Euclidean distance) to 
yield a distance matrix. Matrix regression is then used to test whether each phenotypic 
variable explains the distances among each participant’s activation patterns. In contrast 
to other multivariate methods, this approach allowed us to examine the influence of 
multiple dimensions of psychopathology simultaneously while also controlling for 
covariates (age, sex, and in-scanner motion).  Multiple tests were accounted for using 
Bonferroni correction as above.   
 
Mass-univariate group-level analysis: Regional associations with psychopathology 
 While the multivariate analysis detailed above provided an estimate of the degree 
to which dimensions of psychopathology impacted the global pattern of activation, this 
analysis does not evaluate regional effects. Accordingly, we next conducted a standard 
mass-univariate analysis using a general linear model implemented in FSL (30). We 
evaluated the effect of each dimension of psychopathology within this linear model, with 
covariates as above. Additionally, we investigated whether dimensions of 
psychopathology that showed a significant effect were significantly different from each 
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other using an F-test across dimensions. Type I error control was provided by cluster 
correction using 10,000 Monte-Carlo simulations (voxel height of z > 3.09; cluster 
probability of p < 0.001; minimum cluster size of k=67) (34). All analyses described 
below used unmasked, whole-brain voxelwise data. Images were displayed using Caret. 
 
Supplementary analyses 
In order to evaluate whether potentially confounding factors influenced observed 
results, we conducted a series of supplementary analyses. This included a) removing 
the minority (11.4%) of subjects who were taking psychoactive medication; b) including 
task performance (d’ ) as a covariate; c) excluding subjects with poor performance (>7 
non-responses) on the 2-back condition; and d) including mean accuracy on an out-of-
scanner computerized neuropsychological battery, race, assessment-scan interval, 
maternal education, and in-scanner performance (d') together as covariates in one 
model.   
 
RESULTS  
 
Multiple dimensions of psychopathology impact task performance 
As expected, increasing working memory load was associated with fewer correct 
responses to targets and increased false positive responses to foils (Figure 2B & C). 
These measures were integrated using the signal detection measure d’. As expected, d’ 
varied considerably by screening categorical diagnosis (see Table 1). When 
summarized as psychopathology dimensions, several factors significantly impacted 
working memory task performance (Figure 2D). Higher levels of both overall 
psychopathology (t[1124]=2.58, p=0.001) and behavioral symptoms (t[1124]=3.82, 
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p=0.0001) were associated with lower working memory performance. In contrast, higher 
levels of anxious-misery symptoms were associated with a trend towards better working 
memory performance (t[1124]=2.45, p=0.015). There was not a significant relationship 
between fear or psychosis and working memory performance.  
 
Overall psychopathology alters global patterns of executive system recruitment 
 As expected, the 2-back > 0-back contrast robustly recruited the entire executive 
network, and resulted in de-activation of non-executive regions (Figure 2E). We next 
evaluated whether dimensional psychopathology was associated with changes in this 
multivariate pattern of activation and de-activation using multivariate distance-based 
matrix regression. This procedure revealed that overall psychopathology was associated 
with a significant disturbance in the global pattern of executive system recruitment 
(p=0.009). Other symptom dimensions did not have a significant relationship; non-
significant trends were observed for behavioral (p=0.044) and anxious-misery (p=0.092) 
symptoms.   
 
Dimensions of psychopathology differentially impact regional executive activation 
Multivariate distance-based matrix regression evaluates the presence of global 
multivariate effects, but is not sensitive to regional changes. Accordingly, we used mass-
univariate generalized linear models to examine the relationship between dimensions of 
psychopathology and executive system activation (Figure 3, Table S1). As suggested 
by multivariate results, overall psychopathology had the most robust impact on executive 
activation. Higher levels of overall psychopathology were associated with diminished 
activation of bilateral frontal pole, anterior cingulate cortex, anterior insula, thalamus, and 
precuneus. Behavioral symptoms were associated with diminished activation of 
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frontoparietal cortex as well as thalamus and cerebellum. Psychosis-spectrum 
symptoms were associated with diminished activation of the left dorsolateral prefrontal 
cortex. Fear (phobia symptoms) was associated with diminished activation of a 
marginally significant cluster of medial frontal cortex, but this effect did not survive 
supplementary analyses (see below) and was not evaluated further. Finally, in contrast 
to the hypo-activation described above, anxious-misery symptoms were associated with 
a marked hyper-activation of multiple executive regions including anterior cingulate 
cortex, dorsolateral prefrontal cortex, parietal cortex, and thalamus. Notably, a small 
area of overlapping significant effects across dimensions was seen in the left 
dorsolateral prefrontal cortex (MNI coordinates: x=-28, y=-6, z=58; k=10). Significant 
differential effects of each dimension were present in multiple executive regions (Figure 
4, Table S2). This was driven by the divergent impact of global psychopathology (hypo-
activation) and anxious misery (hyper-activation).  We did not find any differences in 
default mode regions where task-induced deactivation was present. 
 
Supplementary analyses 
Overall, convergent results were obtained from supplementary analyses where 
participants taking psychoactive medications were excluded (Table S3), when working 
memory performance was included as a covariate (Table S4), and when multiple 
additional covariates were included (Table S5). When participants with poor 
performance on the 2-back condition were excluded, psychosis-spectrum symptoms 
were associated with a marginally significant cluster of hyperactivation in the cingulate 
gyrus; otherwise results were similar (Table S6). As noted above, fear did not have a 
significant association with activation in any of the supplementary analyses.  
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DISCUSSION  
 
In this large study of psychopathology in youth, we examined associations 
between diverse psychopathology and activation of the brain’s executive system during 
a working memory task. To account for the fact that psychiatric disorders are highly co-
morbid, factor analysis of the psychopathology data using a bifactor model allowed us to 
examine both general psychopathology and orthogonal dimensions of psychopathology. 
Overall psychopathology was associated with a significant alteration of the global 
multivariate pattern of activation. Furthermore, dimensions of psychopathology 
significantly influenced regional patterns of activation in different ways. In contrast to the 
hypo-activation seen in association with overall psychopathology, anxious misery 
symptoms were associated with hyper-activation of the same network. Taken together, 
these data emphasize that dimensions of psychiatric symptomatology are associated 
with both common and distinct deficits within the executive system. 
 
Evidence for common executive deficits across psychiatric syndromes in youth 
The most robust finding in the present study is evidence of common executive 
deficits attributable to overall psychopathology present across categorical clinical 
diagnoses. This was observed on both a global and local scale: overall psychopathology 
was associated with an alteration of the global multivariate pattern of activation, driven 
by regional hypoactivation in a network of executive regions including the frontal pole, 
anterior cingulate, anterior insula, and precuneus. These results accord with a copious 
literature of case-control studies from multiple individual disorders, and moreover 
highlight the centrality of executive dysfunction across major psychiatric syndromes.  
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We were able to estimate the influence of overall psychopathology across 
disorders through the use of a bifactor analysis of the item-level responses from the 
psychopathology screening interview. This approach obviates several major obstacles to 
estimating common deficits across traditional categorical diagnoses. First, when co-
morbidity is represented in standard models as shared variance, it is controlled for but 
cannot be estimated.  Estimating overall psychopathology may be particularly important 
in youth where the pattern of psychopathology may not fit standard diagnostic criteria in 
context of ongoing development. Second, strongly non-random patterns of comorbidity 
exist between different disorders (19). For example, mood and anxiety disorders have a 
high rate of comorbidity, as do ADHD and conduct disorders. Third, the frequency of 
each diagnosis varies considerably; thus the statistical power to estimate the impact of 
each individual diagnosis is not equal. Fourth, categorical diagnoses are by definition 
dichotomous, and important dimensional effects cannot be examined.  
Crucially, each of these problems can be overcome through modeling of latent 
dimensions of psychopathology. Here we used confirmatory factor analysis to estimate a 
bifactor model, which provides orthogonal scores for every subject in each 
psychopathology domain, as well as a score for general psychopathology. These 
orthogonal scores can thus be included in a single model that can estimate dissociable 
dimensions of psychopathology with equal power, as well as the impact of overall 
psychopathology through the general score. The regions implicated by overall 
psychopathology include the frontal pole, anterior cingulate cortex, and anterior insula. 
Notably, all these regions are part of the cingulo-opercular control network (also called 
the salience or ventral attention network), which is consistently identified as among the 
most reproducible large-scale functional brain networks both at rest and during task 
performance (35). This network is critical for cognitive control, and is particularly 
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implicated in maintenance of task sets and error monitoring (36). These regions are 
among the most commonly impaired in case-control studies of schizophrenia, ADHD, 
and conduct disorder, suggesting that dysfunction of this network is not associated with 
one specific domain of psychopathology (4,10,37). Further support is provided from a 
large-scale meta-analysis by Goodkind et al., who found that gray matter loss in these 
cingulo-opercular regions was present across psychiatric disorders and associated with 
impaired executive function (38).    
 
Orthogonal dimensions of psychopathology are associated with dissociable deficits 
In addition to robust effects of overall psychopathology, we also identified both 
regionally and directionally dissociable effects of specific dimensions of 
psychopathology.  Behavioral symptoms were associated with diminished activation of a 
network of regions including fronto-parietal cortex, thalamus, and cerebellum, whereas 
psychosis-spectrum symptoms were associated with hypo-activation of the left 
dorsolateral prefrontal cortex.  The behavioral dimension loaded most prominently onto 
items assessing externalizing disorders such as ADHD, conduct disorder, and 
oppositional defiant disorder. Results are consistent with case-control studies in each of 
these disorders, which have demonstrated hypo-function of executive regions including 
most commonly fronto-parietal regions (10,20). Similarly, dysfunction of the dorsolateral 
prefrontal cortex is considered one of the cardinal impairments of psychosis (39). 
However, it should be noted that the effects of the psychosis spectrum observed here 
are more circumscribed than those typically reported; this may be due to the use of a 
population rather than a clinical sampling strategy, a focus on sub-threshold psychosis 
symptoms, and accounting for overall psychopathology through the bifactor model. 
However, consistent with the current results, in our previous report on psychosis-
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spectrum symptoms in this sample we observed that hypo-activation of executive 
regions was linked to cognitive performance but not to severity of positive psychotic 
symptoms, suggesting a substantial effect of overall impairment rather than psychosis 
per se (25).  
In contrast to the diminished recruitment seen in other symptom domains, 
anxious-misery symptoms were associated with widespread hyper-activation of the 
executive network.  Indeed, after accounting for overall psychopathology, anxious-
misery symptoms were associated with a trend towards better working memory 
performance. However, executive hyper-activation is unlikely to be simply an 
epiphenomenon associated with working memory performance, as hyper-activation was 
still seen in sensitivity analyses that controlled for both in-scanner and out-of-scanner 
cognitive performance. This result is consistent with several studies of executive function 
in major depression and anxiety disorders that have found over-activation of executive 
regions (15-17). In contrast to the deficient ability to recruit the executive network seen in 
association with other symptom dimensions, these data suggest that mood and anxiety 
symptoms are associated with an inefficient executive system, where higher levels of 
executive network activation occur. It should be noted that participants in our sample 
who screened positive for mood and anxiety disorders frequently also had high levels of 
overall psychopathology. As these dimensions have directionally opposite associations 
with executive recruitment, the relative presence of co-morbidity in a given sample could 
conceivably result in divergent results.  
 
Limitations 
Certain limitations of the present work should be noted. First, the young 
community-based sample studied here had diminished symptom severity compared to 
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that found in typically older help-seeking samples drawn from clinical practices. Drawing 
from a different distribution of symptoms may result in reduced generalizability to clinical 
populations. However, the approach used here allowed us to accrue a larger, mainly 
unmedicated sample at a single site and scanner, and is well suited to investigating 
broad dimensions of psychopathology. A second important limitation is that this cross-
sectional report does not include longitudinal data. As our prior work in this dataset has 
demonstrated that between-subject cross-sectional age effects are relatively subtle (24), 
within-subject longitudinal data will be particularly informative regarding whether specific 
symptom domains are associated with development of executive deficits over time. 
Third, certain important classes of psychopathology such as substance use that have 
been shown to impact executive function were not considered in the current analysis 
(40). Fourth, despite prior research showing abnormalities of the default mode network 
in multiple psychiatric disorders, we did not find significant effects in the default mode 
network; this may be due to the task paradigm employed. Finally, as previously noted 
(26,27), the highly-structured screening format of GOASSESS may have resulted in high 
sensitivity but relatively diminished specificity, leading to over-estimation of the 
frequency of several disorders. Alternatively, high rates of endorsed symptoms may 
accurately reflect this particular sample. Although factor-analytic results of the 
GOASSESS appear consistent with prior findings and lend support to the validity of the 
measure, ongoing longitudinal follow-up with semi-structured assessments applying 
DSM disorder criteria will allow further evaluation of the clinical relevance and stability of 
the current findings. 
 
Conclusions 
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These data provide novel evidence regarding common and dissociable executive 
system deficits across multiple dimensions of psychopathology in young people. Results 
emphasize that executive dysfunction is present in association with overall 
psychopathology across traditional categorical psychiatric diagnoses, underscoring this 
system’s central relevance for circuit-based conceptualizations of neuropsychiatric 
disorders such as the NIMH Research Domain Criteria (RDoC) (21). These results may 
suggest that interventions seeking to enhance executive function may not fit well within 
the existing categorical diagnostic framework, and may be beneficial to individuals 
across diverse clinical syndromes where executive deficits are present. Future research 
employing longitudinal designs may motivate targeted early interventions that seek to 
mitigate executive dysfunction in youth before negative outcomes accrue.    
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TABLES 
 
Table 1. Demographic information by screening diagnostic category.  Individual 
subjects may be present in multiple categories due to co-morbidity.   
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FIGURE LEGENDS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Bifactor model of common and divergent dimensions of 
psychopathology across categorical screening diagnoses.  The input data to the 
bifactor model were 112 items from the GOASSESS screening diagnostic interview, 
resulting in orthogonal dimensions of psychopathology (A).   Mean (SD) factor scores of 
each dimension for each screening diagnosis (with at least n=20) is displayed in (B). 
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Figure 2.  Working memory task paradigm, behavioral performance and contrast 
of interest.  A fractal version of the n-back task was used to probe working memory 
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function where working memory load was varied parametrically across three levels (A). 
Higher working memory load was associated with fewer correct responses to targets (B) 
and more false positive responses to foils (C). Correct responses and false positives 
were summarized across all levels of working memory load using the signal detection 
metric d’ to provide an integrated measure of working memory performance. Task 
performance was reduced in association with both overall psychopathology and 
behavioral symptoms; anxious-misery was conversely associated with a trend towards 
improved task performance (D).   The contrast of interest (2-back > 0-back) robustly 
activated the entire executive system and de-activated non-executive regions (E).  
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Figure 3. Relationship of orthogonal dimensions of psychopathology with 
executive network recruitment.  The association of each dimension of 
psychopathology with executive network activation (2-back > 0-back) was examined 
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using linear regression.  The most robust effects were seen for overall psychopathology, 
where greater symptom severity was associated with diminished activation of the frontal 
pole, anterior cingulate, anterior insula, thalamus, and precuneus.   Behavioral 
symptoms were associated with fronto-parietal, thalamic, and cerebellar hypoactivation; 
psychosis-spectrum symptoms were associated with diminished activation of the left 
dorsolateral prefrontal cortex.   In contrast to the observed hypo-activation for all other 
dimensions of psychopathology, anxious misery was associated with hyper-activation of 
regions within the executive network, including the dorsolateral prefrontal cortex and 
anterior cingulate cortex.   All analyses included age, sex, and in-scanner motion as 
covariates; images thresholded at z>3.09, corrected p<0.001.  Scatter plots were drawn 
from significant clusters identified by red circles.  Activation is plotted in arbitrary BOLD 
units. For detailed results see Tables S1. 
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Figure 4. Differential effects of psychopathology on executive system activation.  
A linear model comparing the differential impact of each dimension of psychopathology 
revealed significant differences in multiple executive regions including the anterior 
cingulate cortex, frontal pole, and dorsolateral prefrontal cortex.   Differential effects 
were driven by the divergent impact of anxious misery (hyper-activation) and overall 
psychopathology (hypo-activation).  Activation is plotted in arbitrary BOLD units.  
Shaded area represents 95% confidence intervals.  For detailed results see Table S2. 
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SUPPLEMENTARY METHODS 
Participants: Exclusion Criteria 
The Philadelphia Neurodevelopmental Cohort is a collaboration between the 
Center for Applied Genomics at CHOP and the Brain Behavior Laboratory at the 
University of Pennsylvania (Penn). Children, adolescents, and young adults between the 
ages of 8 and 21 who presented to the Children’s Hospital of Philadelphia (CHOP) or a 
CHOP-affiliated clinic for a pediatric visit and volunteered to participate in genomic 
studies of complex pediatric disorders were eligible for inclusion in the Philadelphia 
Neurodevelopmental Cohort (1-3). Participants and/or their parents signed an informed 
consent form approved by the Institutional Review Boards at CHOP and Penn. After 
stratification by age and sex, a subsample of 1,601 randomly selected participants 
underwent multi-modal neuroimaging. Of these participants, 1,462 completed the n-back 
task described below. Subject exclusion criteria included medical conditions that might 
impact brain function (n=151), incidentally encountered structural brain abnormalities 
(n=20), and inadequate task performance (>7 nonresponses on the 0-back condition; 
n=65). As part of image quality assurance, subjects were also excluded for excessive 
motion (mean relative displacement > 0.5mm or maximum displacement > 6 mm; n=94) 
or poor image coverage (n=73). Many of the subjects excluded met multiple exclusion 
criteria. The final sample included in analyses was 1,129. This sample thus constitutes a 
super-set of subjects previously included in reports which focused on normative 
development (4) and psychosis-spectrum symptoms (5).  
 
Clinical Assessment   
Psychopathology was assessed using a structured screening instrument 
(GOASSESS) administered by trained assessors (1). Participants age 11-21 were 
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interviewed individually; collateral information was obtained independently from a 
caregiver for children age 8-17. To allow rapid training and standardization across a 
large number of assessors, GOASSESS was designed to be highly structured, with 
screen-level symptom and episode information. The instrument is abbreviated and 
modified from the epidemiologic version of the NIMH Genetic Epidemiology Research 
Branch Kiddie-SADS (6). Assessors underwent a common training protocol developed 
and implemented by MEC that included didactic sessions, assigned readings, and 
supervised pair-wise practice. They were certified for independent assessments through 
a standardized procedure requiring observation by a certified clinical observer who rated 
the proficiency of the assessor on a 60-item checklist of interview procedures. 
The psychopathology screen in GOASSESS assessed psychiatric and 
psychological treatment history, as well as lifetime occurrence of major domains of 
psychopathology including mood (major depressive episode, mania), anxiety 
(agoraphobia, generalized anxiety, panic, specific phobia, social phobia, separation 
anxiety), behavioral (oppositional defiant, attention deficit/hyperactivity, conduct), eating 
disorders (anorexia, bulimia), and suicidal thinking and behavior. Substance use 
disorders were assessed with a different instrument for a subset of participants and are 
not evaluated here.  Each section included a screen for relevant symptoms and 
additional DSM-IV criteria such as symptom frequency, duration, onset, and offset. 
Associated distress and impairment were each rated on 11-point scales ranging from 0 
to 10. To establish screening diagnostic criteria for each domain of psychopathology, a 
computerized algorithm integrated information regarding symptom frequency and 
duration approximating each DSM-IV disorder or episode criteria, accompanied by 
significant distress or impairment rated>=5 on the 11-point scale.  
 
219	
	
Assessment of Psychosis Spectrum Symptoms 
As described in detail in our prior articles focused on psychosis-spectrum 
symptoms (5,7,8), GOASSESS provided three measures of psychosis-spectrum 
symptoms. First, sub-threshold positive symptoms in the past year were assessed with 
the 12-item assessor administered PRIME Screen-Revised (PS-R)(9). Items were read 
aloud by the assessor and self-rated on a 7-point scale (0 = Definitely Disagree; 6 = 
Definitely Agree). Second, lifetime threshold hallucinations and delusions were 
evaluated with the K-SADS (6) psychosis questions and structured follow-up probes. 
Third, negative and disorganized symptoms were evaluated using six assessor rated 
items from the Scale of Prodromal Symptoms (SOPS) in the Structured Interview for 
Prodromal Syndromes (SIPS)(10), including: N2 Avolition; N3 Expression of Emotion; 
N4 Experience of Emotions and Self; N6 Occupational Functioning; D3 Trouble with 
Focus and Attention; and P5 Disorganized Communication. We identified subjects as 
psychosis-spectrum if they: 1) had an age-deviant PRIME total score >= 2SD above age 
matched peers or had >= one PRIME item rated 6 or >= three items rated 5 (Somewhat 
Agree); 2) endorsed definite or possible hallucinations or delusions on the K-SADS 
psychosis screen; or 3) had an age deviant total negative/disorganized SOPS score 
>=2SD above age-matched peers. 
 
Factor Analysis Methods 
Factor analysis methods and results have been previously presented (11) and 
will be detailed in a separate manuscript (Calkins et al., In Preparation). Briefly, factor 
analyses proceeded in several phases. First, we performed exploratory factor analyses 
in order to determine which items loaded on which factors, with the ultimate goal of 
estimating a confirmatory factor analysis model from which to calculate scores. Because 
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there are multiple exploratory factor analyses extraction methods (and an even greater 
number of factor rotations), we decided to estimate several exploratory factor analyses 
for thoroughness. Methods provided convergent results, supporting a four-factor model.   
Because all exploratory factor analyses indicated correlated traits of 
psychopathology, and because a goal of the item-wise confirmatory analysis was to 
generate orthogonal scores, we opted to use the only type of confirmatory model 
capable of accommodating such a combination, which is the bifactor model (12-14). 
Bifactor modeling is a way to estimate the contribution of an item to an overall dimension 
(psychopathology in this case) after controlling for its specific factor, and vice versa.  
Bifactor models are similar to higher-order models, except in a bifactor model there are 
direct effects of the general factor on the individual items. 
The confirmatory bifactor model was estimated using the Bayesian estimator in 
Mplus (15).  The Bayesian estimator comes with the drawback of not producing 
conventional fit indices, but was chosen because the computation time of other 
estimators (e.g. wlsmv) was anticipated to be much longer. The model was later 
estimated using the other estimators (wlsmv and MLR), and the minimum correlation 
between scores calculated using the different methods was 0.93 (mean = 0.98). The fit 
indices provided by the wlsmv-estimated model suggest acceptable fit, with a 
Comparative Fit Index (CFI) of 0.91 and Root Mean-Square Error of Approximation 
(RMSEA) of 0.027 ± 0.0005.   
 
Task Paradigm 
Subjects completed a fractal version of the n-back task (16) during their fMRI 
scan. During the task, a fractal was presented for 500 ms followed by a 2500 ms 
interstimulus interval. This task was used to probe working memory and had 3 
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conditions: 0-, 1-, and 2-back. During the 0-back, subjects responded by pressing a 
button when the fractal presented matched a predefined fractal. During the 1-back, 
subjects responded when the fractal presented was the same as the one preceding it. 
During the 2-back, subjects responded when the fractal was identical to the one two 
before it. Each condition consisted of three 20-trial blocks, each preceded by a 9s 
instruction period, with a target to foil ratio of 1:3. The task included a total of 45 targets 
and 135 foils, as well as three 24 s blocks of rest during which a fixation crosshair was 
displayed. 
 
Image Acquisition 
Imaging data were acquired on 3T Siemens TIM Trio whole-body scanner using 
a 32-channel head coil. A magnetization-prepared rapid acquisition gradient echo T1-
weighted (MPRAGE) image (TR, 1810 ms; TE, 3.51 ms; TI, 1100 ms; FOV, 180 × 240 
mm; matrix, 192 × 256; 160 slices; slice thickness/gap, 1/0 mm; flip angle, 9°; effective 
voxel resolution, 0.9 × 0.9 × 1 mm) and B0 field map (TR, 1000 ms; TE1, 2.69 ms; TE2, 
5.27 ms; 44 slices; slice thickness/gap, 4/0 mm; FOV, 240 mm; effective voxel 
resolution, 3.8 × 3.8 × 4 mm) were acquired to aid spatial normalization to standard 
space and application of distortion correction procedures, respectively. Functional 
images were then obtained using a whole-brain, single-shot, multislice, gradient-echo 
echoplanar sequence (231 volumes; TR, 3000; TE, 32 ms; flip angle, 90°; FOV, 192 × 
192 mm; matrix 64 × 64; 46 slices; slice thickness/gap 3/0 mm; effective voxel 
resolution, 3.0 × 3.0 × 3.0 mm). 
 
Image Processing 
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As previously described (4), fMRI data was pre-processed with FSL (17), 
including skull removal with BET (18), slice time correction, motion-correction with 
MCFLIRT (19), spatial smoothing (6 mm FWHM), and mean-based intensity 
normalization. Subject-level timeseries analyses were carried out using FILM (FMRIB's 
Improved Linear Model) with local autocorrelation correction (20). The three condition 
blocks (0-back, 1-back, and 2-back) were modeled using a canonical (double-gamma) 
hemodynamic response function with six motion parameters and the instruction period 
included as nuisance covariates. The rest condition served as the unmodeled baseline. 
The median functional and anatomical volumes were co-registered using boundary-
based registration (21) with integrated distortion correction using FUGUE. The 
anatomical image was normalized to the Montreal Neurologic Institute 152 1 mm 
template using the top-performing diffeomorphic SyN registration of ANTS (22,23). All 
transformations (distortion correction, co-registration, normalization, and down-sampling 
to 2mm3) were concatenated so only one interpolation was performed. The statistical 
maps for the contrast of interest (2-back > 0-back) were then used in the group-level 
analyses. Statistical maps were downsampled further to 4mm3 for the multivariate 
distance-based matrix regression analysis (see below) for computational feasibility; 
generalized linear model analyses used 2mm3 resolution data. 
 
Matrix Regression 
 Multivariate distance-based matrix regression operates in two steps. In the first 
step, the overall multivariate pattern of activation and de-activation in down-sampled 
data (4mm isotropic voxels) was compared among subjects using a distance metric 
(Euclidean distance). This produces a matrix (size 1,129 x 1,129) representing how 
similar the overall pattern of activation is between each combination of subject pairs. 
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Second, matrix regression is used to test how well each phenotypic variable explains the 
distances between each participant’s pattern of activation created in step 1. This 
provides a measure of how the overall pattern of activation is impacted by each group 
level variable entered into the design matrix in standard regression format. Our group-
level design matrix included symptom dimensions (from the factor analysis), age, sex, 
and in-scanner motion. As in our prior work, motion was summarized for each subject as 
the mean relative displacement of realignment parameters across the time series (24-
26). This multivariate distance-based matrix regression procedure yields a pseudo-F 
statistic, the significance of which was tested using 1,000 permutations.  
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Figure S1 
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Table S1. Main effect of psychopathology dimensions in complete sample (n=1129) 
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Table S1 continued. 
 
 
 
 
 
 
 
 
Table S2. Differential effects of psychopathology dimensions in complete sample 
(n=1129) 
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Table S3. Main effect of psychopathology dimensions in sub-sample of participants not 
taking psychotropic medication (n=1007) 
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Table S4. Main effect of psychopathology dimensions with working memory 
performance (d' ) as a covariate (n=1129) 
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Table S5. Main effect of psychopathology dimensions while including additional 
covariates (n=1112 due to missing covariate data in 17 subjects). Covariates included: 
age, sex, race, in-scanner motion, maternal education, time between assessment and 
imaging, out-of-scanner cognitive performance, and in-scanner working memory 
performance. 
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Table S6. Main effect of psychopathology dimensions after excluding for poor 2-back 
performance (n=963) 
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ABSTRACT 
Executive functions are involved in the development of academic skills and are 
critical for functioning in school settings. The relevance of executive functions to 
education begins early and continues throughout development, with clear impact on 
achievement. Diverse efforts increasingly suggest ways in which facilitating development 
of executive function may be used to improve academic performance. Such 
interventions seek to alter the trajectory of executive development, which exhibits a 
protracted course of maturation that stretches into young adulthood. As such, it may be 
useful to understand how the executive system develops normally and abnormally in 
order to tailor interventions within educational settings. Here we review recent work 
investigating the neural basis for executive development during childhood and 
adolescence.   
 
Introduction 
Executive function (EF) is a broad category of cognition, including cognitive 
control, sustained attention, inhibition, error monitoring, and working memory. Unlike 
other cognitive domains, the executive system undergoes a protracted period of 
development that extends into young adulthood. Behavioral studies have suggested that 
different domains of EF may develop at different rates during this time [1]. These 
processes are necessary for the normal development of nearly all academic areas 
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including math [2,3] and language [3] skills. The importance of early EF capacity to 
academic achievement begins as early as preschool [4] and continues throughout 
adolescence [5]. As such, there has been much interest in methods to facilitate the 
development of EFs in school settings in an effort to improve academic performance. 
Accordingly, an understanding of the neural basis of the executive system’s 
development could help target interventions to facilitate the development of executive 
function.    
Here we review the existing literature regarding brain systems implicated in the 
development of the executive system and its significance for academic achievement. We 
first describe recent behavioral and neuroimaging studies regarding the maturation of 
the executive system from childhood through adolescence. Second, we describe 
moderating factors that have been shown to affect the course of executive development. 
Third, we review studies documenting executive dysfunction in neuropsychiatric 
disorders, which often begin in adolescence and are associated with poor educational 
outcomes [6]. Finally, we present examples of educational interventions that have been 
proposed as ways of facilitating EF development. 
 
Normative development of executive function: behavioral studies 
Childhood and adolescence are periods of rapid development of EF. Dajani and 
Uddin [7] note that different domains of EF develop at various times during development:  
inhibition and attentional control emerge and develop in early childhood, information 
processing abilities improve in mid childhood, while cognitive flexibility and goal setting 
continue to develop into adolescence. For instance, a longitudinal study of young 
children charting trajectories of inhibitory control and cognitive flexibility found that these 
processes developed most rapidly during 3-4 years of age [1]. Though cognitive 
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flexibility develops more slowly than inhibitory control [1], age-related improvements in 
inhibition have been observed through mid-childhood [8]. Attention and working memory 
(WM) are additional domains of EF that continue to mature throughout adolescence, 
while other cognitive domains such as spatial memory and verbal memory do not [9].  
 
Normative development of executive function: neuroimaging studies 
Though it is clear from behavioral studies that EF matures during childhood and 
adolescence, neuroimaging studies provide information regarding how 
neurodevelopmental processes may underlie the improvement in performance. Studies 
of brain structure, function, and connectivity provide complementary evidence regarding 
maturation of the executive system. Structural brain imaging studies indicate that grey 
matter volume increases during childhood and subsequently declines during 
adolescence, whereas white matter volumes increase throughout development [10]. 
However, the trajectory of development may be more important in predicting intelligence 
and EF than cross-sectional measurements [11]. For example, the correlation between 
prefrontal cortical thickness and IQ is negative in early childhood but becomes positive in 
late childhood through early adulthood. Additionally, the trajectory of these changes in 
cortical thickness are more reflective of IQ than cortical thickness itself [11].  
More recent studies have examined how changes in cortical thickness of specific 
brain regions correlate with EF. For example, in healthy older children, cortical grey 
matter thinning in the inferior frontal gyrus and anterior cingulate cortex is associated 
with age-related improvements in cognitive control, while thinning in the superior parietal 
cortex is associated with improvements in working memory [12]. In contrast, a 
longitudinal study showed that increased rate of cortical thinning in medial cortical 
regions during development is associated with more executive deficits in adulthood [13]. 
237	
	
While age is strongly related to changes in brain structure, this relationship is 
less robust for functional measures of executive function.  In young children, age was 
found to be correlated with increased lateral PFC recruitment during a working memory 
task [14]. In addition, cognitive control studies have shown that children with good task 
performance recruit different prefrontal regions than adults [15]. However, age effects on 
task-induced activation of executive regions during sustained attention and inhibition are 
not completely consistent [16-18]. Cognitive control studies have shown that there is a 
shift from diffuse to focal patterns of activation during development, with increased 
activation in regions necessary for effective task performance [19,20].  
More recently, a large study of 951 youths showed that increased activation of 
executive regions and reciprocal deactivation of default mode network (DMN) regions 
underlie the improvements in WM seen during adolescence (see Figure 1). Executive 
activation and DMN de-activation was more strongly correlated with WM performance 
than chronological age [21], suggesting that executive development may be understood 
as a process of functional (rather than chronologic) maturation.  Notably, multivariate 
pattern regression demonstrated that while both executive activation and DMN de-
activation could be used to predict performance, maximum accuracy required integration 
of features from both networks.   
Studies of resting-state functional connectivity provide evidence regarding the 
development of interacting functional networks, which support EF.  Both cross-sectional 
[22] and longitudinal studies [23] demonstrate that correlations among regions within the 
DMN are weak in childhood but become stronger with age.  Furthermore, a recent study 
in a large cohort of youth found that the DMN’s role as a “cohesive connector” system 
within the functional connectome increased with age, and was correlated with cognitive 
performance [24]. This finding contrasts with a longitudinal study in young adolescents, 
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which found weaker between network correlations between the central executive 
network and the DMN with age [23].  The divergence of these findings may be due to the 
different edge measures used for the network analyses of the two studies: wavelet 
coherence was used as an edge measure in Gu et al., 2015, which quantifies highly 
related, but out-of-phase (anti-correlated) signals as strongly connected, and all values 
range from 0-1.  This contrasts with the commonly-used Pearson’s correlation (as in 
[23]), where out-of-phase signals will be represented with negative values.   
Such developmental changes in resting state connectivity have been associated 
with EF capacity. Hyper-connectivity within the DMN and cingulo-opercular network are 
seen in children with executive deficits [25]. Greater anti-correlation between the DMN 
and lateral frontal cortex is associated with better inhibitory performance in children [25], 
but the relationship between inhibition and strength of anti-correlation between the task-
positive executive system and DMN is also stronger in adults than in children [26]. These 
studies support the idea that the development of functional network topology contributes 
to the maturation of EF during this critical period. 
 
Moderating factors 
Development of EF is influenced by several factors including sex and 
socioeconomic status (SES). Females demonstrate better working memory and attention 
from childhood through adolescence [9], though males show more improvement in these 
domains during adolescence [27]. In contrast, males show better processing speed at 
the beginning of adolescence but improve less [27]. SES also affects multiple domains 
of EF, including sustained attention and inhibition [27]. Inhibitory control and cognitive 
flexibility develop more slowly in preschool-aged children with less access to learning 
resources [1]. In contrast to findings from behavioral studies, a longitudinal neuroimaging 
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study found an interactive effect of SES and sex on both behavior and brain function, but 
no effect of SES or sex alone [28]. Sex differences in EF that are present before puberty 
have been attributed to organizational effects of exposure to gonadal hormones in early 
development on emerging neural circuits, whereas sex differences that first appear 
during puberty may be due to activational effects of differences in gonadal steroid levels 
associated with puberty [29]. 
 
Relevance for psychopathology 
Executive deficits are present in a wide range psychiatric disorders affecting 
children and adolescents including attention deficit hyperactivity disorder (ADHD) [30], 
conduct disorder [31], substance use disorders [32], and psychotic disorders [33,34]. 
Consequences of executive deficits during childhood and adolescence include 
decreased academic achievement, social isolation, low self-esteem, and risk-taking 
behavior [35]. Individuals with these disorders are thus most likely to benefit from 
educational interventions aimed at improving EF. Therefore, understanding how 
psychopathology is related to failures of executive development is critical. 
Recent behavioral studies in neuropsychiatric disorders have examined how 
executive dysfunction impacts academic and social aspects of school performance, with 
most evidence accumulating in ADHD and substance use disorders. Developmental 
trajectories in adolescents with ADHD compared to healthy individuals are delayed for 
inhibition and shifting but similar for WM and planning [36]. In youths with ADHD, those 
with worse EF have more problems with academic performance and peer interactions 
[37]. Additionally, poor EF in adolescence is associated with early and greater use of 
alcohol and other substances [32]. 
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Many neuroimaging studies have examined the relationship between executive 
system dysfunction and neuropsychiatric disorders during development. Case-control 
studies often attribute dysfunction of executive regions such as the dorsolateral 
prefrontal cortex, anterior cingulate, and anterior insula to disorders such as ADHD [38], 
schizophrenia [39], and conduct disorder [40]. However, a recent study of 1,129 youths 
with diverse psychopathology found that overall psychopathology (as measured using a 
bi-factor model, Figure 2A) is associated with reduced recruitment of the executive 
network (Figure 2B) [41]. Such functional data is convergent with recent evidence 
demonstrating grey matter loss in similar regions across several disorders that exhibit 
executive deficits [42]. In contrast, anxious-misery symptoms are associated with 
widespread hyper-activation of the executive network (Figure 2C) [41], suggesting that 
there are both common and dissociable deficits in executive system recruitment among 
neuropsychiatric disorders. Taken together, these studies emphasize the degree to 
which failures of executive function are a central feature of diverse psychopathology that 
often emerge in school-age children and adolescents, and frequently present as 
difficulties within educational environments. 
 
Educational interventions 
Understanding executive development and the factors that moderate it are 
important for developing interventions to improve it. Cognitive remediation has been 
shown to significantly improve multiple executive domains in patients with schizophrenia 
[43] and ADHD [44]. These improvements in EF are correlated with changes in brain 
activation such that cognitive remediation diminishes the degree of hypoactivation 
observed in psychosis [45]. However, the majority of recent studies proposing 
educational interventions that would improve EF, such as music and physical education 
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classes, do not include a neuroimaging component, and thus brain-based data are 
limited. Two recent exceptions include one study that demonstrated improved EF and 
increased task-induced prefrontal activation in healthy young adults following exercise 
[46].  Another recent study suggested that musically trained children exhibit better verbal 
fluency and processing speed as well as increased activation of executive regions [47]. 
While cognitive training [48], neurofeedback training [49], and mindfulness training [50] 
are additional methods that have shown early positive results in improving executive 
deficits, the impact of these interventions on brain function has not yet been evaluated. 
Given the paucity of studies in this area, it is clear that more work is needed to 
understand how proposed educational interventions may impact EF at a neural level.  
 
Limitations of current research 
While much progress has been made regarding our understanding of executive 
system development, there are several limitations that should be noted.  First, many of 
the studies investigating EF in development are cross-sectional, and thus are unable to 
delineate the longitudinal developmental trajectory of EF. While cross-sectional studies 
are often the basis of longitudinal inferences regarding development, factors such as the 
selection of time points, trajectory of developmental process, and test-retest reliability of 
methods employed affect the extent to which cross-sectional findings accurately 
represent longitudinal processes [51]. Many of the few longitudinal neuroimaging studies 
suffer from relatively small sample sizes or relatively brief longitudinal follow-up. 
Furthermore, existing work has used a variety of tasks to probe EF, and results may not 
be generalizable across tasks or executive domains. Additionally, task difficulty likely 
decreases with age, and the strategies used to perform such tasks evolve during 
development [7], limiting the ability to similarly probe EF across age groups. 
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Similarly, few studies evaluate the impact of educational interventions on brain 
measures of EF. As such, it is not known how such interventions lead to improvements 
in EF or whether they produce lasting neural changes that affect the course of executive 
system development. Additionally, methods of assessing EF and task paradigms vary 
across studies, limiting replication of existing results.   
 
Future directions 
Studies reviewed here emphasize that EF undergoes an extended maturational 
period throughout childhood and young adulthood. It is clear from both behavioral and 
neuroimaging studies that different domains of EF exhibit different developmental 
trajectories. However, charting these trajectories remains incomplete. Large longitudinal 
neuroimaging studies that consistently account for factors that would affect the course of 
development are necessary in determining how the executive system develops normally 
and abnormally in association with performance deficits. Determining the normal 
developmental trajectory of the executive system is a necessary step in identifying both 
abnormal development in youth at risk for poor outcomes as well as critical periods 
where interventions might be most effective. Notably, the Adolescent Brain Cognitive 
Development (ABCD) initiative will provide detailed cognitive and clinical phenotyping in 
concert with longitudinal multi-modal neuroimaging on a large cohort of 10,000 youth 
followed over 10 years. This landmark study has the potential to provide data that may 
transform our understanding regarding how the executive system develops during youth.   
Additionally, it is evident that there are several factors that moderate the 
development of EFs. Preliminary studies indicate cognitive remediation [43,44], cognitive 
training [48], music classes [47], and physical education [46] may be ways to improve EF 
during development. However, more information regarding their impact and mode of 
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action are needed before these factors can be used to inform the implementation of 
educational strategies that can facilitate EF development. For example, while several 
studies have identified factors that correlate with better or worse EF, the optimal time 
periods for implementation remain unclear. Similarly, the mechanisms by which 
educational interventions exert their effects are yet to be determined. Incorporating 
brain-based measurements within such studies may be an important step in 
understanding the mechanisms of interventions that have the potential to produce long-
term benefits for academic achievement.  
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FIGURE LEGENDS 
 
Figure 1. Brain response to WM load is more significantly related to WM performance 
than subject age. In a sample of 951 youths ages 8-22 imaged as part of the 
Philadelphia Neurodevelopmental Cohort using a fractal version of the n-back working 
memory task, working memory load was associated with executive activation and 
reciprocal de-activation of non-executive regions including the default mode network 
(DMN).  This pattern of activation was weakly associated with chronological age (A), but 
strongly associated with WM performance (B).  The complex multivariate pattern of brain 
response could be used to predict WM performance with a relatively high degree of 
accuracy using a cross-validated multivariate pattern regression (C), which included 
features from both the executive and default mode system (D).  Notably, while both 
executive and non-executive regions could predict WM performance, maximally accurate 
predictions required the combined feature set which spanned both networks (E).  All 
data from Satterthwaite et al., 2013.   
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Figure 2.   Psychopathology is associated with common and dissociable patterns of 
executive dysfunction.  In a sample of 1,129 youths imaged as part of the Philadelphia 
Neurodevelopmental Cohort, a bifactor factor analysis identified common and divergent 
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dimensions of psychopathology across categorical screening diagnoses (A). When 
these dimensions of psychopathology were related to activation during a fractal version 
of the n-back working memory task, overall psychopathology across categorical 
screening diagnoses was associated with hypo-activation of the executive system (B), 
whereas anxious-misery symptoms (depression, anxiety) were associated with elevated 
activation of the executive system (C).  All data from Shanmugan et al., 2016. 
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